Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.7786531301663759,-2.2480485379925343,0.0,0.0,0.0,9/22,13.51%,ALDH1A2;PTGDS;NR2F2;ABCA4;RBP4;RXRA;RBP1;RARA;CYP26B1
prerank,retinoic acid binding (GO:0001972),-0.8160107065761961,-2.0151070292775035,0.0,0.019270886467813258,0.028,4/12,13.51%,NR2F2;RXRA;RARA;CYP26B1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.5417684500422169,-2.004299574022754,0.0,0.015572433509344048,0.033,23/60,10.93%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;NRP1;AXL;RYK;EPHA7;ROR1;EFEMP1;KIT;CRIM1;DDR1;PDGFRA;EPHB4;NRP2;EPHB2;EPHA3;IGF2R
prerank,platelet-derived growth factor binding (GO:0048407),-0.8239000109300483,-1.9901399209246773,0.0,0.014891139543310243,0.043,7/11,6.19%,COL1A2;COL1A1;PDGFRB;COL3A1;COL5A1;COL6A1;PDGFRA
prerank,cation channel activity (GO:0005261),-0.4925023822590181,-1.96958615543083,0.0,0.01354801715312932,0.05,42/94,28.97%,TRPM3;SLC24A3;HCN1;NALCN;MCU;CACNA1D;PKD1;UNC80;ANXA2;TRPM6;TRPC5;SEC61A1;PIEZO2;KCNK5;TRPC1;KCNA1;SLC24A2;ANO1;KCNK10;TMEM63A;ABCC9;TMCO1;ANO6;TMEM63B;TMEM38A;KCNQ4;ANO10;KCNA2;GRIN1;TRPC6;MCOLN1;ANXA6;PANX1;CALHM5;KCNK9;CHRNA7;TRPV2;SLC24A4;KCNK1;TRPC3;TMEM63C;CACNA1E
prerank,voltage-gated cation channel activity (GO:0022843),-0.47712967361044206,-1.9318575919251106,0.0,0.018102953954612453,0.078,40/97,28.97%,CACNA2D3;KCNQ3;KCNB2;CACNA1C;HCN1;KCNH7;KCNQ5;KCNMA1;CACNA1D;CACNB4;GRIN2B;KCNC2;KCND2;CACNA1B;KCNH5;KCNA1;CACNG7;CACNG4;KCNS3;OPRM1;KCNQ4;CACNG2;NCS1;KCNA6;KCNA2;GRIN2D;GRIN1;CACNA2D1;KCNC1;CACNG3;CACNG8;CACNB1;KCNC3;HCN2;KCNQ1;CACNA2D2;KCNQ2;KCNK1;LRRC38;CACNA1E
prerank,nucleotidyltransferase activity (GO:0016779),0.6899307102798952,1.7971967727430258,0.005484460694698354,0.8270282762571391,0.544,9/19,15.07%,THG1L;MOCS3;NUDT5;TENT4A;TERT;CRPPA;TUT7;PAPSS1;TUT4
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4821765258722883,-1.7830586225121066,0.0027100271002710027,0.12246606638419853,0.46,21/60,12.18%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;TGFBR2;AXL;RYK;EPHA7;ROR1;KIT;DDR1;PDGFRA;EPHB4;ACVR1;EPHB2;EPHA3;ACVR1B
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.5594781341961865,-1.779547632106618,0.002369668246445498,0.11168354657482682,0.471,13/32,28.07%,KCNQ3;KCNB2;KCNQ5;KCNC2;KCNA1;KCNS3;KCNQ4;KCNA6;KCNA2;KCNC1;KCNC3;KCNQ1;KCNQ2
prerank,solute:sodium symporter activity (GO:0015370),0.605418757685654,1.762406441923123,0.00338409475465313,0.6363792819438605,0.697,3/27,0.83%,SLC5A7;SLC4A4;SLC4A5
prerank,voltage-gated potassium channel activity (GO:0005249),-0.4381977887130794,-1.7230837193624877,0.0,0.18777759406684028,0.718,28/80,29.44%,KCNK2;KCNQ3;KCNB2;HCN1;KCNH7;KCNQ5;KCNMA1;KCNC2;KCND2;KCNH5;KCNJ2;KCNA1;KCNJ6;KCNJ13;KCNS3;KCNQ4;KCNJ10;KCNA6;KCNA2;KCNT1;KCNC1;KCNC3;HCN2;KCNQ1;KCNQ2;KCNK1;LRRC38;KCNJ12
prerank,glycine binding (GO:0016594),-0.7192509253909116,-1.7151999726138871,0.014141414141414142,0.18546768309628758,0.751,5/11,7.73%,GRIN2B;GLRB;SRR;GLRA3;GLRA1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.6887792865938798,1.7148747765928618,0.0037735849056603774,0.5565008838635286,0.886,7/16,6.45%,PTPRR;PTPRG;PTPRC;PTPRM;PTPRB;PTPRE;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.6887792865938798,1.7148747765928618,0.0037735849056603774,0.5565008838635286,0.886,7/16,6.45%,PTPRR;PTPRG;PTPRC;PTPRM;PTPRB;PTPRE;PTPRT
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.7231978388775527,1.711002727461587,0.01,0.4617942306699415,0.897,9/12,16.46%,CNOT2;CNOT7;PAN3;PAN2;CNOT6;CNOT1;CNOT6L;NOCT;PARN
prerank,organic cation transmembrane transporter activity (GO:0015101),0.6704612517397267,1.6952186548361352,0.019197207678883072,0.4533797843159912,0.937,4/16,7.94%,SLC5A7;SLC7A8;SLC44A1;SLC25A26
prerank,gap junction channel activity (GO:0005243),-0.5739609981531374,-1.673999818168859,0.009324009324009324,0.2598118963456696,0.877,5/22,11.17%,GJB6;GJC1;GJD3;GJA1;GJB2
prerank,R-SMAD binding (GO:0070412),-0.5944996990134905,-1.6727167912697907,0.013186813186813187,0.24117806397596592,0.88,7/18,12.13%,DDX5;LDLRAD4;SMAD3;SMAD4;SMAD6;RANBP3;PPM1A
prerank,solute:anion antiporter activity (GO:0140323),-0.6422791364509434,-1.662798148686183,0.00684931506849315,0.24319948563342886,0.902,6/14,20.02%,SLC7A11;SLC26A7;SLC26A2;SLC26A11;SLC4A2;SLC4A3
prerank,calcium channel activity (GO:0005262),-0.4208900681696751,-1.6580419201628818,0.006230529595015576,0.23775769018730644,0.911,36/84,28.97%,CACNA2D3;SLC24A3;CACNA1C;STIM2;MCU;CACNA1D;CACNB4;PKD1;ANXA2;TRPC5;P2RX4;SEC61A1;CACNA1B;TRPC1;SLC24A2;CACNG7;TMCO1;CACNG4;OPRM1;CACNG2;NCS1;GRIN1;CACNA2D1;TRPC6;MCOLN1;ANXA6;PANX1;CACNG3;CACNG8;CACNB1;CHRNA7;TRPV2;SLC24A4;CACNA2D2;TRPC3;CACNA1E
prerank,wide pore channel activity (GO:0022829),-0.5675430304939147,-1.6526738569296695,0.014423076923076924,0.23327505396997383,0.917,5/23,11.17%,GJB6;GJC1;GJD3;GJA1;GJB2
prerank,metalloendopeptidase activity (GO:0004222),-0.43210988835937053,-1.6522042089898674,0.0,0.2202282745204265,0.918,28/76,20.60%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;MMP16;ADAMTS6;ADAMTSL5;ADAMTS17;MMP14;ADAMTS9;ADAM19;ADAMTS5;NLN;ADAMTS1;ADAMTSL4;ADAMTS3;AFG3L2;ADAMTS10;MBTPS2;PITRM1;ADAMTS15;ADAMTS16;SPG7;MMP2;ADAM33;ADAMTS20
prerank,potassium channel regulator activity (GO:0015459),-0.4591162663470191,-1.6503676334816946,0.0027548209366391185,0.2107087657639332,0.92,15/49,13.20%,DPP6;KCNIP4;KCNIP1;WNK1;FLNA;KCNIP3;ENSA;AKAP9;ARPP19;WNK4;SGK1;DPP10;ABCC9;DLG1;WNK3
prerank,alanine transmembrane transporter activity (GO:0022858),0.702233898198775,1.642278676551239,0.013207547169811321,0.6463404397155199,0.986,4/12,5.53%,SLC7A8;SLC36A4;SLC3A2;SLC6A6
prerank,monocarboxylic acid binding (GO:0033293),-0.5937067239091363,-1.629295240383328,0.022540983606557378,0.24013990174200964,0.951,6/18,13.51%,NR2F2;PSAP;NAPEPLD;RXRA;RARA;CYP26B1
prerank,leak channel activity (GO:0022840),-0.5822509484345164,-1.624071435336671,0.02959830866807611,0.23813529242841647,0.96,4/18,10.34%,KCNK2;NALCN;KCNK5;KCNK10
prerank,phosphatase binding (GO:0019902),-0.39072449050520686,-1.6184816776362296,0.006968641114982578,0.23930937195484464,0.967,45/105,21.96%,MAGI2;EGFR;SMAD3;IQGAP1;AP3B1;JAK1;MAPK14;DLG4;SYTL2;CTNNB1;WNK1;PXN;VCP;MYO16;CRY2;ELL;STAT6;CDKN1B;DLG3;MAP3K5;TP53;CRY1;IKBKE;KIF3A;SIRPA;VRK3;DLG1;RACK1;PTK2;MTMR9;PPME1;MTMR4;NFATC2;TRAF2;FBXL2;TSC2;SNX3;CNST;SHOC2;MET;PIK3R1;PPP6R3;ITGA1;SH3RF2;PDLIM4
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5949214335013449,-1.6152931594379114,0.015217391304347827,0.23542182516090485,0.968,7/18,16.87%,PDLIM5;ANXA2;ANXA1;BAIAP2L1;PDLIM1;S100A11;CDC42EP1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.6902258332705525,-1.6132531817572424,0.013636363636363636,0.22891477258735748,0.969,4/11,8.30%,AKAP13;KSR1;IQGAP1;MAP2K2
prerank,acid-thiol ligase activity (GO:0016878),-0.6282438559941544,-1.595563069394913,0.017543859649122806,0.25420305048187924,0.978,6/13,27.58%,ACSL1;ACSS3;ACSS2;AASDH;AACS;ACSS1
prerank,poly(A) binding (GO:0008143),-0.5514009399579033,-1.589242443697115,0.02702702702702703,0.25655584206644316,0.983,7/21,7.46%,RBMS1;TIA1;KHDRBS1;KHDRBS2;HNRNPDL;ELAVL4;DDX1
prerank,metallopeptidase activity (GO:0008237),-0.38643794541481546,-1.5879117013150443,0.0,0.24956381942074768,0.983,37/113,20.75%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;ADAM12;THSD4;ADAM23;MMP16;PAPPA;ADAMTS6;ADAMTSL5;ADAMTS17;MMP14;ADAMTS9;RNPEP;ADAM19;ADAMTS5;ANPEP;NLN;ADAMTS1;ADAMTSL4;ADAMTS3;AFG3L2;ADAMTS10;MBTPS2;LAP3;ACE;PITRM1;ADAMTS15;ADAMTS16;SPG7;MMP2;COPS5;ADAM33;ADAMTS20;MYSM1
prerank,estrogen receptor binding (GO:0030331),0.5490327335527073,1.5860521408570751,0.024916943521594685,0.9285312130443013,0.999,11/32,10.52%,DCAF1;ARID5A;LEF1;DDX54;RERG;SRARP;CCDC62;PHB2;WBP2;ESR1;TACC1
prerank,poly-purine tract binding (GO:0070717),-0.517246423248781,-1.5787261707413793,0.028985507246376812,0.2591462564867475,0.993,11/27,16.13%,RBMS1;TIA1;KHDRBS1;KHDRBS2;HNRNPDL;ELAVL4;DDX1;ATXN1;DAZAP1;PABPC4;RBMS3
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.5441657016158753,-1.5785871051572056,0.02386117136659436,0.24985104430547558,0.993,8/21,9.54%,ARFGEF2;AKAP6;WASF2;PRRC1;WASF1;AKAP9;EZR;PRKACA
prerank,adenylate cyclase binding (GO:0008179),-0.6769022723943625,-1.5782279456577177,0.02127659574468085,0.2420123014853951,0.993,4/10,2.65%,ADCY5;AKAP6;AKAP12;ADCY2
prerank,ion channel activity (GO:0005216),-0.404466676702992,-1.5510580876855513,0.003048780487804878,0.28827796308590864,0.998,33/80,28.79%,TRPM3;GABRB1;NALCN;GRIA4;GRIA2;GRID2;GRIN2B;UNC80;TRPM6;PIEZO2;GRID1;TRPC1;TMEM63A;ABCC9;GRIK4;TMEM63B;TMEM120B;GRIK1;GRIK3;MCUB;GRIN2D;GRIN1;TMEM120A;TRPC6;MCOLN1;ANXA6;CALHM5;CHRNA7;TRPV2;LRRC8A;GRIA1;TMC4;TMC6
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.4600313269594588,-1.5505929999060324,0.013761467889908258,0.27979769907913915,0.998,16/42,17.32%,LRRC4C;CNTN4;PDLIM5;CNTN6;NTNG1;ANXA2;DSCAM;JAM3;PALLD;ANXA1;BAIAP2L1;SIRPA;PDLIM1;S100A11;CDC42EP1;NEXN
prerank,CoA-ligase activity (GO:0016405),-0.5998882002871386,-1.542803560753854,0.026373626373626374,0.28893143366893426,0.998,3/14,6.30%,ACSL1;ACSS3;ACSS2
prerank,voltage-gated calcium channel activity (GO:0005245),-0.46181506102132097,-1.5374353884584209,0.029333333333333333,0.2933700481596268,0.998,15/37,24.82%,CACNA2D3;CACNA1C;CACNA1D;CACNB4;CACNA1B;CACNG7;CACNA1G;CACNG4;OPRM1;CACNG2;NCS1;CACNA2D1;CACNG3;CACNG8;CACNB1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6576194011523049,-1.5300459488935516,0.03143418467583497,0.3005833586246795,0.998,3/10,7.64%,SLC6A13;SLC6A1;SLC6A12
prerank,ATPase activator activity (GO:0001671),-0.5410073274727331,-1.501864650362053,0.035046728971962614,0.3601697764973654,1.0,7/20,9.45%,TOR1AIP2;ATP1B1;DNAJC24;ATP1B3;DNAJC19;TOR1AIP1;ATP1B2
prerank,potassium:proton antiporter activity (GO:0015386),0.663713247446405,1.4988872351019635,0.06019417475728155,1.0,1.0,3/10,6.96%,SLC9A7;SLC9A6;SLC9A8
prerank,translation elongation factor activity (GO:0003746),0.6091160096220503,1.4971907626535916,0.053604436229205174,1.0,1.0,6/14,13.37%,EIF5AL1;EIF5A;EEF1A1;TSFM;GTPBP2;EEF1B2
prerank,RNA polymerase II complex binding (GO:0000993),-0.459563334135367,-1.492987291936236,0.029490616621983913,0.3727373192129421,1.0,16/32,27.53%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;BRD4;WDR43;PAF1;SMYD2;RTRAF;PCIF1;GTF2B;ZNF326;SUPT4H1;SCAF1
prerank,GTP binding (GO:0005525),0.39122010436366966,1.4873835927865153,0.003926701570680628,1.0,1.0,35/172,12.99%,PCK1;THG1L;RAC2;ARF5;RALB;EEF1A1;RAP2A;ARL5C;ARL4D;RERG;NRAS;TUBB;NME1;ATL1;GBP3;RRAD;RAB7A;RAB11B;RALA;GBP4;RAB6A;RAB14;RANBP17;ARL5B;ARF1;RHOQ;MFHAS1;RHOG;DRG2;GNAI1;RAB22A;LANCL2;RAP2C;RIT1;RRAGC
prerank,damaged DNA binding (GO:0003684),0.4782536869496985,1.4776566348886009,0.046104928457869634,1.0,1.0,14/44,13.19%,ERCC3;RAD18;PNKP;ERCC4;RAD1;XRCC1;EP300;TDG;DCLRE1B;CREBBP;APTX;RPS3;NBN;MPG
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.47796807533023944,-1.4757216334931749,0.038461538461538464,0.4113069000655496,1.0,13/27,27.15%,SLC22A8;SLC26A7;SLC39A14;SLC26A2;ANKH;ANO1;SLC39A8;SLC22A6;SLC26A11;SLC5A5;SLC25A30;SLC25A11;LRRC8A
prerank,hexosaminidase activity (GO:0015929),-0.5996722346269786,-1.4753825687633844,0.07439824945295405,0.4009480752074759,1.0,7/12,29.56%,CEMIP;CEMIP2;HEXA;HEXB;HEXD;HYAL1;NAGA
prerank,deoxyribonuclease activity (GO:0004536),0.6172302046739552,1.4753471884790448,0.059674502712477394,1.0,1.0,5/14,5.73%,ZRANB3;NME1;MAP1S;ERCC4;APLF
prerank,neurexin family protein binding (GO:0042043),-0.6192074523534327,-1.4664669826768109,0.0577319587628866,0.41596838509630724,1.0,6/10,25.98%,SYTL2;NLGN2;NLGN1;SYTL5;NLGN3;SYTL4
prerank,phospholipase inhibitor activity (GO:0004859),-0.6260211796439733,-1.4649520302448094,0.06560636182902585,0.40982452418341014,1.0,4/10,12.40%,ANXA2;ANXA4;ANXA1;ANXA5
prerank,cysteine-type peptidase activity (GO:0008234),-0.37216929505327595,-1.4580011483527966,0.017142857142857144,0.4189373924851282,1.0,40/73,28.43%,USP40;USP29;CAPN2;MALT1;USP13;PDIA3;USP11;LGMN;OTULIN;CTSO;USP38;USP50;USP34;USP20;USP7;CASP7;USP10;USP1;USP16;CTSZ;USP42;OTULINL;USP5;CASP2;GGH;USP35;USP49;USP2;USP46;CASP9;CASP3;USP24;ATG4D;OTUD7B;CTSK;SFRP1;CTSF;CTSB;CTSC;UCHL1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.44952778661776704,-1.4486528302463477,0.045454545454545456,0.4364364398719393,1.0,14/34,18.32%,IQGAP1;OGT;ADAP2;ZFYVE16;CYTH3;PLEKHB2;GAB2;HIP1R;FCHSD2;DAPP1;COMMD1;IQGAP2;MYO1B;ARAP3
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6045173226444736,-1.446857306001021,0.05567010309278351,0.4317457190465637,1.0,2/11,2.09%,KCNK2;KCND2
prerank,protein tyrosine kinase activity (GO:0004713),-0.3492984205042481,-1.4465745048472005,0.013289036544850499,0.422682924893742,1.0,25/108,11.07%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;JAK1;AXL;RYK;FER;EPHA7;ROR1;KIT;TEC;DDR1;PDGFRA;HIPK3;FRK;EPHB4;EPHB2;CSK;EPHA3;HIPK1
prerank,chloride channel regulator activity (GO:0017081),-0.563452752593911,-1.4460050795823438,0.05733944954128441,0.4148283935523217,1.0,8/14,26.54%,WNK1;STX8;WNK4;SGK1;WNK3;STX1A;VAMP8;CHRNA7
prerank,potassium ion leak channel activity (GO:0022841),-0.5496835581629886,-1.4459619081418882,0.07203389830508475,0.40568784697426136,1.0,3/15,10.34%,KCNK2;KCNK5;KCNK10
prerank,zinc ion binding (GO:0008270),0.360839180137866,1.4456089133461845,0.0024242424242424242,1.0,1.0,61/293,15.30%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;LVRN;TRIM28;ARIH1;SOD1;TAB2;SHANK3;MYRIP;DUSP12;TRIM8;BIRC2;NUDT12;PHF5A;CA2;SIRT3;MME;MMP12;QPCTL;HPF1;KDM2A;CHMP1A;ZNF205;BMI1;TET3;ZNF3;TAB3;WDFY1;ESCO1;MDM2;MYCBP2;ZDHHC15;NQO2;RBSN;ACER3;TNKS;PAM;CHD3;HHIP;RNF11;CZIB;USP33;CSRP1;ZKSCAN5;PGGT1B;KDM5C;PHF8;GCH1;GRIN2A;MT2A;QPCT;CRIP2;S100A13;CLIP1;PTGR2
prerank,metal ion binding (GO:0046872),0.35014616594354453,1.442966763171827,0.0,1.0,1.0,79/477,13.17%,PCK1;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;THG1L;SPOCK2;EFHD2;LCP1;MAP2K7;GCLC;SNRK;CSGALNACT1;EML1;RAP2A;SLC25A24;OXSR1;CABYR;ASTN2;CETN3;PPP3CB;ADGRL3;NUCB2;LTBP4;MEX3B;NUDT5;NME1;NUDT12;ATP2A2;CDH2;ITSN1;ESYT2;MMP12;EFHD1;SDF4;APOE;RASGRP3;CIB1;TDG;RET;SELP;MCTP2;SIK3;CALM3;CDH12;UBA2;RCN2;AIF1L;DXO;EXD2;NIM1K;S100A16;TRPM4;PAPOLA;SRPK2;NLK;MCTP1;PGP;GNAI1;ACER3;PAM;PPP3CA;PRNP;PPP3R1;AGRN;MICU3;ADPRH;LETM1;IDS;SLC25A12;CDH5;MAPK12;HSPE1;RRAGC;GSS
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.6122513609870308,-1.437925392472713,0.06995884773662552,0.41855146695902706,1.0,2/11,1.57%,ITPR1;RYR3
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5929553947818429,1.437404949812398,0.09236234458259325,1.0,1.0,3/13,9.94%,EBP;ECH1;IDI1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4797218464011246,1.437244657038278,0.05650684931506849,1.0,1.0,15/34,16.46%,REXO2;CNOT2;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN3;PAN2;CNOT6;CNOT1;CNOT6L;NOCT;ERI2;PARN
prerank,cAMP response element binding (GO:0035497),-0.6126261354924574,-1.433454597780193,0.06875,0.4224933742434055,1.0,7/10,29.16%,CREB5;ATF7;CREB3L2;E4F1;JUN;CREB3L1;HMGA2
prerank,ligand-gated anion channel activity (GO:0099095),-0.5322553570210469,-1.431439026834336,0.09482758620689655,0.4187768017645631,1.0,11/17,24.43%,GABRB1;GLRB;GABRA2;GLRA3;GABRG2;GLRA1;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,potassium channel activity (GO:0005267),-0.36499511675530927,-1.4313412838828568,0.01730103806228374,0.4105163607113763,1.0,23/89,20.95%,KCNK2;KCNQ3;KCNB2;HCN1;KCNH7;KCNQ5;KCNMA1;KCNC2;KCND2;KCNH5;KCNK5;KCNA1;KCNK10;ABCC9;GRIK4;TMEM38A;KCNS3;KCNQ4;KCNA6;KCNA2;GRIK1;GRIK3;KCNT1
prerank,phospholipase C activity (GO:0004629),-0.4775338492639248,-1.4287329851513146,0.0475,0.4087530209700172,1.0,10/25,19.65%,PLCE1;PDIA3;EDNRA;PLCD3;CHRM3;PLCB3;PLCH1;PLCL1;PLCD1;BDKRB2
prerank,tRNA binding (GO:0000049),0.4643154594589027,1.4286320114952646,0.05149501661129568,1.0,1.0,11/43,16.27%,THG1L;EEF1A1;EIF2A;FARS2;YARS2;ELP1;TRMT10B;TERT;PTCD1;SSB;NSUN6
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.568707775863908,-1.4280512634757263,0.10129310344827586,0.40238710175394743,1.0,10/13,24.43%,GLRB;GABRA2;GLRA3;GABRG2;GLRA1;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,general transcription initiation factor binding (GO:0140296),0.5197160810325454,1.4215781809180077,0.055970149253731345,1.0,1.0,12/25,15.70%,RUVBL2;PSMC1;DRAP1;RUVBL1;RELA;PSMC2;ESR1;GTF2A2;TBP;THRA;DR1;TAF1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5688073862389924,-1.4213683976360612,0.07296137339055794,0.41306628558223035,1.0,4/13,4.74%,BMP6;BMP5;BMP7;BMP4
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5870724679221554,-1.4207942046524957,0.08577405857740586,0.40659476983147225,1.0,8/11,32.76%,ITPR1;TRPC5;TRPC1;ITPR2;RPH3A;TRPC6;TRPC3;TRPC7
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.43674604092520003,-1.4198914341268618,0.04864864864864865,0.40127133180397234,1.0,15/33,26.44%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;WDR43;PAF1;SMYD2;RTRAF;SPTY2D1;GTF2B;ERBB2;ZNF326;SUPT4H1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.6364799917492622,1.417264760219369,0.09210526315789473,1.0,1.0,4/10,18.78%,NAA25;NAA80;NAA15;NAA50
prerank,transmitter-gated ion channel activity (GO:0022824),-0.4576232732719488,-1.4151491163948984,0.05128205128205128,0.40622816322784305,1.0,17/29,24.43%,GABRB1;GRIA4;GRIA2;GRID2;GABRA2;GLRA3;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GRIN2D;GABRG1;GABRA1
prerank,acetylcholine receptor activity (GO:0015464),0.5306266096295392,1.4132217769047613,0.08547008547008547,1.0,1.0,1/22,0.03%,HRH4
prerank,protease binding (GO:0002020),-0.3512550911387091,-1.4122849464405887,0.010309278350515464,0.40604425177690084,1.0,27/99,12.39%,COL1A2;SLC2A13;TIMP3;COL1A1;CFLAR;TIMP2;NTRK2;COL3A1;PSAP;ANXA2;STIM1;ATP9A;F3;VCP;DPP4;LDLR;ADAMTSL4;CCBE1;BIN1;FAP;DVL3;GSK3B;UBC;FN1;TP53;SRI;ECM1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6065730424466397,-1.4113764278100354,0.06720977596741344,0.40111310313015663,1.0,4/10,6.12%,CACNA1C;CACNA1D;CACNB4;CACNA1B
prerank,tropomyosin binding (GO:0005523),-0.5449911189095553,-1.4092054506949205,0.08714596949891068,0.3999363387013993,1.0,2/16,2.45%,CALD1;TMOD2
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5079177443116258,-1.4090345483477646,0.07142857142857142,0.3937120297466234,1.0,4/19,4.75%,ITPR1;GRIN2B;RYR3;P2RX4
prerank,BMP receptor binding (GO:0070700),-0.5688103422871442,-1.4016933262921043,0.08977035490605428,0.4049805989523786,1.0,4/12,4.74%,BMP6;BMP5;BMP7;BMP4
prerank,pyrophosphatase activity (GO:0016462),0.4447106922784635,1.3977155767630898,0.0685805422647528,1.0,1.0,9/50,10.80%,NUDT14;BNIPL;NUDT11;FITM2;NUDT5;PLPP1;DXO;PRUNE1;DDX3X
prerank,anion:anion antiporter activity (GO:0015301),-0.49755310089758287,-1.3941408680368326,0.08294930875576037,0.4171625179937558,1.0,8/17,31.44%,SLC26A7;SLC26A2;SLC26A11;SLC4A2;SLC19A1;SLC4A3;SLC25A11;SLC25A5
prerank,glutathione transferase activity (GO:0004364),-0.4708566206664858,-1.392858212065026,0.07373271889400922,0.4135611354001684,1.0,14/23,40.22%,GSTT1;GSTZ1;GSTT2;PTGES;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;LANCL1;GSTM5;GSTO1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.597749878265049,1.3883185500909008,0.10588235294117647,1.0,1.0,1/12,0.99%,GPR52
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5753216094118708,1.3874359757367296,0.11708253358925144,1.0,1.0,1/14,0.03%,CAPN8
prerank,guanyl ribonucleotide binding (GO:0032561),0.3603757141723962,1.3864253713792858,0.01020408163265306,1.0,1.0,37/196,12.99%,PCK1;THG1L;RAC2;ARF5;RALB;EEF1A1;RAP2A;ARL5C;ARL4D;RERG;RAB5C;NRAS;TUBB;NME1;ATL1;GBP3;RRAD;RAB7A;RAB11B;RALA;GBP4;RAB6A;RAB14;RANBP17;ARL5B;ARF1;RHOQ;MFHAS1;RHOG;DRG2;GNAI1;RAB5B;RAB22A;LANCL2;RAP2C;RIT1;RRAGC
prerank,ephrin receptor activity (GO:0005003),-0.5067173204139598,-1.3846856997242865,0.08791208791208792,0.42103967100888967,1.0,6/17,10.80%,EPHA6;EPHB1;EPHA7;EPHB4;EPHB2;EPHA3
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5067173204139598,-1.3846856997242865,0.08791208791208792,0.42103967100888967,1.0,6/17,10.80%,EPHA6;EPHB1;EPHA7;EPHB4;EPHB2;EPHA3
prerank,sodium:proton antiporter activity (GO:0015385),0.5954142919592799,1.3838671134465075,0.11259541984732824,1.0,1.0,3/11,6.96%,SLC9A7;SLC9A6;SLC9A8
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4946965262560022,1.3835612135415127,0.08561643835616438,1.0,1.0,7/27,13.47%,POLR2J;POLR2B;POLR1D;POLR1C;TERT;POLR3F;POLR3B
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4563924790502311,1.3802451958036221,0.0757825370675453,1.0,1.0,14/37,17.80%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;NARS2;RARS2;EARS2;WARS2;LARS1;HARS2;WARS1;IARS2
prerank,peptidase inhibitor activity (GO:0030414),-0.42422226926117257,-1.374958831963604,0.08,0.4389629430383943,1.0,8/33,18.36%,TIMP2;TFPI;GPC3;PSMF1;ITIH2;RENBP;CAST;SERPIND1
prerank,sterol transfer activity (GO:0120015),-0.5019465379530365,-1.369739607680221,0.11283185840707964,0.4459909565181795,1.0,7/17,18.71%,GRAMD1B;GRAMD1C;OSBP;ABCA1;STARD5;GRAMD1A;MTTP
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.46594038831765944,1.3681785685805479,0.09044368600682594,1.0,1.0,10/32,17.97%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6;SFXN1;SLC38A5;SLC25A38;SLC7A5;SLC43A2
prerank,ligand-gated ion channel activity (GO:0015276),-0.43135003437389585,-1.3681745771493141,0.07623318385650224,0.4435528775879768,1.0,5/30,1.54%,GABRB1;GRIA4;GRIA2;GRID2;GRIN2B
prerank,ligand-gated channel activity (GO:0022834),-0.4325687475006243,-1.3670178459966542,0.07317073170731707,0.4404479613017854,1.0,5/29,1.54%,GABRB1;GRIA4;GRIA2;GRID2;GRIN2B
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.40744324053843567,-1.3653704033965413,0.06763285024154589,0.4381947377064116,1.0,17/35,18.86%,MPPED2;PLCXD3;PLCE1;ENPP1;PDIA3;NAPEPLD;TDP2;ENPP6;SMPD3;PLCB3;PDE11A;PLCL1;GPLD1;PLD3;APEX2;ENPP3;GDPD3
prerank,solute:proton symporter activity (GO:0015295),-0.5108279499026058,-1.3652735092052593,0.10666666666666667,0.43213502988429725,1.0,10/16,36.93%,SLC2A13;SLC25A3;CTNS;SLC39A8;SLC15A4;SLC11A2;SLC2A10;SLC36A1;SLC17A5;SLC2A9
prerank,ephrin receptor binding (GO:0046875),0.5104364750875614,1.3649460509149036,0.0974264705882353,1.0,1.0,6/21,9.31%,PIK3CG;CBL;SRC;FYN;EFNA1;LYN
prerank,rRNA binding (GO:0019843),0.4413611590009611,1.3637679418294744,0.0718954248366013,1.0,1.0,11/42,11.52%,RPL23;FASTKD2;MRPL18;RPS14;RPL5;EMG1;RPLP0;NGRN;MDM2;RPS9;RPS3
prerank,glucuronosyltransferase activity (GO:0015020),0.5244123915402454,1.3613066851893763,0.11510791366906475,1.0,1.0,3/19,9.20%,CSGALNACT1;EXT2;B3GAT2
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3389727060950039,-1.3610523179113514,0.037162162162162164,0.4360994205276972,1.0,34/100,21.96%,PLA2G4A;IQGAP1;OGT;ADAP2;MAPT;WIPI1;SNX21;GAP43;PLEKHA8;CLVS2;ZFYVE16;CYTH3;OSBP;OSBPL5;PLEKHB2;GAB2;HIP1R;RNF34;FCHSD2;DAPP1;COMMD1;IQGAP2;MYO1B;ARAP3;SNX3;ARFIP2;BBS5;SAP30L;SNX11;GSDMD;OSBPL8;ATG2A;SH3PXD2B;RPH3A
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.575594131305725,-1.360320792376766,0.08898305084745763,0.43197281703524165,1.0,1/11,0.75%,HCN1
prerank,insulin-like growth factor binding (GO:0005520),-0.5088656616611588,-1.3598302082138858,0.10089686098654709,0.4273833044538776,1.0,6/15,16.08%,IGFBP5;IGFBP2;IGFBP6;IGF2R;IGFBP4;ITGB4
prerank,TBP-class protein binding (GO:0017025),0.5112373700984564,1.3579653800348745,0.12098298676748583,1.0,1.0,10/21,15.70%,RUVBL2;PSMC1;DRAP1;RUVBL1;PSMC2;ESR1;GTF2A2;THRA;DR1;TAF1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4871019941411805,1.3577267235863324,0.09743589743589744,1.0,1.0,4/27,2.49%,POLR2J;POLR2B;POLR1D;POLR1C
prerank,transition metal ion binding (GO:0046914),0.3296993299194655,1.3546566889449538,0.0057670126874279125,1.0,1.0,78/397,15.49%,PCK1;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;LVRN;RNF7;TRIM28;ARIH1;GYG1;SOD1;TAB2;SHANK3;MYRIP;DUSP12;TRIM8;BIRC2;NUDT12;PHF5A;CA2;SIRT3;MME;MMP12;QPCTL;FBXL5;HPF1;KDM3A;KDM2A;CHMP1A;ZNF205;PIM1;ISCU;BMI1;TET3;ZNF3;TAB3;WDFY1;SOD2;ESCO1;MDM2;MYCBP2;ZDHHC15;EXD2;PARK7;PAPOLA;NQO2;RBSN;NOS3;ACER3;TNKS;PAM;PRNP;CUTC;MGAT5;CHD3;HHIP;RNF11;CZIB;USP33;CSRP1;ZKSCAN5;PGGT1B;KDM5C;PHF8;GCH1;GRIN2A;MT2A;QPCT;IMPA1;CRIP2;S100A13;CLIP1;PTGR2;DYRK2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5711186688888119,1.3512598113691123,0.12154696132596685,1.0,1.0,4/12,12.25%,SLC9A7;SLC9A6;SLC9A8;LETM1
prerank,adrenergic receptor binding (GO:0031690),-0.5070606708727258,-1.3512488404831402,0.10412147505422993,0.44278846834930463,1.0,3/16,6.20%,MAGI2;DLG4;ARRDC3
prerank,dynactin binding (GO:0034452),-0.5610914464886965,-1.3510385756333627,0.10833333333333334,0.43738293997694627,1.0,6/12,21.10%,BICD1;MAPT;HTT;GSK3B;BICDL1;SNX6
prerank,O-acyltransferase activity (GO:0008374),0.4734304519494197,1.3492111538346092,0.11492281303602059,0.9918423280227099,1.0,6/30,7.72%,GPAM;LPCAT2;SOAT1;LPCAT3;GPAT4;MBOAT1
prerank,cell adhesion mediator activity (GO:0098631),-0.45579609319371917,-1.3489150208861203,0.10492505353319058,0.43636110147811596,1.0,7/24,6.72%,LRRC4C;CNTN4;CNTN6;NTNG1;DSCAM;JAM3;PALLD
prerank,semaphorin receptor activity (GO:0017154),-0.5575247174687041,-1.347970938422943,0.11646586345381527,0.4328782596654251,1.0,6/11,15.76%,PLXNA2;NRP1;NRP2;PLXND1;PLXNB2;PLXNC1
prerank,chloride channel activity (GO:0005254),-0.36762263288271657,-1.3473948436307674,0.04927536231884058,0.42873604680100774,1.0,22/59,27.17%,GABRB1;GLRB;GABRA2;ANO3;CLIC4;SLC26A7;GLRA3;GABRG2;GLRA1;CLCN6;ANO1;CLCN2;ANO6;GABRA5;GABRG3;GABRA4;GABRG1;TTYH3;GABRA1;TTYH1;FXYD1;SLC1A4
prerank,GABA receptor activity (GO:0016917),-0.4841343489375146,-1.3468507746097926,0.10823529411764705,0.42463956426160354,1.0,10/21,24.43%,GABRB1;GABRA2;GABRG2;GABBR2;GABRA5;GABRG3;GABRA4;GPR156;GABRG1;GABRA1
prerank,death receptor activity (GO:0005035),0.5887937878906188,1.3455141233026866,0.13706563706563707,0.985600484368342,1.0,6/11,20.73%,TNFRSF10B;TNFRSF1B;TNFRSF19;TNFRSF1A;TNFRSF11A;FAS
prerank,metal ion:proton antiporter activity (GO:0051139),0.553128276915256,1.3448587098427804,0.1384335154826958,0.9638818456555717,1.0,4/13,12.25%,SLC9A7;SLC9A6;SLC9A8;LETM1
prerank,serotonin receptor activity (GO:0099589),0.5023409874039563,1.3432180169687546,0.13508771929824562,0.9030398957931983,1.0,3/22,6.74%,HRH4;HTR1F;HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5023409874039563,1.3432180169687546,0.13508771929824562,0.9030398957931983,1.0,3/22,6.74%,HRH4;HTR1F;HTR2A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5023409874039563,1.3432180169687546,0.13508771929824562,0.9030398957931983,1.0,3/22,6.74%,HRH4;HTR1F;HTR2A
prerank,GDP binding (GO:0019003),0.4115165521077166,1.3429887700445031,0.08668730650154799,0.882921602216986,1.0,20/63,17.51%,RALB;RAP2A;RERG;RAB5C;NRAS;RAB7A;RAB11B;RALA;RAB14;GNAI1;RAB5B;RAB22A;RAP2C;RIT1;RRAGC;MIEF1;ARF6;MRAS;RAB28;RAB27A
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.3317582969408226,-1.3418210055042747,0.05194805194805195,0.4307043125556263,1.0,31/91,22.41%,SVIL;GSN;ADAP2;TULP3;SNAP91;ANXA2;SYTL2;MAPT;FRMPD4;WIPI1;SNX21;GSDME;KCNJ2;CLVS2;ACTN2;HIP1R;SYT7;COMMD1;MYO1B;EXOC1;PLCD1;TWF2;SNX3;SNX18;GSDMD;FZD7;VILL;SH3PXD2B;PFN2;RPH3A;AMER1
prerank,water transmembrane transporter activity (GO:0005372),-0.5620331818215754,-1.3411113261644285,0.12738853503184713,0.4271028268335926,1.0,3/11,24.91%,PDPN;AQP4;AQP11
prerank,poly(U) RNA binding (GO:0008266),-0.4704860751577997,-1.3386751299243833,0.09579439252336448,0.4279902937703774,1.0,7/20,16.13%,RBMS1;HNRNPH1;KHDRBS1;ATXN1;DAZAP1;PABPC4;RBMS3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.34602949503868397,-1.3266915934382408,0.0513595166163142,0.4515536668507685,1.0,26/72,22.41%,SVIL;GSN;ADAP2;TULP3;SNAP91;ANXA2;SYTL2;FRMPD4;SNX21;GSDME;KCNJ2;ACTN2;HIP1R;SYT7;COMMD1;MYO1B;EXOC1;PLCD1;TWF2;SNX18;GSDMD;FZD7;VILL;PFN2;RPH3A;AMER1
prerank,retinoid X receptor binding (GO:0046965),0.5695631955518373,1.3251166615189056,0.14538310412573674,0.9506371886054581,1.0,3/11,10.52%,ARID5A;NR4A2;TACC1
prerank,AMP binding (GO:0016208),-0.546676832894845,-1.3195641624511563,0.12903225806451613,0.46384995920109534,1.0,4/11,6.30%,PRKAG2;MPPED2;PRKAG1;ACSS2
prerank,ubiquitin-specific protease binding (GO:1990381),0.49568761333866984,1.3088324009023642,0.14051094890510948,1.0,1.0,5/19,10.24%,DERL2;SPATA2;RAD23A;PARK7;RHBDD2
prerank,lipase activator activity (GO:0060229),0.5830187451728979,1.3049927164888053,0.1807465618860511,1.0,1.0,2/10,4.94%,SRC;FYN
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.40741586656598644,1.3047669156007708,0.11864406779661017,0.9891137244366021,1.0,18/49,18.05%,ZRANB3;ABRAXAS1;RAD18;TNFAIP3;TAB2;UBL7;TAB3;SPRTN;RAD23A;UBQLN1;TNIP2;BRCC3;MINDY2;UBQLN4;UFD1;UBQLN2;RAD23B;AGAP3
prerank,galactosyltransferase activity (GO:0008378),-0.5528910339733848,-1.3026308240182873,0.17473684210526316,0.5001361829176005,1.0,8/11,33.66%,A4GALT;B4GALT1;B4GALT6;B4GALT4;B4GALT7;B4GALT3;B4GALT2;B4GALT5
prerank,magnesium ion binding (GO:0000287),0.35862913784371947,1.3019832893154202,0.05631868131868132,0.9825373951718186,1.0,26/135,13.66%,PCK1;THG1L;MAP2K7;GCLC;SNRK;RAP2A;OXSR1;NUDT5;NME1;NUDT12;TDG;SIK3;UBA2;DXO;EXD2;NIM1K;PAPOLA;SRPK2;NLK;PGP;GNAI1;ADPRH;MAPK12;RRAGC;GSS;NEK6
prerank,N-acyltransferase activity (GO:0016410),0.4409149441248096,1.2966354353714626,0.125,0.9877577713683812,1.0,7/32,12.78%,CERS1;CERS4;PLAAT3;EP300;SIRT1;ESCO1;NAA80
prerank,kinesin binding (GO:0019894),0.4633324675808107,1.2966044817314033,0.12286689419795221,0.9681967954722583,1.0,8/27,14.63%,CLSTN1;ACTB;KIFAP3;KIF1B;AP1G1;NEK6;AP1AR;ARHGEF10
prerank,GABA-A receptor activity (GO:0004890),-0.4772950583578448,-1.2935257209495001,0.16179775280898875,0.518371907312496,1.0,8/18,24.43%,GABRB1;GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.552574104775847,-1.2920442379372057,0.17903930131004367,0.5164812365560288,1.0,8/10,38.79%,PML;FAN1;DNAJB2;ANKRD13D;ANKRD13B;LAPTM5;FAAP20;IDE
prerank,GABA receptor binding (GO:0050811),-0.5431922466977988,-1.2886830631086224,0.1752136752136752,0.5194512572064346,1.0,3/11,6.93%,ARFGEF2;PLCL2;TRAK1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3313771983589037,1.2884639917630933,0.03940886699507389,0.9881176770439946,1.0,49/248,13.12%,RAC2;DYNC1I1;RALB;DNM3;ABCB10;EEF1A1;RAP2A;PIN1;RUVBL2;GNAQ;RERG;RAB5C;NRAS;ATL1;GBP3;RAB7A;RAB43;RAB11B;RALA;VWA8;GBP4;GNB1;RAB6B;HBS1L;IFT22;RAB6A;RAB14;RUVBL1;GNA12;DNAJC27;GNA11;KIF15;RAB1A;KIF2A;RHOQ;DDX3X;EFTUD2;RHOG;DRG2;GNAI1;RAB5B;RAB22A;RAP2C;EFL1;TBC1D24;CHD3;RIT1;RRAGC;MYO1E
prerank,symporter activity (GO:0015293),0.5696668497818552,1.288192166252407,0.20355731225296442,0.9706091027258023,1.0,1/10,0.82%,SLC4A4
prerank,chloride channel inhibitor activity (GO:0019869),-0.5561306332820956,-1.2868079500800103,0.14012738853503184,0.5189032296290581,1.0,6/10,23.89%,WNK1;STX8;WNK4;WNK3;STX1A;VAMP8
prerank,calcium-release channel activity (GO:0015278),-0.4715214076276404,-1.2856714669609517,0.17787418655097614,0.5163040330023019,1.0,5/17,22.74%,ITPR1;RYR3;TPCN1;ITPR2;MCOLN1
prerank,semaphorin receptor binding (GO:0030215),0.47324277150196736,1.285388404173873,0.16847826086956522,0.9664844850603708,1.0,6/23,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5601142884957095,1.284414217464982,0.19076305220883535,0.9537026337612465,1.0,7/10,19.28%,TNFAIP3;YOD1;DESI2;OTUD5;OTUD4;ATXN3;STAMBP
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.4317652250778633,-1.2827085828801361,0.15046296296296297,0.5183310162431609,1.0,12/25,30.06%,MICAL2;CYP27A1;MICAL3;MSMO1;CYP26B1;FMO2;FMO5;MTRR;MICAL1;SQLE;POR;NOS1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.351196876360444,-1.2821194348236482,0.12464589235127478,0.5144234923904669,1.0,10/55,9.99%,SLC24A3;ITPR1;MCU;CACNA1D;PKD1;ANXA2;TRPC5;SEC61A1;TRPC1;SLC24A2
prerank,ATPase binding (GO:0051117),-0.3336506318721014,-1.281082987192226,0.08605341246290801,0.5115293239537111,1.0,19/71,12.07%,ANK2;SLC2A13;EGFR;SNTA1;TMTC4;TOR1AIP2;ATP1B1;ATP6V1E1;ATP1B3;PTPN3;TRPC1;TOR1AIP1;EZR;ZNHIT6;ATP1B2;CLPP;TCIRG1;ATP6V0A4;ABCA1
prerank,phospholipase binding (GO:0043274),0.5295375098294854,1.2808650065559226,0.18762088974854932,0.9530363489295184,1.0,3/13,6.70%,SRC;FYN;SYK
prerank,phospholipase activator activity (GO:0016004),0.5757062927041429,1.280606874322065,0.20440881763527055,0.9371684194665629,1.0,2/10,4.94%,SRC;FYN
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.31078794892181966,1.2784359077343839,0.02159090909090909,0.9310087828209521,1.0,92/431,15.88%,PCK1;THG1L;RAC2;ARF5;SNRK;PPIP5K2;RALB;EEF1A1;RAP2A;HSPA8;OXSR1;HSPA4L;ARL5C;ARL4D;NEK11;PNKP;RPS6KA4;RERG;PYGL;RPS6KA5;NRAS;TUBB;NME1;ATL1;GBP3;RRAD;RAB7A;MLKL;RAB11B;RALA;TDG;PEX1;MTHFS;YARS2;GBP4;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;RAB6A;SYN3;RAB14;PEAK1;MINK1;RANBP17;ACVRL1;LATS2;ARL5B;ARF1;RHOQ;NIM1K;MFHAS1;PAPOLA;SRPK2;NLK;P2RX7;RHOG;DRG2;OLA1;PNPLA8;GNAI1;RAB22A;LANCL2;PRKCI;RAP2C;MYO9B;MAP4K4;ABCF2;RIT1;RRAGC;NDUFA13;GSS;PPP5C;TLK2;NEK6;PTPA;GCH1;TWF1;ABCF3;RRM1;DYRK2;ARF6;CDKL5;TOP1;MYH9;MRAS;TUBA1B
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5268280935982115,-1.2782136141069533,0.16595744680851063,0.5132566402958723,1.0,8/12,19.91%,TGFBR3;TGFBR1;TGFBR2;ACVR1;LTBP1;BMPR1B;BMPR1A;BMPR2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.46359464900202746,-1.2769813249933961,0.14545454545454545,0.5110380916708526,1.0,5/18,8.66%,TGFBR3;SMAD3;TGFBR1;TGFBR2;SMAD6
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.49065040926661374,-1.2767283610670843,0.16666666666666666,0.5065420637461319,1.0,5/14,3.54%,SPOCK3;TIMP3;SPOCK1;TIMP2;COL4A3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4271128940492549,-1.275749957089587,0.15012106537530268,0.5038846159272209,1.0,8/23,19.65%,PLCE1;EDNRA;PLCD3;CHRM3;PLCB3;PLCH1;PLCD1;BDKRB2
prerank,adenylyltransferase activity (GO:0070566),0.4817065070376617,1.272971581516385,0.17857142857142858,0.9395489231243471,1.0,10/21,21.52%,GPHN;FLAD1;TENT4A;PAPOLA;NMNAT1;SELENOO;PAPOLG;COASY;TENT2;MTPAP
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.3254385991195347,-1.2727639161950968,0.07621951219512195,0.5061676500067809,1.0,42/78,29.72%,CFLAR;USP40;USP29;CAPN2;MALT1;USP13;PDIA3;USP11;LGMN;CASP12;CTSO;USP38;USP34;USP20;USP7;CASP7;USP10;USP1;USP16;CTSZ;USP42;USP5;CAPN15;CASP2;USP35;USP49;CAPN1;USP2;USP46;CASP9;CASP3;USP24;CTSK;CAPN10;SFRP1;CAPN5;CTSF;CTSB;CTSC;UCHL1;GPAA1;CTSS
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5501485884544662,1.2693716502483023,0.2029520295202952,0.9406038541625387,1.0,4/11,15.70%,RDH13;RDH11;RDH14;AKR1A1
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.4445026580943689,-1.2691042601738858,0.15932914046121593,0.5099382109404519,1.0,4/19,6.32%,GRM5;EFNA5;ABI1;ERCC6
prerank,cGMP binding (GO:0030553),-0.5256840858764863,-1.2638776433865444,0.20867768595041322,0.517545934574672,1.0,4/11,26.25%,PDE5A;PDE11A;RAPGEF2;PDE2A
prerank,MAP kinase kinase activity (GO:0004708),0.5081533972815604,1.2637568236068955,0.19029850746268656,0.9509648331313191,1.0,4/15,6.54%,MAP2K7;MAP2K5;MAP3K9;PAK3
prerank,cation transmembrane transporter activity (GO:0008324),0.4014014856752541,1.2626793245143824,0.13395638629283488,0.9404395404820539,1.0,12/48,17.21%,SLC7A8;SLC1A1;SLC36A4;SLC39A1;SLC3A2;SLC6A6;SLC25A2;SFXN1;SLC38A5;SLC66A1;SLC25A38;SLC7A5
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5169151315701477,-1.260771222996886,0.2045929018789144,0.5203197164750827,1.0,8/12,24.43%,GABRB1;GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.35912332204248376,-1.259925930372991,0.11370262390670553,0.5176803613168778,1.0,16/48,24.83%,TRPM3;NALCN;UNC80;SLC41A1;TRPM6;PIEZO2;SLC12A2;TRPC1;ABCC9;SLC12A6;SLC12A4;TRPC6;MCOLN1;DMAC2L;SLC12A7;CALHM5
prerank,insulin-like growth factor I binding (GO:0031994),-0.4916318608020081,-1.2589189475090419,0.19736842105263158,0.5154324302918031,1.0,5/13,16.08%,IGFBP5;IGFBP2;IGFBP6;IGFBP4;ITGB4
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5396928402454617,-1.2588160128293269,0.18219461697722567,0.5106897215173706,1.0,7/10,33.66%,B4GALT1;B4GALT6;B3GALT5;B3GALT1;B4GALT7;B3GALT2;B4GALT5
prerank,syntaxin-1 binding (GO:0017075),-0.4360704136974657,-1.2587227228028237,0.16981132075471697,0.5059483647185881,1.0,13/22,35.92%,SNAP25;STXBP5;UNC13C;STXBP1;SNPH;UNC13B;VAMP2;DAPK1;CPLX1;SYP;SYNPR;UNC13A;CPLX2
prerank,FAD binding (GO:0071949),-0.4269127016833394,-1.2585783369837615,0.1580188679245283,0.5016049779572319,1.0,13/24,27.34%,MICAL2;DDO;MICAL3;CRY2;MTHFR;CRY1;SQOR;PRODH;QSOX1;KDM1B;MTRR;MICAL1;SQLE
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5154278399525853,1.2545394455093182,0.2018348623853211,0.9623845066880421,1.0,2/14,0.92%,ALDH1L1;AASS
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.545982669320348,1.2526501131343688,0.21523809523809523,0.9552484111744765,1.0,4/11,11.12%,PRMT3;FBXO11;PRMT9;CARM1
prerank,cholesterol transfer activity (GO:0120020),-0.46845190088899064,-1.2515925019248706,0.19068736141906872,0.514490644950653,1.0,6/16,18.71%,GRAMD1B;GRAMD1C;ABCA1;STARD5;GRAMD1A;MTTP
prerank,exonuclease activity (GO:0004527),0.3954344282352482,1.2513044123319563,0.14991762767710048,0.946570050179846,1.0,12/46,13.15%,AEN;REXO2;RAD1;APLF;DCLRE1B;CNOT7;EXOSC9;XRN2;DXO;EXD2;CNOT6;EXOSC1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4585336136384538,-1.2498582990465819,0.1857451403887689,0.5137064645794238,1.0,9/18,19.91%,TGFBR3;TGFBR1;TGFBR2;ACVR1;LTBP1;ACVR1B;BMPR1B;BMPR1A;BMPR2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5430731353016969,1.2452353917305659,0.21920289855072464,0.9578754065422356,1.0,4/11,18.78%,NAA25;NAA80;NAA15;NAA50
prerank,chemorepellent activity (GO:0045499),0.44517890149768224,1.2447670739039345,0.19090909090909092,0.9454082494376345,1.0,6/25,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,endopeptidase activity (GO:0004175),-0.27275955423694215,-1.2446377335633934,0.027472527472527472,0.5217015241764581,1.0,78/257,22.86%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;USP40;USP29;PCSK2;PCSK5;MMP16;ADAMTS6;ADAMTSL5;MALT1;ADAMTS17;MMP14;USP13;BACE2;ADAMTS9;F3;RHBDL3;ADAM19;ADAMTS5;PDIA3;USP11;RHBDD1;HTRA3;DPP4;NLN;TPP2;ADAMTS1;PSMA2;ADAMTSL4;BACE1;PSMA6;FAP;LGMN;CLPP;PREP;PSMA1;ADAMTS3;CTSO;USP38;PIK3IP1;USP34;AFG3L2;PCSK6;USP20;PSMA5;DDI2;ADAMTS10;USP7;MBTPS2;CASP7;USP10;USP1;USP16;CTSZ;USP42;PSMB3;ACE;PITRM1;USP5;ADAMTS15;ADAMTS16;SPG7;MMP2;ADAM33;CASP2;ADAMTS20;RHBDF1;USP35;USP49;KLK2;USP2;USP46;CASP9;CASP3
prerank,Wnt-activated receptor activity (GO:0042813),-0.4780287028659207,-1.2438050455380676,0.2026431718061674,0.519092914276248,1.0,6/15,10.31%,PKD1;FZD6;RYK;ROR1;LRP5;FZD2
prerank,regulatory RNA binding (GO:0061980),-0.3749801511235073,-1.2433935981032433,0.13367609254498714,0.5152686766122212,1.0,11/38,14.64%,ZC3H7A;PUM1;ZC3H7B;PUM2;HNRNPA2B1;AGO3;HNRNPA1;RBM4;DDX21;DICER1;ZNF346
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.4071944170291698,-1.2427798179566913,0.1759465478841871,0.5121384070385523,1.0,8/25,18.32%,ADAP2;PLEKHA2;GAB2;HIP1R;FCHSD2;DAPP1;COMMD1;ARAP3
prerank,miRNA binding (GO:0035198),-0.39705161116701904,-1.2414935411029342,0.15113350125944586,0.5105725506159866,1.0,10/30,14.64%,ZC3H7A;PUM1;ZC3H7B;PUM2;HNRNPA2B1;AGO3;HNRNPA1;RBM4;DDX21;ZNF346
prerank,mRNA 3'-UTR binding (GO:0003730),-0.3199647112774134,-1.241077762726459,0.10826210826210826,0.5069236908173312,1.0,26/79,20.34%,CELF2;DDX5;RBMS1;CPEB4;CPEB1;CPEB2;ELAVL2;PUM1;ELAVL4;YBX3;PUM2;HNRNPA2B1;SECISBP2;ELAVL3;TP53;RBM4;RPS7;DAZAP1;CSDC2;PABPC4;RBMS3;RNPS1;CIRBP;HNRNPA0;RNF40;IGF2BP2
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.3984236244135481,-1.240662737436954,0.15980629539951574,0.5034195369291359,1.0,12/27,23.48%,ITPR1;SLC41A1;MRS2;SLC12A2;KCNA1;SLC9B2;MAGT1;ITPR2;SLC11A2;CNNM2;ATP2B3;SLC4A8
prerank,GTPase activity (GO:0003924),0.3257839505227111,1.2395813646505833,0.08260325406758448,0.9544701205762834,1.0,39/192,12.99%,RAC2;RALB;DNM3;EEF1A1;RAP2A;GNAQ;RERG;RAB5C;NRAS;ATL1;GBP3;RAB7A;RAB43;RAB11B;RALA;GBP4;GNB1;RAB6B;HBS1L;IFT22;RAB6A;RAB14;GNA12;DNAJC27;GNA11;RAB1A;RHOQ;DDX3X;EFTUD2;RHOG;DRG2;GNAI1;RAB5B;RAB22A;RAP2C;EFL1;TBC1D24;RIT1;RRAGC
prerank,anion channel activity (GO:0005253),-0.33198120916994983,-1.239243473087992,0.1393939393939394,0.5027143998630699,1.0,12/61,7.73%,GABRB1;GLRB;GABRA2;ANO3;CLIC4;LRRC8D;SLC26A7;LRRC8B;VDAC1;GLRA3;GABRG2;GLRA1
prerank,filamin binding (GO:0031005),-0.5108160099563309,-1.230538706846224,0.21703853955375255,0.5191310286239982,1.0,8/11,38.49%,DPYSL3;SYNPO2;CEACAM1;FBLIM1;CRMP1;MICALL2;RFLNA;RFLNB
prerank,nuclear receptor binding (GO:0016922),0.3422780092498585,1.229013493144874,0.12083333333333333,0.9883945819013847,1.0,29/111,14.55%,DCAF1;ARID5A;NR4A2;GAS2L1;LEF1;DDX54;RERG;SRARP;CCDC62;PHB2;KDM3A;EP300;MED12;ACTN4;SIRT1;GTF2H1;PKN1;PARK7;RNF6;BUD31;WBP2;ESR1;TACC1;MED4;JMJD1C;YWHAH;NCOA7;CNOT1;BAZ2A
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3682361020507618,1.2290039178269216,0.15535444947209653,0.9740956063443481,1.0,17/69,16.50%,CERS1;ZDHHC17;CERS4;ZDHHC13;PLAAT3;SOAT1;EP300;LPCAT3;ZDHHC14;ESCO1;ZDHHC15;CREBBP;ZDHHC9;ZDHHC7;NAA15;MBOAT7;ELP3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.44805539488485385,-1.2244004680650462,0.2266355140186916,0.529320871809032,1.0,9/17,30.00%,DPYD;TECR;BLVRA;BLVRB;LBR;SRD5A3;DECR2;PECR;DHCR24
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4657666489920671,-1.2208657729030163,0.22271714922049,0.5332249869092408,1.0,5/15,23.48%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8
prerank,motor activity (GO:0003774),0.3754969202295019,1.2200835534459904,0.16358024691358025,0.9988771614089694,1.0,15/60,15.74%,DYNC1I1;KIF18A;PIN1;DNAH3;KIF1B;KIF15;STARD9;KIF2A;KIF13A;MYO1E;KIF3B;KIF6;APPBP2;DYNC1I2;MYH9
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4262184673906686,1.2192437349225798,0.20526315789473684,0.9886995185005003,1.0,4/27,6.96%,SLC9A7;SLC3A2;SLC9A6;SLC9A8
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5281332274093291,-1.2158794564134037,0.22406639004149378,0.5407138225281987,1.0,7/10,24.43%,GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,poly-pyrimidine tract binding (GO:0008187),-0.4098416781665949,-1.2124066480815778,0.1828978622327791,0.5451156089505403,1.0,7/23,16.13%,RBMS1;HNRNPH1;KHDRBS1;ATXN1;DAZAP1;PABPC4;RBMS3
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.46261529699278264,-1.210800913046941,0.23044397463002114,0.5447064923656764,1.0,1/15,1.27%,PLA2G4A
prerank,U6 snRNA binding (GO:0017070),0.5013122528985718,1.2104919331256305,0.22244094488188976,1.0,1.0,2/14,1.26%,EIF5A;RBM22
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.337462124840278,-1.2101899785659125,0.16759776536312848,0.5418732091937418,1.0,16/55,19.18%,SLC16A12;SLC6A13;SLC13A3;SLC7A2;PDPN;SLC16A7;SLC7A14;SLC6A12;SLC22A4;SLC25A32;SLC38A11;SLC16A11;SLC19A1;SLC16A2;SLC38A7;SLC16A9
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4875627585865281,1.2072083855451268,0.2281021897810219,1.0,1.0,6/15,14.60%,PIK3CG;PIK3C2G;PIKFYVE;PI4KA;PIK3CD;PIK3C2A
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5187148953659914,1.20708823102039,0.2485207100591716,0.9894329751165987,1.0,3/11,6.61%,PFN1;BAG1;GRPEL2
prerank,adenyl nucleotide binding (GO:0030554),0.5187148953659914,1.20708823102039,0.2485207100591716,0.9894329751165987,1.0,3/11,6.61%,PFN1;BAG1;GRPEL2
prerank,WW domain binding (GO:0050699),0.42630799448888024,1.206916955925966,0.22183098591549297,0.9772386863721455,1.0,2/26,4.98%,PRRG4;TCEAL9
prerank,tRNA methyltransferase activity (GO:0008175),0.4829062785984859,1.2065229426460855,0.24723247232472326,0.9664959478426166,1.0,4/16,11.84%,BCDIN3D;THUMPD2;METTL2A;METTL2B
prerank,epidermal growth factor receptor binding (GO:0005154),-0.40232819878979675,-1.2053575783824144,0.1990632318501171,0.5494180593550748,1.0,8/25,12.24%,ERBB4;SNX2;SNX4;FER;EFEMP1;CNOT9;PLSCR1;GRB2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3981223065065498,-1.203343638839767,0.20094562647754138,0.5498345968346214,1.0,12/26,23.54%,SLC16A12;SLC6A13;SLC6A1;SLC16A7;SLC6A12;SLC27A1;SLC16A11;SLC16A2;SLC5A6;SLC16A9;SLC16A4;SLC6A11
prerank,active ion transmembrane transporter activity (GO:0022853),-0.36137865817583403,-1.2013436667387343,0.16414141414141414,0.5507265265024804,1.0,12/37,18.42%,SLCO3A1;SLC22A8;SLC16A7;CYB5A;UQCRH;SLC22A4;COX8A;UQCRC1;NDUFA4;SLC22A6;COX7A2L;COX6A1
prerank,Tat protein binding (GO:0030957),0.5302481120000813,1.2003166493650876,0.2651821862348178,0.9808555809042611,1.0,6/10,19.08%,ACTB;MDFIC;GABARAPL1;SMARCA4;NPM1;SMARCB1
prerank,pre-mRNA binding (GO:0036002),-0.39315898438641217,-1.1996881052804818,0.2034313725490196,0.5505100480726496,1.0,9/28,16.91%,CELF2;DDX5;CELF4;SRSF6;RNPC3;HNRNPA1;RBM4;SLU7;RBM7
prerank,death receptor binding (GO:0005123),-0.4519285529827428,-1.197338409844711,0.20718816067653276,0.5516838719777107,1.0,5/15,17.88%,EDA;CASP8AP2;MADD;NGF;TMBIM1
prerank,aspartic-type peptidase activity (GO:0070001),-0.5204034770377165,-1.1969184211529889,0.25260960334029225,0.5484212717412827,1.0,4/10,13.98%,BACE2;BACE1;CTSD;DDI2
prerank,alpha-actinin binding (GO:0051393),-0.4002242089433836,-1.1947443399900295,0.2234762979683973,0.5495032633647227,1.0,8/24,13.61%,CACNA1C;PDLIM5;CACNA1D;PDLIM7;PALLD;SYNPO2;RARA;PDLIM1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3540622767293924,1.1930772372416705,0.19676945668135096,0.9998569971333761,1.0,15/71,11.62%,PTPRR;PTPN18;PTPRG;PTPRJ;PTPRC;PTPRM;PTPRB;PTPRE;PTP4A2;PTPN12;PTPRT;EYA3;DUSP11;PGP;HACD2
prerank,muscle alpha-actinin binding (GO:0051371),-0.4562408039355874,-1.1857557363017255,0.23780487804878048,0.5669554532783625,1.0,7/15,21.96%,PDLIM5;PDLIM7;PALLD;SYNPO2;PDLIM1;PDLIM2;PDLIM4
prerank,transcription coregulator binding (GO:0001221),0.3704902635901543,1.1854638749747999,0.20766773162939298,1.0,1.0,16/50,13.66%,EZH2;RPL23;EED;HDAC3;UBE2I;CNOT2;PPARD;RELA;LMO2;ESR1;TERT;THRB;CTBP1;HDGF;CTBP2;NEK6
prerank,clathrin adaptor activity (GO:0035615),-0.44544388780336047,-1.185414989360774,0.2334047109207709,0.5634035659891997,1.0,7/15,13.04%,DAB2;AP2B1;AP2A2;STON2;AP2A1;STON1;HIP1R
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.41322886638337214,1.184479252007245,0.23851590106007067,1.0,1.0,6/28,10.33%,MAP2K7;RPS6KA1;MAP2K5;MAP3K9;PAK3;PRKAA2
prerank,phosphatidate phosphatase activity (GO:0008195),-0.47933714805943584,-1.1834322716130983,0.2532188841201717,0.5638216161095548,1.0,9/13,30.93%,PLPPR1;PLPP3;PLPPR5;LPIN1;PLPPR4;LPIN2;PLPP5;LPIN3;PLPPR2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.39909344363438504,1.1785349138005998,0.21176470588235294,1.0,1.0,12/33,16.46%,REXO2;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN2;CNOT6;CNOT6L;NOCT;ERI2;PARN
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.33577507920425415,-1.175214682875459,0.20454545454545456,0.5799830837755303,1.0,15/49,14.53%,ANXA3;PLA2G4A;CPNE8;PCLO;ANXA2;ANXA4;SYT9;ESYT1;ANXA1;ANXA5;SYT12;SYT11;SYT4;CPNE2;SYT7
prerank,CXCR chemokine receptor binding (GO:0045236),0.5078539497502721,1.1741855057160575,0.27631578947368424,1.0,1.0,1/11,2.58%,CXCL12
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4910182661425198,1.172838297852628,0.28277153558052437,1.0,1.0,6/13,17.83%,PRKAR1A;GSK3A;PJA2;PKIA;RYR2;PRKAR2A
prerank,neuropeptide binding (GO:0042923),-0.42586167690024374,-1.170989415489518,0.25,0.5859647189007676,1.0,4/18,22.53%,SORL1;GPR37;OPRM1;GPR149
prerank,carboxypeptidase activity (GO:0004180),-0.36038484027757667,-1.1699725013030862,0.20631067961165048,0.5841551868598901,1.0,9/35,16.77%,AEBP1;AGBL4;PEPD;AGBL3;SCPEP1;CPM;CTSA;NAALAD2;CTSZ
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.35216027615252476,-1.165995833118656,0.19387755102040816,0.5896695182889516,1.0,14/33,27.31%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;WDR43;PAF1;SMYD2;RTRAF;GTF2B;ZNF326;SUPT4H1;LLPH
prerank,RNA binding (GO:0003723),0.2707447468880743,1.1640681878766863,0.029263370332996974,1.0,1.0,368/1321,19.41%,THG1L;LRRFIP1;SORBS2;MAZ;CMSS1;SNRPD2;ZC3H12D;RPS19BP1;NCBP1;RPL30;EIF5A;ILF3;THUMPD1;UTP20;RSRC2;SYNE1;KHDRBS3;RBM22;FAU;RALYL;TRIM28;RSL24D1;EEF1A1;RPP25L;UTP18;HSPA8;POLR2B;MRPL23;RPL17;RPL23;PATL2;EIF2S1;EIF2A;FASTKD2;RPL31;PRPF31;PRPF3;RPL3;SNRPD1;RPS21;HNRNPH2;DDX54;MANF;DDX10;LARP4B;PCBP1;NAP1L4;FLNB;MEX3B;FARS2;UBA1;PPIB;IFIT1;NUDT5;NME1;PHF5A;ZFP36L1;HNRNPAB;SLC3A2;GOT2;SF1;QKI;PRPF40A;PFN1;EIF3B;RBBP6;SMG1;HNRNPK;YY1;PPIG;METAP2;RPL35A;SEC23IP;PSMC1;SAMSN1;FAM50A;MYO5A;UBE2I;CPSF4;MYEF2;RPS14;FXR1;NFX1;RTCA;RPL8;CHTOP;YARS2;RPL5;SRSF10;ABCF1;SSBP1;RO60;POLR1G;MRPS12;RPS12;CDK11B;RBM20;SLC4A1AP;SFPQ;LONP1;RPS26;ACTN4;RPL37A;HNRNPC;TXN;ZNF638;GEMIN5;MAP4;CS;SMNDC1;FAM120C;PUS10;ADAR;YTHDC1;IMMT;PYM1;ELP1;ZFR;TRMT10B;FYTTD1;RPL4;RARS2;SRSF4;RBM34;EMG1;TRIM25;MRPL20;SECISBP2L;EIF4H;SNU13;XPO5;POP5;RPLP0;NOVA2;SARNP;DHX32;EXOSC9;NGRN;SF3A1;XRN2;ARF1;PCID2;BCLAF1;DXO;FBRSL1;PATL1;PARK7;SUCLG1;AKAP8L;SYF2;TARDBP;ZMAT3;TSFM;RPS28;U2AF1;CPSF6;TAF15;RPS24;RRP7A;DUSP11;S100A16;ASCC3;FAM133B;GLRX3;EIF4G2;CCAR2;RBM45;BCCIP;NCBP3;TERT;SRPK2;RPS9;RPS23;RPL24;DDX3X;ADARB2;RPL34;NGDN;CISD2;EFTUD2;FAM32A;ERH;TDRD3;NANOS3;MATR3;APTX;DRG2;AGO4;HELZ;EIF4B;RPS11;RPS3;PA2G4;ANKHD1;ZBED4;PTBP1;DDX27;HDGF;PCBP3;MRPS15;ACO1;NUFIP2;ILF2;MRPS24;CRKL;FKBP4;G3BP2;ARCN1;ZC3H14;RBM10;API5;SRFBP1;STRAP;NDUFV3;CHD3;HELB;HSPE1;TUT7;RRP8;RNMT;EXOSC1;PPHLN1;UTP11;DDX55;HEATR6;CSRP1;ANKRD17;RPS15A;RBM26;RPL23A;PTCD1;RPL21;SRP9;RPL35;YBX1;SRSF7;PURG;HEATR1;CNOT1;TASOR;CAPRIN1;BAZ2A;SCAF8;DCP1A;ATP5F1C;UCHL5;SNRPA;FUS;TFAM;SSB;PTCD2;PCDHGA9;TUT4;MRPS28;MRPS35;LARP1B;EIF5;TCF20;RBM4B;SF3B6;MOV10;PPP1R8;HNRNPL;NOCT;NKAP;TCERG1;TRA2B;TOP1;ADARB1;ANG;MYH9;SLBP;TUBA1B;TCP1;PRKRIP1;TDRD7;UPF3B;EIF1AX;DKC1;U2AF2;RSL1D1;PURB;ZCCHC17;OTUD4;NSUN6;NAA15;ENDOV;HARS2;PARN;ACAA2;WDR33;N4BP1;LARP4;PRKDC;KPNB1;SPATS2;LSM1;CALR;RPL19;STAU2;SERPINH1;NONO;URB1;NPM1;RPL38;EIF2S2;SNRPA1;HNRNPF;CKAP4;UBAP2;RANGAP1;EIF3A;RPL36;RCC1L;YTHDC2;DCAF13;SMG6;STAT3;RPSA;ZC3H13;DHX8;DDX23;TSNAX;RPL26;LUC7L2;RPS8;SMG5;HEXIM1;SAFB;MYO18A;RPL15;RPL10;NUP42;HDAC2;RDX;CCDC47;PDIA4;USP36;DDX60;RPL32;ZYX;SNRPD3;MRPS9;RC3H1;RPS2;ZNF106;NSUN2;NSRP1;EIF4G1;CLUH;TRIM56;PRRC2C;PRRC2B;MRPL13;TFRC;DHX36;TOP3B;TFB1M;YWHAE;RPL27A;HNRNPM;TRNT1;EIF3E;NOP58;LARP1;NVL;DCP1B;MTIF2
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3617320955640093,-1.1634936813029262,0.22418136020151133,0.5917609366341549,1.0,17/31,28.64%,HCN1;SLC12A2;KCNK5;KCNA1;KCNK10;ABCC9;SLC12A6;TMEM38A;SLC12A4;KCNQ4;SLC12A9;KCNA2;SLC12A7;KCNK9;SLC12A8;SLC12A5;KCNK1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4044877506603059,1.1634441758741036,0.2789115646258503,1.0,1.0,5/29,5.65%,PRKAR1A;RPTOR;SPRED1;CIB1;CDKN1A
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4826319286098738,1.1609516726812055,0.2903225806451613,1.0,1.0,6/13,17.17%,PIK3CG;PIK3C2G;PIKFYVE;PIK3CD;PIK3C2A;PIP4K2A
prerank,beta-tubulin binding (GO:0048487),-0.3580817883940031,-1.1548315909281766,0.2199074074074074,0.608585265691613,1.0,11/31,13.07%,EML4;GJB6;SMC3;PACRG;LRPPRC;PEX14;HTT;IFT74;ARL8A;TAOK1;PDCD5
prerank,frizzled binding (GO:0005109),-0.35862314527174866,-1.1547425505720843,0.2210796915167095,0.6044884993323587,1.0,13/34,28.38%,WNT5B;RYK;RNF43;WNT4;DVL3;ZNRF3;WNT9A;LRP6;DVL1;FZD7;SFRP1;FZD1;MYOC
prerank,PDZ domain binding (GO:0030165),-0.3120786198755426,-1.1528742144791178,0.22413793103448276,0.6047405455586118,1.0,14/61,10.31%,TGFBR3;GRID2;PLEKHA2;SDC2;CXADR;ARHGAP29;DLG4;SRR;CRIM1;CIT;MAP2K2;NLGN1;SLC22A4;FZD2
prerank,actin binding (GO:0003779),-0.26614445852184127,-1.1515863269436342,0.11618257261410789,0.6034098654821392,1.0,29/170,8.83%,SORBS1;CALD1;MAP1B;PAWR;KCNMA1;PDLIM5;GSN;SYNE2;PARVA;MICAL2;PLEKHH2;LIMA1;PACRG;MOBP;MAPT;TPM1;MACF1;MTSS1;PDLIM7;MICAL3;FMN2;VCL;ARPC1A;COBL;TLN2;P4HB;PHACTR3;EZR;SMTN
prerank,transcription corepressor binding (GO:0001222),0.41479497128109344,1.1506417365912947,0.25486725663716814,1.0,1.0,10/27,15.78%,EZH2;EED;HDAC3;CNOT2;ESR1;CTBP1;HDGF;CTBP2;NEK6;WIZ
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.3479719993796347,-1.148797906788685,0.22727272727272727,0.6061978111523779,1.0,2/38,0.17%,MAGI2;SORBS1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3867015608473375,-1.1473307015554757,0.25952380952380955,0.60567033580405,1.0,3/21,4.02%,PDE1A;PDE5A;PDE1C
prerank,tubulin binding (GO:0015631),0.28580154106583644,1.145904081478341,0.16548463356973994,1.0,1.0,58/296,14.17%,REEP1;ABRAXAS1;DYNC1I1;EML1;KIF18A;DNM3;TTLL1;GAS2L1;MAP1LC3B;ALMS1;CETN3;TTLL12;EML6;CLASP2;TUBGCP5;MAP1S;SGIP1;KIF1B;CCT5;FYN;DST;KRIT1;DIP2B;CRIPT;FGF13;ARHGEF7;CCDC88C;DNAL1;UXT;CLIP2;AGTPBP1;MAP4;DAG1;TRPV4;RAB11FIP5;TBCEL;REEP3;KIF15;STARD9;PRUNE1;KIF2A;PAK1;KIF13A;DDX3X;RMDN3;RPS3;PRNP;CENPJ;MAP4K4;AGBL5;MID1;KIF3B;KIF6;RABGAP1;TTLL7;APC;SPEF1;EFHC2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4362400947153866,-1.1435473109695105,0.2876712328767123,0.610812594990045,1.0,5/14,26.04%,SLC26A7;SLC26A2;SLC26A11;SLC25A30;SLC25A11
prerank,GTPase inhibitor activity (GO:0005095),-0.44787730651925384,-1.1431205579560733,0.28870292887029286,0.6074928971574125,1.0,7/13,29.14%,CPEB2;IQGAP1;IQGAP2;CDC42SE1;ARL2;RHOH;RTKN
prerank,3'-5' exonuclease activity (GO:0008408),0.35730270726045915,1.142236185608155,0.26283048211508553,1.0,1.0,14/45,16.46%,REXO2;RAD1;APLF;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN2;CNOT6;CNOT6L;NOCT;ERI2;PARN
prerank,SUMO transferase activity (GO:0019789),0.4472770304387406,1.1421955553063183,0.301056338028169,1.0,1.0,5/16,11.39%,TRIM28;UBE2I;MDM2;PIAS2;PIAS1
prerank,ubiquitin protein ligase binding (GO:0031625),0.2890455066539898,1.141481877698459,0.1927710843373494,1.0,1.0,62/254,17.18%,PRKAR1A;RAD18;PRR5L;TRIB3;RALB;TRIM28;ARIH1;SLF1;MAP1LC3B;HSPA8;RPL23;CCT2;SPOP;RFFL;TUBB;YOD1;TNFRSF1B;WFS1;RALA;CDKN1A;TPI1;RPL5;BAG1;TRAF5;SMAD7;AXIN1;MAGEC2;NDUFS2;TRAF3;RELA;MDM2;AUP1;FBXO7;MFHAS1;NAE1;ERLIN2;GPI;NLK;SPOPL;PA2G4;ELOB;CUL3;MID1;CHEK2;NEK6;PSMD1;FAF1;APC;NFKBIA;RNF20;FANCL;UBE2G1;GABARAPL1;TUBA1B;TCP1;LAPTM4B;DNM1L;ABI2;SLF2;BECN1;CALR;ATXN3
prerank,store-operated calcium channel activity (GO:0015279),-0.49907693263259867,-1.1401525740674432,0.29375,0.6105585703533479,1.0,3/10,8.60%,STIM2;TRPC5;TRPC1
prerank,endopeptidase inhibitor activity (GO:0004866),-0.28551616130497176,-1.13950324782612,0.18,0.6080193532236183,1.0,12/82,11.69%,SPOCK3;TIMP3;SPOCK1;TIMP2;TFPI;ANXA2;COL4A3;ROCK1;BIN1;PSMF1;ITIH2;RENBP
prerank,cyclic nucleotide binding (GO:0030551),-0.4013652655395122,-1.1390300112297014,0.2646370023419204,0.6051850036690902,1.0,6/21,16.20%,HCN1;PDE5A;PDE11A;PDE4B;SLC19A1;RAPGEF2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.32817619172818685,1.1355954097864978,0.25748502994011974,1.0,1.0,15/75,15.80%,IMPDH1;ABCC4;SPR;ME3;HMGCR;KDSR;KCNAB1;HSD17B11;NSDHL;RDH11;HSD17B4;RDH10;BDH2;AKR1A1;HPGD
prerank,amyloid-beta binding (GO:0001540),-0.2922385786226859,-1.135591701814611,0.2018348623853211,0.6094739026887073,1.0,19/79,13.50%,LRP1;GRIA4;GRIA2;GRIN2B;COL25A1;FZD6;PGRMC1;SORL1;CACNA1B;TM2D1;HSPG2;LDLR;NLGN1;BACE1;EPHB2;VBP1;APBA1;GSAP;PFDN2
prerank,I-SMAD binding (GO:0070411),-0.44984710222766866,-1.1319448240361945,0.29938900203665986,0.614773377130725,1.0,6/13,14.22%,SMAD3;TGFBR1;CTNNB1;SMAD4;SMAD6;SMAD5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.46712780276668536,1.1315365540205728,0.31135531135531136,1.0,1.0,7/14,17.18%,YOD1;DESI2;USP15;OTUD5;MINDY2;USP9X;ATXN3
prerank,microtubule motor activity (GO:0003777),0.3567836613292921,1.1287589790329626,0.2780337941628264,1.0,1.0,12/51,14.75%,DYNC1I1;KIF18A;DNAH3;KIF1B;KIF15;STARD9;KIF2A;KIF13A;KIF3B;KIF6;APPBP2;DYNC1I2
prerank,tau protein binding (GO:0048156),0.36930408243143326,1.1284105992962172,0.29545454545454547,1.0,1.0,8/40,6.91%,GSK3A;PIN1;ACTB;PPP2CA;APOE;FYN;EP300;PPP2CB
prerank,microtubule binding (GO:0008017),0.29014659091493517,1.1280536430675023,0.20423412204234123,1.0,1.0,39/222,13.23%,REEP1;ABRAXAS1;DYNC1I1;EML1;KIF18A;DNM3;GAS2L1;MAP1LC3B;ALMS1;CETN3;HAUS4;EML6;CLASP2;TUBGCP5;MAP1S;SGIP1;KIF1B;DST;KRIT1;CRIPT;FGF13;CCDC88C;UXT;CLIP2;CAMSAP2;MAP4;TRPV4;REEP3;KIF15;STARD9;KIF2A;KIF13A;RMDN3;RPS3;PRNP;MAP4K4;MID1;KIF3B;KIF6
prerank,ribosomal large subunit binding (GO:0043023),-0.4569599557108958,-1.122230920970063,0.31982942430703626,0.6353860222473741,1.0,4/11,13.85%,CPEB2;LTN1;RBM3;MRRF
prerank,DNA binding (GO:0003677),0.2642945608707167,1.1196584149582374,0.14135021097046413,1.0,1.0,131/694,16.20%,TBX4;LRRFIP1;IRX1;ERCC3;IMPDH1;CTCFL;RAD18;MECOM;CHCHD2;SIM1;ARID5A;ILF3;TFCP2;NR4A2;BANF1;ATF6;TRIM28;CTC1;LEF1;PNKP;KLF2;GTF3C1;PCBP1;PAX8;ZBTB33;ZMYM4;NR5A1;MAP1S;RLF;SIRT3;MMP12;ERCC4;RAD1;FLI1;SMARCA2;SOX2;MEIS1;YY1;USF2;EP300;RFX3;TBX1;TDG;CARF;GTF3C5;SSBP1;CEBPG;CALCOCO1;FOXF2;PPARD;POLE;SFPQ;PMS2;CDC45;LONP1;ZNF638;DRAP1;DCLRE1B;CLOCK;ZNF3;HEY2;ZBTB14;MLH1;PMS1;SOX13;RELA;SPRTN;CENPC;POLA1;HOXA7;PCID2;BCLAF1;RAD23A;TFAP4;MSH3;ERG;PARK7;TARDBP;ZKSCAN3;AIFM1;RYBP;ING2;HIC2;TERT;THRB;DDX3X;RBPJ;RAD51B;HP1BP3;CREBBP;APTX;APP;RPS3;TOP3A;POLR3F;HDGF;TIGD2;ILF2;E2F3;SP1;TAF4B;NBN;IRF2;CHD3;RNF11;NUP35;MPG;EPAS1;DDIT3;HES1;YBX1;GRHL1;BRIP1;TSHZ1;TFAM;INO80;EZH1;TAF6L;TOP1;FOXJ3;TAF1;ANG;ELK4;BCL6;GTF3C2;SMARCA4;TCF7L1;TCF3;TSHZ2;ZBTB18;PURB
prerank,ATP binding (GO:0005524),0.28152207270855695,1.119412526349994,0.20899149453219928,1.0,1.0,56/266,15.74%,THG1L;SNRK;PPIP5K2;HSPA8;OXSR1;HSPA4L;NEK11;PNKP;RPS6KA4;PYGL;RPS6KA5;NME1;MLKL;TDG;PEX1;MTHFS;YARS2;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;SYN3;PEAK1;MINK1;ACVRL1;LATS2;NIM1K;PAPOLA;SRPK2;NLK;P2RX7;OLA1;PNPLA8;LANCL2;PRKCI;MYO9B;MAP4K4;ABCF2;NDUFA13;GSS;PPP5C;TLK2;NEK6;PTPA;TWF1;ABCF3;RRM1;DYRK2;CDKL5;TOP1;MYH9
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4062752131356514,1.1186778875049366,0.3090277777777778,1.0,1.0,3/26,3.56%,CSGALNACT1;CHSY3;EXTL2
prerank,alkali metal ion binding (GO:0031420),-0.44106683527886426,-1.1123286308817495,0.3135593220338983,0.6564773085147444,1.0,3/13,7.60%,ATP1A2;HDAC4;ATP1A1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.38847770895084976,-1.112094057135459,0.3,0.652752931241514,1.0,5/21,32.46%,GRM5;CHRFAM7A;CHRNA7;GRIA1;CHRNB1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.35722960272493043,1.110145659749142,0.3098827470686767,1.0,1.0,14/42,19.52%,PIN1;BCAR3;PFN1;SAMSN1;YWHAB;SYK;YES1;CRKL;LDLRAP1;SHC1;PTPN11;IRS1;YWHAE;FBXW7
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.28094659826989876,1.1095560029645544,0.24455205811138014,1.0,1.0,36/254,12.67%,SOX30;ATF3;CTCFL;MECOM;ONECUT1;TFCP2;NR4A2;ATF6;LEF1;ELK3;GABPA;SMAD1;PRDM15;RLF;PRDM4;MYBL2;MEIS1;YY1;VEZF1;CEBPG;FOXF2;CLOCK;RELA;HOXA7;MDM2;TFAP4;ERG;KLF6;ESR1;RBPJ;NFIC;E2F3;SP1;MZF1;SMARCD1;IRF2
prerank,adenyl ribonucleotide binding (GO:0032559),0.27660255314925214,1.1083734697255805,0.21672555948174324,1.0,1.0,60/291,15.74%,THG1L;GCLC;SNRK;PPIP5K2;PDE4D;HSPA8;OXSR1;HSPA4L;NEK11;PNKP;RPS6KA4;HMGCR;PYGL;RPS6KA5;NME1;MLKL;TDG;PEX1;MTHFS;YARS2;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;SYN3;PEAK1;MINK1;ACVRL1;LATS2;NIM1K;PAPOLA;SRPK2;NLK;P2RX7;OLA1;PNPLA8;LANCL2;PRKCI;MYO9B;MAP4K4;ABCF2;NDUFA13;GSS;PPP5C;TLK2;NEK6;MIEF1;PTPA;TWF1;ABCF3;RRM1;DYRK2;CDKL5;TOP1;MYH9
prerank,protein serine/threonine kinase activity (GO:0004674),0.2722872590899418,1.108072026371692,0.20681551116333724,1.0,1.0,75/335,16.75%,STK32A;MAP3K11;MAPK3;SNRK;GSK3A;OXSR1;MAP3K7;CDK19;PLK2;NEK11;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;PRKD2;RPS6KA5;STK35;MAP3K9;PKN3;SMG1;SLK;MAP3K4;MAPK8;PAK3;CSNK1G3;SIK3;SYK;CDK11B;SBK1;PIM1;TRIO;PIKFYVE;MOK;MINK1;CDK4;ACVRL1;LATS2;CDKL4;NRBP1;PKN1;PAK1;NIM1K;PRKAA2;ACVR2A;SRPK2;NLK;NEK7;PRKCI;MAST4;MAP4K4;MAPK6;IKBKB;MAPK12;CHUK;CHEK2;TLK2;NEK6;BRD2;CSNK2A2;MAP3K10;BMP2K;DYRK2;CDKL5;TOP1;CAMK2G;TAF1;ATR;BRAF;PTK2B;PIK3R4;CDK14;WNK2;RPS6KC1;PRKDC
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.47709011302565363,-1.1080646966764003,0.35918367346938773,0.6592866011291453,1.0,4/10,16.97%,DSE;GLCE;RENBP;DSEL
prerank,vitamin D receptor binding (GO:0042809),-0.4302398499638902,-1.1077338616035022,0.33954451345755693,0.6559064073654435,1.0,11/14,32.37%,MED13;MED1;MED17;SNW1;RXRA;THRAP3;TAF11;MED24;MED16;MED30;TAF7
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.30462653794829575,-1.103879564659724,0.2694300518134715,0.6614961461072729,1.0,15/53,16.05%,DPYD;MICAL2;AOX1;DDO;MICAL3;CRY2;XDH;DLD;MTHFR;CRY1;NOX4;KDM1A;SQOR;PRODH;QSOX1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.37285449069714893,1.103196046154681,0.3089983022071307,1.0,1.0,12/33,16.97%,ARIH1;DCUN1D4;UBA2;AUP1;UBE3D;PARK7;RPS3;RNF180;TCERG1;RNF125;DCUN1D2;DCUN1D1
prerank,hormone receptor binding (GO:0051427),-0.4215507184720789,-1.1023255529066467,0.33192389006342493,0.6611532901626979,1.0,3/14,10.53%,JAK1;NCOA6;SOCS2
prerank,chemokine binding (GO:0019956),-0.34774289331868624,-1.1009321509987073,0.31496062992125984,0.6604107450587713,1.0,24/30,63.14%,PDPN;CCR9;ACKR3;ITGA4;CX3CR1;ITGB3;HMGB1;ZFP36;ITGAV;CCR5;ACKR1;CCR2;CXCR4;PLP2;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;FGF2;ITGB1;CCR6;CXCR2
prerank,calcium-activated potassium channel activity (GO:0015269),0.4741993097438484,1.1003259942820949,0.3504761904761905,1.0,1.0,4/11,9.46%,KCNN2;KCNU1;KCNMB2;KCNMB3
prerank,metalloexopeptidase activity (GO:0008235),-0.3100914156768875,-1.1003234542737146,0.28342245989304815,0.6579985787809177,1.0,10/51,8.27%,CPQ;AEBP1;MMP16;AGBL4;MMP14;PEPD;RNPEP;TRHDE;ANPEP;AGBL3
prerank,carboxy-lyase activity (GO:0016831),0.4024950451288171,1.0998895822566015,0.3315508021390374,1.0,1.0,7/23,16.01%,MLYCD;DDC;AMD1;UXS1;ODC1;ECHDC1;CSAD
prerank,DNA polymerase activity (GO:0034061),0.41184703203943707,1.0987874625170548,0.33220338983050846,1.0,1.0,5/22,10.58%,POLK;POLE;POLD3;POLA1;TERT
prerank,GTPase binding (GO:0051020),0.2861547702210696,1.0966504164973847,0.26700251889168763,1.0,1.0,58/195,17.01%,LCP1;SOD1;CHML;CHM;EVI5L;EXOC8;TBC1D30;CYRIB;MYO5A;CIB1;GNB1;IARS1;LAMTOR1;USP6NL;AP1G1;TRIP11;RABGAP1L;FGD5;RAPGEF6;XPO5;RASIP1;MYCBP2;RANBP1;PKN1;PAK1;GCC2;DOCK7;ATP6AP1;DMXL2;PICALM;MYO9B;PDE6D;ERC1;RRAGC;USP33;KIF3B;RABGAP1;AP3M1;YBX1;ANKRD27;BICD2;ATG16L1;RCC1;RUSC2;PPP6R1;TMEM127;ATG14;RAB3GAP1;WHAMM;CDKL5;BRAF;DOCK4;EXOC2;DNM1L;ABI2;BNIP3;CYFIP1;BECN1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.44103745695449337,-1.0954142165623382,0.3248407643312102,0.6660552275282297,1.0,4/12,20.01%,IGF1;SOCS2;IGF2;PIK3R1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.3222328677489835,-1.0951217651540746,0.3109919571045576,0.6626214647425052,1.0,3/38,2.62%,SPOCK1;TFPI;ANXA2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.35457078334754094,1.0951076105972888,0.32305194805194803,1.0,1.0,11/44,14.55%,MECOM;EZH2;EED;TTLL12;SMYD3;SETD5;SETD3;SETD1B;KMT5B;DOT1L;NSD2
prerank,retinoic acid receptor binding (GO:0042974),0.42361518785009605,1.0922022248192997,0.3732142857142857,1.0,1.0,5/17,14.50%,ARID5A;NR4A2;ACTN4;TACC1;CNOT1
prerank,actinin binding (GO:0042805),-0.3743897213328174,-1.090872549177461,0.35730858468677495,0.6691966691434911,1.0,7/21,12.04%,CACNA1C;PDLIM5;CACNA1D;SYNPO2;NFKB1;RARA;CSRP2
prerank,Toll-like receptor binding (GO:0035325),0.47264131665651077,1.0900429252387174,0.36363636363636365,1.0,1.0,1/11,2.92%,TIRAP
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.4435398267266917,1.0890110512036169,0.3609022556390977,1.0,1.0,5/14,14.37%,MAL;BCL2L13;BAD;NOD1;APAF1
prerank,3'-5' DNA helicase activity (GO:0043138),0.43952020432283384,1.0883367360554235,0.3602811950790861,1.0,1.0,6/16,21.38%,ERCC3;ASCC3;FBH1;NAV2;MCM2;DHX9
prerank,calcium channel inhibitor activity (GO:0019855),0.4794868532238721,1.0858442221935747,0.34962406015037595,1.0,1.0,1/11,0.30%,PHPT1
prerank,GTPase regulator activity (GO:0030695),-0.2425860725618154,-1.083130550348604,0.2,0.6854339544545789,1.0,57/212,16.62%,RIMS1;RANBP3L;ARHGAP42;ALDH1A1;ADGRB3;CPEB2;IQGAP1;DOCK1;TBCK;ERRFI1;ARHGAP10;NRP1;HACD3;ARHGEF10L;DEPDC5;SGSM2;WASL;ARHGAP29;RGS7;GARNL3;ARHGAP32;ARHGAP28;RAB3GAP2;ARFGAP1;BCR;ARHGAP20;ELMOD1;TBC1D22B;NPRL3;TBC1D8B;RGS12;STARD13;ELMOD2;SMAP2;STXBP5;SEC23A;GPSM1;RANBP3;RP2;GMIP;ARHGAP22;GDI1;MTSS2;SIPA1;SIRPA;TBC1D13;TBC1D10A;GNB5;RALBP1;ELMOD3;TBC1D9B;RALGDS;IQGAP2;ARHGAP26;RAPGEF2;RGS20;JUN
prerank,MAP kinase phosphatase activity (GO:0033549),0.45587188145314544,1.0816370311631014,0.367816091954023,1.0,1.0,1/12,1.27%,DUSP7
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3570609765530688,-1.0815794710951632,0.3548387096774194,0.685194152790006,1.0,5/26,11.91%,AEBP1;AGBL4;PEPD;AGBL3;CPM
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.3746037349856358,-1.0813285684339,0.352112676056338,0.6817489437598281,1.0,1/20,0.02%,DLG2
prerank,endonuclease activity (GO:0004519),0.345981444395589,1.08008569004192,0.35303514376996803,1.0,1.0,5/49,5.73%,ZRANB3;ZC3H12D;PNKP;ERCC4;APLF
prerank,glutamate receptor activity (GO:0008066),-0.3906288400171126,-1.0799059116025784,0.363013698630137,0.6811983867263344,1.0,4/19,1.54%,GRIA4;GRIA2;GRID2;GRM5
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3618785736704453,-1.0779713407412304,0.331002331002331,0.6821768673979479,1.0,11/25,21.49%,PARP4;ZC3HAV1;PARP14;SIRT2;PARP6;PARP3;ART3;PARP1;SIRT5;PARP16;PARP2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.2716983343016403,1.0760096964795012,0.2967818831942789,1.0,1.0,62/269,17.18%,PRKAR1A;RAD18;PRR5L;TRIB3;RALB;TRIM28;ARIH1;SLF1;MAP1LC3B;HSPA8;RPL23;CCT2;SPOP;RFFL;TUBB;YOD1;TNFRSF1B;WFS1;RALA;CDKN1A;TPI1;RPL5;BAG1;TRAF5;SMAD7;AXIN1;MAGEC2;NDUFS2;TRAF3;RELA;MDM2;AUP1;FBXO7;MFHAS1;NAE1;ERLIN2;GPI;NLK;SPOPL;PA2G4;ELOB;CUL3;MID1;CHEK2;NEK6;PSMD1;FAF1;APC;NFKBIA;RNF20;FANCL;UBE2G1;GABARAPL1;TUBA1B;TCP1;LAPTM4B;DNM1L;ABI2;SLF2;BECN1;CALR;ATXN3
prerank,voltage-gated sodium channel activity (GO:0005248),-0.3627683452626541,-1.0746336931883047,0.36515513126491644,0.6865577249936912,1.0,5/22,13.05%,HCN1;SCN8A;SCN3A;SCN1A;CACNA1G
prerank,hydro-lyase activity (GO:0016836),0.34941740096951435,1.073283746201336,0.3520900321543408,1.0,1.0,11/41,16.08%,ENO4;CA2;CA4;CDYL;PARK7;HACD2;HSD17B4;ACO1;ECHDC1;NAXD;ECHS1
prerank,syntaxin binding (GO:0019905),-0.2883502427582153,-1.0730287853972202,0.2969187675070028,0.6867168369970559,1.0,22/61,18.86%,SNAP25;STX16;STX8;SYT9;GOLGA2;STXBP5;TMED9;STXBP4;ABCA1;SYT12;RAB11A;UNC13C;STXBP1;SNPH;UNC13B;VAMP2;VPS54;PTPN2;SYT2;DAPK1;VAMP1;SNAP29
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.4434931929012259,-1.0707814511024958,0.38585858585858585,0.6882196009366419,1.0,8/11,36.52%,UBR5;UBE4A;UBE2K;STUB1;UBOX5;UBE4B;PRPF19;RBX1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.4638123053975344,-1.0683781723149992,0.3912175648702595,0.6904586147662634,1.0,6/10,22.86%,CFLAR;CASP12;CASP7;CASP2;CASP9;CASP3
prerank,fibroblast growth factor binding (GO:0017134),-0.36853551282540775,-1.0662963588685228,0.3424657534246575,0.6916590857945012,1.0,4/21,10.73%,FGFR2;CEP57;THBS1;KL
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4421603827296815,-1.0645728723442707,0.4064516129032258,0.6920805611413521,1.0,3/11,28.50%,DDAH1;DDAH2;PADI2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.38092382063371255,-1.0636940247394615,0.37662337662337664,0.6905150713046921,1.0,12/19,24.43%,GRID2;GABRA2;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GABRG1;GABRA1
prerank,nuclease activity (GO:0004518),0.3344642209888001,1.0632969395161638,0.3584905660377358,1.0,1.0,7/52,9.41%,AEN;PNKP;NME1;MAP1S;RNASE6;XRN2;RNASE12
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.3403229880457617,-1.0607263041065609,0.35665914221218964,0.6942960632167458,1.0,13/28,26.54%,GRID2;GABRA2;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GABRG1;GABRA1;CHRNA7
prerank,endodeoxyribonuclease activity (GO:0004520),0.4106217083536393,1.059239119494469,0.3857404021937843,1.0,1.0,6/20,17.41%,ZRANB3;ERCC4;APLF;RPS3;ENDOV;DCLRE1C
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.34908351626668555,-1.0592274871973468,0.34872979214780603,0.6943325798534902,1.0,6/23,16.10%,PDE1A;PDE5A;PDE1C;PDE11A;PDE4B;ADPRM
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.43107133826616034,-1.0587180576505164,0.3950617283950617,0.6918097329316849,1.0,7/12,18.93%,SULF1;SULF2;ARSB;ARSG;ARSK;ARSI;GNS
prerank,protein kinase C activity (GO:0004697),0.4401001690989973,1.0584602469663686,0.41081081081081083,1.0,1.0,4/14,12.23%,PRKCH;SMG1;PKN1;PRKCI
prerank,histone methyltransferase activity (GO:0042054),0.36131910758585,1.0581637999456555,0.38344594594594594,1.0,1.0,8/32,14.58%,EZH2;EED;TTLL12;SMYD3;CARM1;KMT5B;DOT1L;NTMT1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3046472310732618,-1.0563297899668243,0.33875338753387535,0.6941694976504663,1.0,8/47,5.61%,SLC7A11;SLC6A13;SLC7A2;SLC47A1;PDPN;SLC6A1;SLC7A14;SLC1A5
prerank,microtubule minus-end binding (GO:0051011),0.43962661536133896,1.056232873433335,0.38405797101449274,1.0,1.0,3/13,7.37%,HAUS4;TUBGCP5;CAMSAP2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.4390908869284923,-1.0557249635584165,0.3876651982378855,0.6920129910994006,1.0,9/12,52.14%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.27838389210313585,1.0548171631521361,0.34753661784287615,1.0,1.0,22/173,10.43%,SOX30;LRRFIP1;ATF3;IRX1;DACH1;KLF8;GTF2IRD1;ELK3;ZBTB33;BCL6B;HEY1;YY1;NFX1;PPARD;ZNF3;HEY2;ZBTB14;SOX13;RELA;TRPS1;ZKSCAN3;HIC2
prerank,double-stranded RNA binding (GO:0003725),0.3155667677400587,1.0546559499997665,0.3890577507598784,1.0,1.0,26/70,21.38%,LRRFIP1;ILF3;SLC3A2;FXR1;ADAR;ZFR;EIF4H;DDX3X;ADARB2;APTX;AGO4;EIF4B;ILF2;ADARB1;TUBA1B;PRKRIP1;STAU2;DDX60;RC3H1;TFRC;DHX36;DHX30;AGO1;HSP90AB1;DGCR8;DHX9
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.36325099763576996,-1.0545672029980795,0.3795620437956204,0.6910676038606611,1.0,14/23,39.72%,WIPI1;CLVS2;HIP1R;COMMD1;SNX3;SH3PXD2B;HIP1;GBF1;JPH2;MAPKAP1;PLA2G4E;PHLDA3;WDR45;ATP13A2
prerank,G protein-coupled receptor activity (GO:0004930),0.2695297050398751,1.0540172824039604,0.34002509410288584,1.0,1.0,13/239,6.34%,MTNR1A;GPR176;GPR52;ADGRE1;GPR63;NPFFR1;ADGRL4;ADGRL3;PAX8;TSHR;HCRTR1;XPR1;RXFP1
prerank,ribosomal small subunit binding (GO:0043024),0.4122292432448402,1.053750557583501,0.39853747714808047,1.0,1.0,9/17,20.22%,NME1;PIM1;EIF4H;DDX3X;EIF4B;NPM1;LARP1;MTIF2;EIF1
prerank,snRNA binding (GO:0017069),0.34042436822850775,1.0521229606071831,0.3818770226537217,1.0,1.0,14/42,18.64%,EIF5A;RBM22;PRPF31;GEMIN5;SF3B3;SNU13;COIL;EFTUD2;SNRPA;RBM41;SNRPA1;HEXIM1;SNRPB2;SNRPD3
prerank,ion gated channel activity (GO:0022839),-0.3483698833548391,-1.0513343758438984,0.3824228028503563,0.6952663747814716,1.0,10/24,28.93%,ANO3;ANO1;TMEM63A;ANO6;TMEM63B;ANO10;KCNT1;TTYH3;TTYH1;TMEM63C
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.4170261094681226,-1.0494419041165193,0.40325865580448067,0.6962600957794627,1.0,5/13,23.63%,FAN1;DICER1;DNASE1L1;ZGRF1;SLX4
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.4636052392586273,1.047106403578079,0.406,1.0,1.0,1/10,1.27%,DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.4636052392586273,1.047106403578079,0.406,1.0,1.0,1/10,1.27%,DUSP7
prerank,amino acid binding (GO:0016597),-0.3284541885302469,-1.0468558847865839,0.3786848072562358,0.6988108379120438,1.0,7/31,10.84%,GRIN2B;GLRB;SRR;GLRA3;CASTOR2;GLRA1;DDAH1
prerank,protein phosphatase binding (GO:0019903),-0.25069416845745796,-1.0466939633007795,0.3377926421404682,0.6955322207803185,1.0,39/117,21.96%,EGFR;IQGAP1;AP3B1;JAK1;MAPK14;DLG4;MAPT;CTNNB1;PXN;VCP;MYO16;ENSA;STAT6;CDKN1B;ARPP19;MAP3K5;TP53;IKBKE;KIF3A;SIRPA;VRK3;RACK1;PTK2;MTMR9;PPME1;MTMR4;TRAF2;FBXL2;SNX3;SHOC2;MET;PPP1R16A;PIK3R1;PPP6R3;ITGA1;PPP1R3B;ADCY8;SH3RF2;PDLIM4
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.45602368389087605,1.0458459552497317,0.3945945945945946,1.0,1.0,2/11,3.76%,NUDT11;NUDT5
prerank,Hsp90 protein binding (GO:0051879),-0.32208879405475244,-1.0453841278639369,0.36828644501278773,0.6951458968086459,1.0,10/33,19.23%,PACRG;MAPT;SLC12A2;PPID;HSF1;USP19;NPAS2;NR3C1;TSC2;STUB1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.27691378253412297,-1.0453188027255045,0.3421828908554572,0.691597171038848,1.0,14/70,17.33%,MGAT4C;GXYLT2;OGT;B4GALT1;CHSY1;HEXA;CSGALNACT2;HEXB;XXYLT1;LARGE1;B3GALT5;B3GALNT1;B3GALT1;POGLUT3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2577900177743546,1.0443678230674247,0.3628938156359393,1.0,1.0,74/346,16.65%,FBXL6;RNF7;CBL;TRIM28;ARIH1;RNF149;TNFAIP3;RNF38;RFFL;BIRC2;RSPRY1;NEDD4L;NEURL2;VPS11;ANKRD39;NHLRC1;RBBP6;FBXL5;UBE3A;TRIM14;FBXW2;IRF2BPL;RNF130;NFX1;COP1;TRAF5;RNF187;PPP1R11;LMO7;TTC3;TRIM25;AKTIP;FBXO11;TRAF3;RBCK1;MDM2;PJA2;RFWD3;MYCBP2;UBE3D;RNF6;ZNRF1;FBXO7;UBE2M;RNF13;RNF25;CHFR;ANAPC11;DTX4;ANAPC4;RNF11;CUL3;UBE2R2;RNF146;RNF216;TSPAN17;RNF180;TRIM27;RNF20;FANCL;TRIM3;NHLRC3;UBE2G1;FBXO22;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF128;RNF125;UBE2H;KLHL13;VPS18
prerank,kinase binding (GO:0019900),-0.21660875456998194,-1.043118327400544,0.25663716814159293,0.6931617341776917,1.0,115/435,19.23%,DLG2;ANK2;PRKAG2;BICD1;MAPK4;NBEAL1;SASH1;EGFR;GSN;SMAD3;IQGAP1;WWC2;PDGFRB;PKD1;DNAJC3;SNAP91;ERRFI1;TNS2;UFL1;CYLD;TOM1L2;DLG4;MAPT;IFNAR2;CTNNB1;WNK1;RHOA;AP2A2;MAML1;FLNA;PRKAG1;UNC5C;GHR;VDAC1;PIP5K1A;SLC12A2;CIT;PRKCD;CAB39;SKI;HTT;IRAK1;IL31RA;SRCIN1;TAX1BP1;CDKN1B;IRAK3;AP2A1;GOLGA2;CEP152;SYN1;SIK1;RND3;CNOT9;DLG3;PRKACA;RHOBTB2;CCND3;GSK3B;STRADA;CAMK2N1;EEF2;VRK2;DCX;TP53;ILK;PER1;PRKAB2;HSF1;RHOB;GRB2;RPS7;TPRKB;RPS6;RHOBTB1;GYS1;TOLLIP;PIK3IP1;DLG1;MSH2;RELB;SHC3;DNM1;POLR2A;CSPG4;PTK2;MAP3K12;CAV2;PTPN22;CCNK;TOM1L1;DCTN1;TRAF2;PTPN23;TCF7L2;PTPN2;CEP250;STX1A;GPRC5B;IRAK4;SLC12A4;NR3C1;SV2A;DVL1;MAP3K1;CDC42;MAVS;JTB;ADD2;PARP1;MSN;TRIM5;ATF5;HNRNPA0;STUB1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.38980643070703047,1.039415467349386,0.41083916083916083,1.0,1.0,5/22,9.11%,ZRANB3;TNFAIP3;TAB2;TAB3;SPRTN
prerank,mRNA 5'-UTR binding (GO:0048027),0.37783074401685596,1.0389748380136068,0.37222222222222223,1.0,1.0,8/24,19.34%,CCT5;RPS14;RPL5;DDX3X;RSL1D1;RPL26;DHX36;LARP1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.4391371710503675,-1.0383801160788275,0.40824742268041236,0.7013094867229948,1.0,6/11,22.86%,CFLAR;CASP12;CASP7;CASP2;CASP9;CASP3
prerank,transforming growth factor beta binding (GO:0050431),-0.3561370939707027,-1.0375941253519387,0.37383177570093457,0.6994870761824159,1.0,11/23,24.93%,TGFBR3;TGFBR1;TGFBR2;ACVR1;THBS1;LTBP1;CD109;TWSG1;NRROS;TGFB3;VASN
prerank,cardiolipin binding (GO:1901612),0.46604893697750166,1.0373959551343555,0.41779497098646035,1.0,1.0,2/10,5.21%,MME;UQCC3
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3852199797657236,1.0367795325350309,0.4080145719489982,1.0,1.0,2/22,3.68%,DUSP7;DUSP12
prerank,protein kinase activator activity (GO:0030295),-0.27911195545252293,-1.0357796357237374,0.3563218390804598,0.700349814316375,1.0,15/60,14.79%,PRKAG2;GRM5;IQGAP1;ABI1;WNK1;ERCC6;CAB39;MAP2K2;STRADA;STK11;TAOK1;FAM20A;IGF2;MADD;RPLP1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.43471605751241726,1.0324552771590136,0.42857142857142855,1.0,1.0,4/13,14.06%,THUMPD2;TRMT11;TRMT10B;WDR4
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.23453535345788548,-1.0322659384302242,0.3378995433789954,0.7056258933921522,1.0,54/181,21.69%,ARNT2;SMAD3;MIER1;PRRX1;HDAC4;CHD4;MAPK14;CTNNB1;RBL2;HDAC1;GTF2I;MED1;TTC8;PPARGC1A;ANXA4;WWP2;PPARA;MTA3;LDB1;SPEN;BHLHE40;SNW1;PSMA6;RXRA;GSK3B;SMARCD3;MTA1;TP53;CRY1;TBX3;DDRGK1;NCOA1;PIAS3;KDM1A;DACT1;ATN1;BBS2;COMMD7;TEAD3;TAF6;CTDP1;TCF7L2;JUN;TADA3;MTDH;BBS5;STAT1;MTA2;PIAS4;BHLHE41;HSPB1;DTX3L;ATF4;ELK1
prerank,peptide hormone receptor binding (GO:0051428),0.4514998044742787,1.0319775765864347,0.4090909090909091,1.0,1.0,1/11,3.53%,GNRH1
prerank,cation:chloride symporter activity (GO:0015377),0.46488699895320623,1.0313744131169278,0.4468503937007874,1.0,1.0,1/10,0.15%,SLC12A1
prerank,protein homodimerization activity (GO:0042803),0.24634524176029865,1.0298009310307181,0.3951965065502183,1.0,1.0,110/590,16.21%,CIDEA;MIGA1;LRRFIP1;ATF3;CADM1;MAP3K11;SYNE1;BANF1;ABCB10;TMEM266;GLB1;GYG1;PECAM1;ABCG2;BCL2L2;GREM1;ZHX3;TRIM8;NUDT5;MAP3K9;GBP3;MME;EXT2;APOE;SLK;PHB2;TOX3;TRIM14;B2M;USF2;TPI1;SMIM1;TBX1;TDG;FXR1;KCNN2;YARS2;GBP4;PRPS1L1;PRPS1;SSBP1;PTPRT;PEX7;CHMP1A;SFPQ;ACTN4;F11R;SPPL3;HARS1;TXN;DCLRE1B;AXIN1;GALM;SNX1;RASIP1;RELA;CARNMT1;CSF1R;RAB11FIP2;RABEP1;NRBP1;FZD9;EXD2;TFAP4;MSH3;PARK7;CACYBP;S100A16;TERT;NQO2;GTF2A2;CISD2;NOD1;HSD17B4;ATG7;BNIP3L;MYO9B;SP1;IKBKB;CRPPA;MZF1;STARD3NL;CHUK;TPM2;DSCAML1;TENM4;PAPSS1;GSS;MID1;PLEK;CHEK2;DDIT3;HES1;GRHL1;TRIM27;PTPA;GCH1;MAP3K10;IMPA1;S100A13;UXS1;ODC1;TPD52L1;CAMK2G;ANG;MYH9;STARD3;KLHL7;TCF3;DNM1L
prerank,GTPase activator activity (GO:0005096),0.25342163391994577,1.0273015480299945,0.4004711425206125,1.0,1.0,85/313,17.58%,THG1L;RGS2;TIAM1;VAV3;GNAQ;EEF1D;RGS5;EVI5L;CYTH4;CHN2;NUCB2;TBC1D30;TBC1D8;RALGAPA2;RGS8;ITSN1;TBC1D9;STXBP5L;RASGRP3;ARHGAP25;TBC1D10B;DENND5B;ARHGEF6;LAMTOR1;USP6NL;ARHGEF7;TBC1D4;CCDC88C;RALGAPB;RAPGEF3;DENND1A;RABGAP1L;RGS10;RAP1GDS1;ARHGEF18;RAPGEF5;RGS3;FGD5;EIF2B3;RAPGEF6;DOCK9;TBC1D12;MYCBP2;RANBP1;PLCB1;ACAP2;OPHN1;TBC1D25;ARHGAP39;SBF2;NF1;PREX2;ADPRH;MYO9B;SMAP1;LARS1;TBC1D14;RABGAP1;EEF1B2;EPS8L1;RGL2;ARHGAP15;ELMO1;ANKRD27;RALGAPA1;DENND4C;SYDE1;ARHGEF10;ASAP1;RCC1;DENND1B;DOCK8;RAB3GAP1;GAPVD1;DOCK4;DNM1L;RASGRF2;ARHGAP27;WDR41;ARFGAP2;ASAP2;ARHGAP9;RGL1;RANGAP1;RCC1L
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.3892472682623789,-1.026380384656918,0.4051172707889126,0.7170621513949016,1.0,10/15,35.98%,KMT2A;RBBP5;KMT2B;KMT2D;SETD4;WDR5;WDR82;PRDM9;CXXC1;SETMAR
prerank,growth factor receptor binding (GO:0070851),-0.2536305649274126,-1.0248426824361418,0.3779264214046823,0.7172189279776522,1.0,18/95,16.34%,ERBB4;PDGFRB;SNX2;FGF1;SNX4;FER;IL6R;PIBF1;EFEMP1;PDGFRA;ITGA5;CNOT9;PLSCR1;KL;GRB2;IL6ST;ARF4;PDGFD
prerank,ubiquitin binding (GO:0043130),-0.27077132501397044,-1.0248113402618333,0.396875,0.7136007761681874,1.0,30/73,20.89%,SMAD3;UBXN7;UBE2N;SIRT2;UBXN2A;USP13;ILRUN;UBXN2B;USPL1;RNF168;NPLOC4;NSFL1C;BUB3;TOLLIP;IKBKG;DDI2;RNFT1;RNF19B;TSG101;TOM1L1;UCHL3;GGA3;USP16;RNF31;OTULINL;USP5;RAE1;NEDD4;DNAJB2;HSPB1
prerank,nuclear receptor coactivator activity (GO:0030374),0.32037920616729076,1.024082615198729,0.41732283464566927,1.0,1.0,16/52,14.35%,CCDC62;DCAF6;CALCOCO1;MED12;ACTN4;ATXN7L3;PKN1;BUD31;CCAR2;TACC1;USP22;CARM1;MED4;SS18;CNOT6;NCOA7
prerank,sequence-specific DNA binding (GO:0043565),0.2448363794646222,1.0235599607483996,0.40108695652173915,1.0,1.0,65/590,10.80%,SOX30;ATF3;IRX1;CTCFL;FOXQ1;CHCHD2;ARID5A;ONECUT1;FOXN2;TFCP2;NR4A2;ATF6;CTC1;LEF1;HES6;KLF2;ELK3;PAX8;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;HEY1;NR5A1;SIRT3;MMP12;IRF9;PRDM4;MYBL2;FLI1;BBX;SOX2;SMG1;YY1;GMEB2;KDM2A;ZNF740;USF2;CPSF4;RFX3;TBX1;CHTOP;CEBPG;CALCOCO1;FOXF2;PPARD;LONP1;CLOCK;TET3;HEY2;ZBTB14;ACD;SOX13;UPF2;JUND;HOXA7;TFAP4;ERG;ZKSCAN3;KLF6;ESR1;TERT;THRB;RBPJ
prerank,myosin binding (GO:0017022),-0.2836389025358658,-1.0233313093972558,0.3902439024390244,0.7135173829753949,1.0,9/55,7.31%,CALD1;KIRREL1;GSN;RAB3C;MOBP;RHOA;SPATA6;TRAK1;RAB27B
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3751242825001251,1.0193918723263453,0.4194107452339688,1.0,1.0,8/22,18.04%,ATP6V1D;ATP2A2;ATP6V0D1;ATP6V0E1;ATP2C1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,cadherin binding (GO:0045296),0.2526641679894193,1.017680300707465,0.4224343675417661,1.0,1.0,98/315,19.94%,LRRFIP1;EFHD2;PSMB6;CBL;PTPRJ;NUDC;VASP;BSG;HSPA8;EIF2A;GLOD4;PTPRM;EEF1D;EHD4;PCBP1;SRC;PTPRB;FLNB;MRTFB;CDH2;SLC3A2;PROM1;ESYT2;PFN1;HNRNPK;SLK;RAB11B;EPS15L1;YWHAB;PTPRT;CDH12;RPS26;F11R;RUVBL1;TRIM25;DOCK9;ITGA6;EIF4H;TJP1;SNX1;RAB1A;RANBP1;PARK7;EIF4G2;RPL24;DDX3X;RPL34;PI4KA;OLA1;AHSA1;PICALM;CRKL;UNC45A;CDH5;ERC1;EPS8L1;RPL23A;GIPC1;APC;HCFC1;TWF1;ABCF3;ASAP1;EIF5;FXYD5;GAPVD1;MYH9;RSL1D1;PACSIN2;CDH13;PFKP;CD2AP;LDHA;BAIAP2;CAPZA1;UBAP2;RANGAP1;PTPN11;EPN2;ARGLU1;CD46;GOLGA3;RPL15;RDX;CNN3;RPS2;FNBP1L;SH3GLB1;BZW2;YWHAE;EIF3E;LARP1;ADD1;KIF5B;SEPTIN9;RPL14;PKN2;PAK2
prerank,deubiquitinase activity (GO:0101005),-0.25346115481937515,-1.0175446069256024,0.4150326797385621,0.7245272309936902,1.0,35/88,23.51%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP38;USP50;USP34;USP19;USP20;UCHL3;USP7;USP10;TANK;USP1;USP16;USP42;USP5;USP45;EIF3F;COPS5;MYSM1;JOSD1;USP35;EIF3H;USP49;USP2;USP46;USP24
prerank,omega peptidase activity (GO:0008242),-0.2518353735967182,-1.015603575780583,0.39869281045751637,0.7257874758675075,1.0,35/89,23.51%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP38;USP50;USP34;USP19;GGT5;USP20;UCHL3;USP7;USP10;TANK;USP1;USP16;USP42;USP5;USP45;COPS5;MYSM1;JOSD1;GGH;USP35;USP49;USP2;USP46;USP24
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.38311355351055854,1.0150147968542498,0.4402730375426621,1.0,1.0,4/21,9.29%,POLK;POLE;POLD3;POLA1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.44629459674157723,1.0100923144916496,0.4563106796116505,1.0,1.0,4/10,14.60%,PIK3CG;PIK3C2G;PIK3CD;PIK3C2A
prerank,chemokine receptor activity (GO:0004950),-0.33534051429401246,-1.0089071314400424,0.41517857142857145,0.7396182072667259,1.0,18/24,63.14%,CCR9;ACKR3;CMKLR1;CX3CR1;CCR5;GPR35;CCR2;CXCR4;GPR75;GPR17;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,single-stranded RNA binding (GO:0003727),0.326672930101578,1.008645158190487,0.4511400651465798,1.0,1.0,18/43,21.38%,ILF3;FXR1;LONP1;ZFR;EIF4H;DDX3X;ADARB2;AGO4;EIF4B;PTBP1;U2AF2;ENDOV;HNRNPF;DDX60;AGO1;AQR;CNBP;DHX9
prerank,disordered domain specific binding (GO:0097718),0.37387196874997347,1.0072375836550636,0.4515539305301645,1.0,1.0,4/23,9.39%,BCL2L2;FYN;CALM3;MDM2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.39811363945110434,1.0070901411253472,0.44609665427509293,1.0,1.0,1/15,0.29%,CISH
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4214088441904123,-1.0066128921551525,0.46331236897274636,0.7418064960969243,1.0,5/11,13.99%,SLC1A3;SLC6A13;SLC6A1;SLC6A12;SLC6A15
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.34039981368707517,1.0038317690994236,0.460655737704918,1.0,1.0,10/34,13.09%,NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.34039981368707517,1.0038317690994236,0.460655737704918,1.0,1.0,10/34,13.09%,NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,intracellular chloride channel activity (GO:0061778),-0.3705758708146909,-1.0028975266856734,0.46637744034707157,0.7438631558705414,1.0,9/16,40.32%,ANO3;ANO1;ANO6;ANO10;TTYH3;TTYH1;ANO5;ANO8;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.3705758708146909,-1.0028975266856734,0.46637744034707157,0.7438631558705414,1.0,9/16,40.32%,ANO3;ANO1;ANO6;ANO10;TTYH3;TTYH1;ANO5;ANO8;ANO2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.45278738732094026,1.0019507698917915,0.49581589958158995,1.0,1.0,2/10,7.85%,MECOM;SETD5
prerank,transferrin receptor binding (GO:1990459),-0.43005841262147415,-1.0011692388114593,0.4693446088794926,0.7444562933281672,1.0,3/10,3.62%,SNX2;RGMA;SNX4
prerank,kinase inhibitor activity (GO:0019210),-0.3086905773337418,-1.000773322984679,0.4212962962962963,0.7418146258232418,1.0,17/33,32.79%,PARVA;DNAJC3;GMFB;TAOK3;CDKN1B;DUS2;LRP6;SH3BP5;SH3BP5L;RHOH;TRIB1;QARS1;SNCA;CDKN1C;NCK1;MAPK8IP1;SMCR8
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.25070871463265626,-1.0006702083538972,0.445859872611465,0.7384751822492105,1.0,34/83,24.42%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP38;USP50;USP34;USP19;USP20;UCHL3;USP7;USP10;TANK;USP1;USP16;USP42;USP5;USP45;COPS5;MYSM1;JOSD1;USP35;USP49;USP2;USP46;USP24;OTUD7B
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.23912164298697317,1.000168259536187,0.49019607843137253,1.0,1.0,80/597,14.11%,SOX30;ATF3;IRX1;CTCFL;FOXQ1;ARID5A;ONECUT1;FOXN2;TFCP2;NR4A2;MTERF3;TAL1;ATF6;LEF1;HES6;KLF2;ELK3;PAX8;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;ORC3;HEY1;NR5A1;IRF9;PRDM4;MYBL2;FLI1;BBX;SMARCA2;SOX2;YY1;GMEB2;ZNF740;USF2;CPSF4;BEND3;RFX3;TBX1;CEBPG;CALCOCO1;PPARD;SFPQ;CDC45;CLOCK;ORC4;HEY2;ZBTB14;SOX13;RELA;CENPC;JUND;POLA1;HOXA7;TFAP4;ERG;KLF6;ESR1;THRB;CARM1;ORC2;NFIC;ZBED4;E2F3;SP1;MZF1;IRF2;CHD3;TBP;ZBTB45;TGIF1;HDAC5;DDIT3;THRA;HES1;YBX1;GRHL1;SP8
prerank,1-phosphatidylinositol binding (GO:0005545),-0.383498725233047,-0.9969068144908859,0.4595744680851064,0.7444095682075353,1.0,4/15,8.83%,WDFY3;SNAP91;EEA1;ZFYVE16
prerank,organic anion transmembrane transporter activity (GO:0008514),0.27254767251125517,0.9968322413367859,0.4535666218034993,1.0,1.0,29/134,16.56%,SLC7A8;SLC1A1;SLC36A4;ABCC4;SLC25A1;SLC25A24;ABCG2;SLC3A2;SLC52A2;SLC52A3;SLC6A6;SLC17A6;SLC1A2;SLC35A1;SLC35B1;SLC25A2;SFXN5;SFXN1;SLC25A12;SLC35A3;MPC2;SLC38A5;SLC66A1;SLCO1C1;SLC25A21;SLC25A42;SLC16A1;SLC25A38;SLC25A25
prerank,potassium ion antiporter activity (GO:0022821),0.39919102172886783,0.9950896185673141,0.4664246823956443,1.0,1.0,3/15,6.96%,SLC9A7;SLC9A6;SLC9A8
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.4236555607699787,0.9948648499116299,0.4806201550387597,1.0,1.0,4/12,14.60%,PIK3CG;PIK3C2G;PIK3CD;PIK3C2A
prerank,phospholipase activity (GO:0004620),0.2925096625323141,0.9948423333881811,0.43517138599105815,1.0,1.0,10/67,14.23%,FAM83B;SMPD4;PLAAT3;PNPLA7;SEC23IP;DDHD1;PNPLA8;ABHD12;ABHD4;PNPLA6
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3389291402594478,-0.9947873330251088,0.46292134831460674,0.7466361227264519,1.0,8/24,21.35%,PLA2G4A;PLEKHA8;OSBP;OSBPL5;SNX3;ARFIP2;GSDMD;OSBPL8
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.3666268956274895,-0.9947753974793615,0.4798387096774194,0.7430746012833727,1.0,8/17,21.78%,GRIA4;GRIA2;GRIN2B;GRIK4;GRIK1;GRIK3;GRIN2D;GRIN1
prerank,G protein-coupled receptor binding (GO:0001664),0.26819600097949486,0.9947536659311348,0.4666666666666667,1.0,1.0,12/132,8.84%,RTP3;REEP1;SAG;HSPA8;GNAQ;CXCL12;INSL3;CCDC88C;GNA12;CCL25;WNT5A;GNA11
prerank,ribosome binding (GO:0043022),-0.2821944311791128,-0.994488239846202,0.46825396825396826,0.7403574494924482,1.0,12/46,14.34%,CPEB4;CPEB1;CPEB2;SEC61A1;EIF3C;YTHDF1;EEF2;TMCO1;SRP72;SRP19;RACK1;NOMO1
prerank,voltage-gated ion channel activity (GO:0005244),-0.3867966114836231,-0.9930554208161647,0.468682505399568,0.7404636517859132,1.0,3/14,5.72%,HCN1;KCND2;VDAC1
prerank,microtubule plus-end binding (GO:0051010),0.37037906359172473,0.9925709315525727,0.4935779816513762,1.0,1.0,9/20,19.51%,KIF18A;CLASP2;DST;CLIP2;APC;CLIP1;CLASP1;PAFAH1B1;MAPRE3
prerank,glycerophospholipid flippase activity (GO:0140333),0.43359472195746107,0.99209609896081,0.4841897233201581,1.0,1.0,4/11,13.90%,ATP8A1;ATP11A;ATP11C;ATP10A
prerank,myosin V binding (GO:0031489),0.40028923173183495,0.9920019793720526,0.48056537102473496,1.0,1.0,4/15,8.22%,RAB11B;RAB6B;RAB6A;RAB14
prerank,ion channel inhibitor activity (GO:0008200),0.3380180245923868,0.9895851332316877,0.47692307692307695,1.0,1.0,3/35,4.22%,PHPT1;RSC1A1;NEDD4L
prerank,glutamate receptor binding (GO:0035254),-0.3587181530784957,-0.9882099872380504,0.4557522123893805,0.7486724170876202,1.0,8/17,26.60%,DLG4;SYNDIG1;SHISA6;IGSF11;SHANK2;SHANK1;CAMK2A;HIP1
prerank,chemoattractant activity (GO:0042056),-0.3271205355880873,-0.9877022619073891,0.4810126582278481,0.7464300764791362,1.0,14/26,44.02%,BMP4;SCG2;CX3CL1;VEGFA;VEGFB;PGF;FGF10;FGF7;HMGB1;HMGB2;HGF;MIF;NTF3;GDNF
prerank,C-C chemokine binding (GO:0019957),-0.33163877303911937,-0.9871333030686639,0.44419134396355353,0.7443239389879956,1.0,16/22,63.14%,CCR9;ACKR3;CX3CR1;ZFP36;CCR5;ACKR1;CCR2;CXCR4;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,mRNA binding (GO:0003729),0.25079862581999407,0.9864269910240616,0.5018773466833542,1.0,1.0,76/249,19.40%,ZC3H12D;NCBP1;KHDRBS3;EIF2A;LARP4B;PCBP1;ZFP36L1;HNRNPAB;SF1;QKI;CCT5;HNRNPK;MYEF2;RPS14;FXR1;RPL5;RBM20;SLC4A1AP;RPS26;HNRNPC;GEMIN5;YTHDC1;FYTTD1;SRSF4;SECISBP2L;XPO5;NOVA2;DXO;MARF1;PARK7;TARDBP;CPSF6;EIF4G2;NCBP3;DDX3X;NANOS3;RPS3;PTBP1;PCBP3;ACO1;G3BP2;RPL35;RNF20;SCAF8;DCP1A;SSB;RBM4B;SF3B6;PPP1R8;HNRNPL;NOCT;TRA2B;ADARB1;SLBP;TDRD7;UPF3B;RSL1D1;PURB;PARN;N4BP1;LARP4;CALR;EIF2S2;EIF3A;RPL26;LUC7L2;RC3H1;RPS2;NSRP1;EIF4G1;CLUH;MRPL13;DHX36;HNRNPM;LARP1;DCP1B
prerank,protein kinase binding (GO:0019901),0.23610019562779955,0.9854575223500438,0.5234375,1.0,1.0,77/480,14.25%,FAM83B;RAC2;FRMD5;PRKAR1A;MAP2K7;MAP3K11;PTPRR;GSK3A;CKS2;TRIB3;DUSP7;PTPRJ;EEF1A1;OXSR1;PIN1;PTPRC;MTCP1;ACTB;RPTOR;TIRAP;HDAC7;HDAC9;RFFL;PRKD2;SMAD1;NEK9;CDK5RAP1;LRBA;RBBP6;SPRED1;DCTN2;TRIM14;CDKN1A;ARHGEF7;RGCC;CALM3;FBXO5;SIRT1;CADPS;AXIN1;TRPV4;PRAM1;PLCG1;ACVRL1;RELA;RAB11FIP2;POLA1;PJA2;PKN1;FBXO7;PPP1R12A;CIR1;RNF13;ESR1;BAD;RHOG;ADIPOR1;USP37;RPS3;NBR1;CENPJ;TNIP2;IKBKB;KIZ;CDH5;TBC1D14;ACTA2;CTBP2;HDAC5;PLEK;CHEK2;NEK6;FAF1;MAP2K6;APC;TRIM27;GCH1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4030941989242777,-0.9847413271391996,0.5086580086580087,0.7469310455918784,1.0,5/11,36.93%,SLC2A10;SLC5A3;SLC17A5;SLC5A11;SLC2A9
prerank,protein tyrosine kinase binding (GO:1990782),-0.2589583445071424,-0.9846158295640964,0.4634146341463415,0.7438046113372411,1.0,18/71,19.91%,GRM5;KHDRBS1;PTPN14;NEDD9;ACVR1;TP53;NOX4;PITPNM3;SIRPA;SHC3;DUSP22;RACK1;TOB1;PTPN2;SOCS5;ANGPT2;CPNE3;BMPR2
prerank,nucleosomal DNA binding (GO:0031492),0.365940695742035,0.9813648472441504,0.4561717352415027,1.0,1.0,8/21,19.08%,ACTL6A;ACTB;HNRNPC;RCC1;SMARCA4;RBBP4;HDAC2;SMARCB1
prerank,vinculin binding (GO:0017166),-0.41174190565431323,-0.9801104733589365,0.4927536231884058,0.751429394870504,1.0,3/11,5.11%,CTNNA1;TLN1;PXN
prerank,small GTPase binding (GO:0031267),0.2597292607130716,0.979831763062116,0.512258064516129,1.0,1.0,46/170,16.30%,SOD1;CHML;CHM;EVI5L;EXOC8;TBC1D30;CYRIB;MYO5A;CIB1;USP6NL;AP1G1;TRIP11;RABGAP1L;FGD5;RAPGEF6;XPO5;MYCBP2;RANBP1;PKN1;PAK1;GCC2;DOCK7;ATP6AP1;DMXL2;PICALM;MYO9B;PDE6D;ERC1;USP33;KIF3B;RABGAP1;AP3M1;ANKRD27;BICD2;RCC1;RUSC2;PPP6R1;TMEM127;RAB3GAP1;WHAMM;CDKL5;BRAF;DOCK4;EXOC2;DNM1L;ABI2
prerank,pyridoxal phosphate binding (GO:0030170),-0.3437270986233026,-0.9783157153461123,0.4851694915254237,0.7525898770546928,1.0,3/20,4.23%,PYGB;ABAT;SRR
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3771557459461571,-0.9780965618887951,0.48156182212581344,0.7497376686346185,1.0,10/16,53.40%,PIR;CDO1;ETHE1;ALOX12;ADI1;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.37452548139093217,0.9780130454874421,0.48807339449541287,1.0,1.0,1/18,0.29%,CISH
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.23192687354109723,0.9771793642754252,0.5727848101265823,1.0,1.0,76/731,10.86%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;ONECUT1;KLF8;FOXN2;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;PAX8;ZBTB24;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;SMAD1;ZKSCAN1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MYBL2;SOX2;MEIS1;YY1;GMEB2;ZNF83;ZNF740;USF2;RFX3;TBX1;ZNF260;CARF;CEBPG;CALCOCO1;FOXF2;PPARD;ZNF205;CLOCK;KDM6A;HEY2;ZBTB14;SOX13;RELA;JUND;HOXA7;TFAP4;ERG;ZKSCAN3;KLF6;WBP2;MGA;HIC2;ESR1;THRB;RBPJ;DACH2
prerank,ATPase regulator activity (GO:0060590),-0.2909308776407669,-0.9764478784937156,0.48641975308641977,0.7502766466650915,1.0,11/38,17.90%,TOR1AIP2;ATP1B1;DNAJC24;ATP1B3;BAG3;DNAJC19;TOR1AIP1;ATP1B2;FNIP1;ATP5IF1;DNAJB4
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.41523821869120303,0.9752564442440923,0.4839924670433145,1.0,1.0,2/13,1.52%,PTPRJ;IL1R1
prerank,thyroid hormone receptor binding (GO:0046966),0.34831936041812306,0.9730726144697985,0.479020979020979,1.0,1.0,7/28,11.72%,ARID5A;GAS2L1;MED12;GTF2H1;TACC1;MED4;JMJD1C
prerank,double-stranded DNA binding (GO:0003690),0.23306770560841436,0.9722110953352986,0.5538793103448276,1.0,1.0,59/531,11.72%,SOX30;ATF3;IRX1;FOXQ1;ONECUT1;FOXN2;TFCP2;NR4A2;ATF6;LEF1;HES6;PNKP;KLF2;ELK3;PAX8;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;HEY1;NR5A1;IRF9;PRDM4;MYBL2;FLI1;BBX;YY1;GMEB2;ZNF740;USF2;CPSF4;RFX3;TBX1;TDG;CEBPG;PPARD;ZNF638;CLOCK;HEY2;ZBTB14;SPRTN;JUND;HOXA7;PCID2;TFAP4;MSH3;ERG;PARK7;TARDBP;KLF6;ESR1;THRB;RAD51B;APTX;NFIC;RPS3;POLR3F;HDGF
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.2587168469353598,0.9720314077587004,0.5045751633986928,1.0,1.0,40/147,17.58%,THG1L;TIAM1;VAV3;EEF1D;CYTH4;NUCB2;ITSN1;DENND5B;ARHGEF6;LAMTOR1;ARHGEF7;CCDC88C;RAPGEF3;DENND1A;ARHGEF18;RAPGEF5;FGD5;EIF2B3;RAPGEF6;DOCK9;MYCBP2;SBF2;PREX2;EEF1B2;EPS8L1;RGL2;ELMO1;ANKRD27;DENND4C;ARHGEF10;RCC1;DENND1B;DOCK8;RAB3GAP1;GAPVD1;DOCK4;RASGRF2;WDR41;RGL1;RCC1L
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.42058018859976165,-0.9698910145801365,0.5283018867924528,0.7627183277457846,1.0,5/10,19.78%,DLG4;SHISA6;IGSF11;SHANK2;SHANK1
prerank,neuropeptide hormone activity (GO:0005184),0.35598969784534207,0.9688908250356694,0.5062836624775583,1.0,1.0,22/22,64.45%,PPY;AGRP;OXT;CORT;QRFP;HCRT;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;NMB;PNOC;NPFF;NPY;GRP;SPX;CCK;PENK;ADCYAP1
prerank,calcium channel regulator activity (GO:0005246),-0.2881595558572521,-0.9683204005349205,0.5278514588859416,0.7628554673327421,1.0,8/37,12.21%,ITPR1;STIM2;NRXN1;STIM1;SGK1;CACNG7;NRXN2;SRI
prerank,LRR domain binding (GO:0030275),0.4014493012207075,0.9677666077339365,0.5163147792706334,1.0,1.0,5/14,13.40%,POLR2J;MRTFA;ZXDC;ERC1;DDIT3
prerank,triglyceride lipase activity (GO:0004806),-0.3415736858015074,-0.9663929048062451,0.5022522522522522,0.763980431394059,1.0,7/20,38.39%,ABHD5;LIPE;PLA2G15;DDHD2;PNPLA2;LPL;PNPLA3
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3039103005757654,-0.9634407641233708,0.5012722646310432,0.767666852566851,1.0,5/29,6.59%,SLC13A3;SLC26A7;SLC1A5;SLC25A13;SLC26A2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.4087288421551592,0.9622074815116722,0.4962686567164179,1.0,1.0,6/12,20.15%,NCBP1;GEMIN5;NCBP3;CYFIP1;LARP1;EIF4E
prerank,copper ion binding (GO:0005507),0.3121612253422265,0.9599196111245212,0.5201288244766505,1.0,1.0,9/42,15.71%,SNCG;RNF7;SOD1;PARK7;PAM;PRNP;CUTC;S100A13;ANG
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.30482548578837715,-0.9596915654317618,0.5234567901234568,0.7731556817856302,1.0,13/30,26.42%,ATP7A;SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC31A1;SLC39A8;SLC11A2;SLC39A7;SLC39A6;SLC25A28;SLC30A5;TTYH1
prerank,SH3 domain binding (GO:0017124),0.2905049642182657,0.9595844795216125,0.52099533437014,1.0,1.0,16/62,17.02%,CBL;VASP;CABYR;SHANK3;EVL;SGIP1;PTPN12;REPS1;SYNJ2;ELMO1;CYBA;RUFY1;ABI2;ARHGAP27;CD2AP;ADAM9
prerank,phosphatidylglycerol binding (GO:1901611),0.4065005611007677,0.9595653449266142,0.48623853211009177,1.0,1.0,3/13,9.93%,MME;UQCC3;PITPNA
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.22667482666331712,0.9567535270323491,0.6293558606124604,1.0,1.0,75/730,10.86%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;ONECUT1;KLF8;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;PAX8;ZBTB24;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;SMAD1;ZKSCAN1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MYBL2;SOX2;MEIS1;YY1;GMEB2;ZNF83;ZNF740;USF2;RFX3;TBX1;ZNF260;CARF;CEBPG;CALCOCO1;FOXF2;PPARD;ZNF205;CLOCK;KDM6A;HEY2;ZBTB14;SOX13;RELA;JUND;HOXA7;TFAP4;ERG;ZKSCAN3;KLF6;WBP2;MGA;HIC2;ESR1;THRB;RBPJ;DACH2
prerank,carboxylic acid binding (GO:0031406),0.3122713641031059,0.9565739289198173,0.5196581196581197,1.0,1.0,2/38,0.78%,PCK1;GCLC
prerank,ATP hydrolysis activity (GO:0140603),0.3128828178945442,0.9560853190137613,0.5150501672240803,1.0,1.0,10/41,18.30%,ABCB10;RUVBL2;VWA8;RUVBL1;DDX3X;CHD3;MYO1E;TOR3A;VPS4B;MYO18A
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3519650916435393,-0.9555311641567084,0.5359477124183006,0.7796806009458377,1.0,6/16,20.88%,MTMR7;SACM1L;MTMR12;MTMR9;MTMR4;MTMR11
prerank,NAD binding (GO:0051287),-0.30913292435314244,-0.9546331277643376,0.5318181818181819,0.778370173775569,1.0,5/26,7.04%,ALDH1A1;ME1;ZC3HAV1;SIRT2;GLUD1
prerank,kinase activator activity (GO:0019209),-0.3012460737533642,-0.9545305542058629,0.5447761194029851,0.7751418882876364,1.0,9/30,16.71%,PRKAG2;WNK1;MALT1;CAB39;STRADA;STK11;MADD;RPLP1;GPRC5B
prerank,protein heterodimerization activity (GO:0046982),0.24942658397047648,0.9545268116056418,0.5487804878048781,1.0,1.0,33/178,14.65%,MIGA1;ATF3;SIM1;NR4A2;ATF6;SAE1;BCL2L2;ZHX3;PPP2CA;RALGAPA2;EXT2;PHB2;USF2;FXR1;RALGAPB;UBA2;SNX1;FZD9;FBXO7;NAE1;GTF2A2;ITGA3;IKBKB;CHUK;TPM2;RRAGC;YWHAH;TENM4;EPAS1;DDIT3;RALGAPA1;CYBA;RCC1
prerank,DNA replication origin binding (GO:0003688),0.3512343665394239,0.9543190072915464,0.541095890410959,1.0,1.0,5/23,11.47%,ORC3;CDC45;ORC4;POLA1;ORC2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.34713909609292615,0.9508332403212809,0.5247706422018349,1.0,1.0,5/24,16.52%,PPIP5K2;NME1;IP6K2;DTYMK;ITPKB
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.29381107410162616,0.9504757359285148,0.5354938271604939,1.0,1.0,14/53,17.97%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC17A6;SLC1A2;SLC25A2;SFXN1;SLC25A12;SLC38A5;SLC66A1;SLC25A38;SLC7A5;SLC43A2
prerank,peptidase activator activity (GO:0016504),-0.32372728150377694,-0.9477651714481321,0.5518763796909493,0.7879600130617859,1.0,15/22,34.70%,CASP8AP2;VCP;PCOLCE2;PSME4;PCOLCE;EBAG9;TANK;PINK1;APH1B;CLPX;PSME2;PSME3;CAV1;PSME1;PSENEN
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3503348994881806,-0.9476293216518981,0.5271867612293144,0.7847894471671915,1.0,8/18,28.12%,ALDH1A1;ALDH1A2;ALDH6A1;ALDH3A2;ALDH2;AKR1B10;ALDH9A1;ALDH18A1
prerank,C-C chemokine receptor activity (GO:0016493),-0.3281095161879686,-0.9475980800408597,0.5103448275862069,0.7814128649081707,1.0,15/21,63.14%,CCR9;ACKR3;CX3CR1;CCR5;CCR2;CXCR4;GPR75;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,sialyltransferase activity (GO:0008373),0.36082434397216645,0.946074899544597,0.5342960288808665,1.0,1.0,6/20,14.61%,ST6GALNAC3;ST8SIA1;ST3GAL6;ST3GAL1;ST6GALNAC2;ST8SIA6
prerank,gamma-tubulin binding (GO:0043015),0.3543091897381461,0.9460531739068033,0.5272407732864675,1.0,1.0,6/22,12.08%,TUBGCP5;ARHGEF7;RAB11FIP5;PAK1;DDX3X;CENPJ
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2935412451767491,0.9450921963145453,0.5332278481012658,1.0,1.0,10/54,13.20%,AMDHD2;ACER2;GLS2;GLS;HDAC9;HDAC3;SIRT1;NADSYN1;ACER3;HDAC5
prerank,lipoprotein particle binding (GO:0071813),-0.3293983935493039,-0.9441650924611457,0.5331905781584583,0.7863371084331955,1.0,6/20,18.45%,MAPT;SORL1;LDLR;THBS1;HSPD1;SCARF1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24408151441992537,-0.9439256409687821,0.5435435435435435,0.7834410751481113,1.0,24/74,23.05%,DGKI;NADK2;PIK3C2B;GK;NADK;DCAKD;PIK3C3;DGKH;PANK3;FAM20C;ADK;PKM;CHKA;AGK;FAM20A;PAPSS2;NT5C3A;IDNK;HYKK;NOL9;DGKQ;HK2;CHKB;RFK
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.37777678846029145,-0.9429231642862161,0.5523012552301255,0.7822942300652214,1.0,8/13,27.06%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH2;ADH5;ALDH9A1;ALDH1L2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3723462127254415,0.9423756105327576,0.5220588235294118,1.0,1.0,6/16,18.04%,ATP6V1D;ATP6V0D1;ATP6V0E1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3723462127254415,0.9423756105327576,0.5220588235294118,1.0,1.0,6/16,18.04%,ATP6V1D;ATP6V0D1;ATP6V0E1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3272180904111599,-0.9403103156123762,0.5342163355408388,0.7850952159356701,1.0,4/20,5.78%,LPGAT1;AGPAT4;ABHD5;AGPAT5
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.22168429543113377,0.9385356126271482,0.7074973600844773,1.0,1.0,84/830,10.86%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;SIM1;ONECUT1;KLF8;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;STOX1;PAX8;ZBTB24;ZBTB33;GABPA;BCL6B;BACH2;BCL11B;SMAD1;ZKSCAN1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MYBL2;BBX;SOX2;MEIS1;YY1;GMEB2;ZNF83;ZNF740;USF2;ZSCAN2;VEZF1;RFX3;TBX1;ZNF260;NFX1;CARF;CEBPG;CALCOCO1;FOXF2;PPARD;ZNF205;ACTN4;CLOCK;ZNF3;KDM6A;HEY2;ZBTB14;SOX13;RELA;JUND;HOXA7;TFAP4;ERG;TRPS1;ZKSCAN3;KLF6;WBP2;MGA;HIC2;ESR1;THRB;RBPJ;DACH2
prerank,androgen receptor binding (GO:0050681),-0.3055288686886072,-0.9374889172623435,0.550761421319797,0.7882500779731925,1.0,5/25,8.52%,DDX5;FOXP1;RNF14;WIPI1;SNW1
prerank,histone acetyltransferase binding (GO:0035035),-0.3281285004909696,-0.9353093041697833,0.5425790754257908,0.7902201691117149,1.0,6/21,19.49%,GLI3;KANSL1L;SIRT2;TP53;EID1;STAT1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2382086309246249,0.9352789008291997,0.6144430844553244,1.0,1.0,50/232,17.71%,RNF7;CBL;ARIH1;RNF149;RNF38;RFFL;BIRC2;NEDD4L;NEURL2;VPS11;NHLRC1;RBBP6;UBE3A;TRIM14;IRF2BPL;RNF130;NFX1;COP1;RNF187;PPP1R11;TRIM25;MDM2;RFWD3;MYCBP2;PIAS2;UBE3D;RNF6;ZNRF1;RNF13;RNF25;ANAPC11;PIAS1;DTX4;RNF11;CUL3;RNF216;RNF180;TRIM27;FANCL;TRIM3;NHLRC3;RNF114;PELI1;RNF128;RNF125;VPS18;UBR3;MSL2;KCMF1;RNF215
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.39545275623812354,-0.9349516246720272,0.5773195876288659,0.7876645284702549,1.0,3/10,4.57%,PRKAG2;PKIG;PRKAG1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.2598641336371597,-0.931392588306075,0.5826771653543307,0.7930850638169523,1.0,14/51,18.15%,SLCO3A1;MCU;SLC22A8;ANKH;SLC25A3;SLC22A4;SLC20A1;TMEM241;SLC35D2;SLC22A6;SLC16A2;SLC16A10;SLC5A6;SLC5A5
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.3933266029162589,-0.9311224656657324,0.5441176470588235,0.7904313138503346,1.0,8/10,38.79%,FAN1;DNAJC2;DNAJB2;ANKRD13D;ANKRD13B;LAPTM5;FAAP20;IDE
prerank,N-methyltransferase activity (GO:0008170),0.34925993492639107,0.9310078321476407,0.5555555555555556,1.0,1.0,4/20,13.14%,TRMO;TRMT11;SETD3;RNMT
prerank,steroid hydroxylase activity (GO:0008395),-0.3535156033970196,-0.9277535294833091,0.565410199556541,0.7947975407750335,1.0,2/16,5.93%,CYP27A1;CYP7B1
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.3681715267809898,-0.9274533536069448,0.5467775467775468,0.7922459393902113,1.0,6/13,27.37%,GPSM1;GDI1;ARHGDIA;ARHGDIB;ITGB1BP1;SH3BP4
prerank,nuclear localization sequence binding (GO:0008139),0.3536734253459367,0.9272688985179773,0.5619223659889094,1.0,1.0,7/18,20.50%,KPNA3;KPNA1;NFKBIA;KPNB1;POM121;BRAP;RANBP6
prerank,voltage-gated chloride channel activity (GO:0005247),-0.4010337800241942,-0.9270602440390329,0.5755693581780539,0.7897878181312888,1.0,4/10,14.21%,CLCN6;ANO1;CLCN2;ANO6
prerank,voltage-gated anion channel activity (GO:0008308),0.3793263484867476,0.9248941805210613,0.5561694290976059,1.0,1.0,3/15,5.58%,CLCN3;GPR89B;GPR89A
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.31339728454705285,-0.9215245294466693,0.5773672055427251,0.7988562264160722,1.0,10/24,27.62%,CAMK4;PHKA2;CAMK2D;CAMK1;DAPK1;PHKG2;MKNK2;CAMK2B;CAMK2A;MAPKAPK2
prerank,histone deacetylase binding (GO:0042826),0.26341668287526493,0.921459730560267,0.6011904761904762,1.0,1.0,16/88,13.91%,TAL1;LEF1;HDAC9;HDAC3;MAPK8;YWHAB;SFPQ;HEY2;RELA;TFAP4;PKN1;AKAP8L;CIR1;SP1;HDAC5;HES1
prerank,mannose binding (GO:0005537),0.39860579454104667,0.9211982960757334,0.5616942909760589,1.0,1.0,1/12,4.27%,LMAN2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3055170559806048,0.9211585031562649,0.5898692810457516,1.0,1.0,5/42,9.02%,CKS2;CCNC;CCNH;CDKN1A;CCNG2
prerank,palmitoyltransferase activity (GO:0016409),0.3224859933487707,0.9194112797614291,0.5865384615384616,1.0,1.0,6/28,14.05%,ZDHHC17;ZDHHC13;ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,acetylation-dependent protein binding (GO:0140033),-0.3218921863292758,-0.9178581139789902,0.5720620842572062,0.8008298724801199,1.0,6/20,12.94%,KMT2A;BRD9;BRD7;PSME4;BRD4;DPF2
prerank,lysine-acetylated histone binding (GO:0070577),-0.3218921863292758,-0.9178581139789902,0.5720620842572062,0.8008298724801199,1.0,6/20,12.94%,KMT2A;BRD9;BRD7;PSME4;BRD4;DPF2
prerank,ubiquitin protein ligase activity (GO:0061630),0.23429397320250164,0.9176788596849796,0.6421568627450981,1.0,1.0,48/228,17.71%,RNF7;CBL;ARIH1;RNF149;RNF38;RFFL;BIRC2;NEDD4L;NEURL2;VPS11;NHLRC1;RBBP6;UBE3A;TRIM14;IRF2BPL;RNF130;NFX1;COP1;RNF187;PPP1R11;TRIM25;MDM2;RFWD3;MYCBP2;UBE3D;RNF6;ZNRF1;RNF13;RNF25;ANAPC11;DTX4;RNF11;CUL3;RNF216;RNF180;TRIM27;FANCL;TRIM3;NHLRC3;RNF114;PELI1;RNF128;RNF125;VPS18;UBR3;MSL2;KCMF1;RNF215
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3864477638402174,0.9176538288081736,0.5547024952015355,1.0,1.0,4/12,14.37%,BCL2L13;BAD;NOD1;APAF1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.38740357414440296,-0.9174352167193119,0.5682326621923938,0.7985287528161901,1.0,2/11,14.14%,SLC22A4;SLC25A47
prerank,transcription cis-regulatory region binding (GO:0000976),0.22342185117280594,0.9168365345812292,0.6962457337883959,1.0,1.0,58/406,14.27%,ATF3;CTCFL;DACH1;SIM1;ARID5A;FOXN2;TFCP2;MTERF3;TAL1;ATF6;LEF1;ELK3;STOX1;PAX8;GABPA;NR5A1;MMP12;FLI1;BBX;SMARCA2;SOX2;YY1;ZSCAN2;VEZF1;RFX3;NFX1;CALCOCO1;FOXF2;SFPQ;LONP1;ACTN4;DRAP1;ZNF3;ZBTB14;SOX13;RELA;XRN2;JUND;TFAP4;PARK7;TRPS1;CARM1;RPS3;ZBED4;E2F3;SP1;MZF1;IRF2;CHD3;TBP;HDAC5;EPAS1;DDIT3;THRA;CREBRF;DR1;GRHL1;PURG
prerank,lipoprotein particle receptor binding (GO:0070325),-0.2948663505652376,-0.9161862398887191,0.5791962174940898,0.7980619988380777,1.0,5/27,12.26%,LRP1;RELN;HSPG2;AP2A1;MESD
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.3909404280063581,-0.9145527041665189,0.5854166666666667,0.7982206505039121,1.0,1/10,1.62%,DPYSL3
prerank,exopeptidase activity (GO:0008238),-0.2587628551421085,-0.9126007886309043,0.6297376093294461,0.7994615315160022,1.0,16/50,21.13%,DPP6;RNPEP;TRHDE;DPP4;ANPEP;FAP;DPP10;CPM;CTSA;NAALAD2;CTSZ;LAP3;ACE;ENPEP;DPP3;GGH
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.288631147933006,-0.9121040211620914,0.5990453460620525,0.7973662136823998,1.0,6/28,19.49%,EDA;CASP8AP2;MADD;TRAF2;TMBIM1;STAT1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.3935610197549246,0.9119337828100053,0.5751503006012024,1.0,1.0,1/11,0.80%,MAP3K11
prerank,calcium ion binding (GO:0005509),0.22651707969819637,0.9105095210929548,0.6955475330926595,1.0,1.0,43/323,12.62%,SPOCK2;EFHD2;LCP1;EML1;SLC25A24;CABYR;ASTN2;CETN3;PPP3CB;ADGRL3;NUCB2;LTBP4;MEX3B;ATP2A2;CDH2;ITSN1;ESYT2;MMP12;EFHD1;SDF4;RASGRP3;CIB1;RET;SELP;MCTP2;CALM3;CDH12;RCN2;AIF1L;S100A16;TRPM4;MCTP1;ACER3;PAM;PPP3CA;PRNP;PPP3R1;AGRN;MICU3;LETM1;IDS;SLC25A12;CDH5
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.353928136808096,-0.9096590881115683,0.5628997867803838,0.7997127064293598,1.0,3/14,5.65%,SLC7A11;SLC1A3;SLC25A13
prerank,anion transmembrane transporter activity (GO:0008509),-0.36737840842552394,-0.9094052716747164,0.5948275862068966,0.7970907669953976,1.0,5/12,15.91%,SLC39A8;SLC22A6;SLC26A11;SLC4A2;SLC19A1
prerank,cytokine receptor binding (GO:0005126),-0.22819073935864181,-0.9087167627494692,0.6666666666666666,0.7954082048301899,1.0,11/83,13.88%,TGFBR3;SMAD3;JAK1;OSMR;IL6R;PIBF1;IL34;IL13RA1;SOCS2;IL18;IL6ST
prerank,NF-kappaB binding (GO:0051059),0.3234066134673888,0.9061787647235483,0.5923344947735192,1.0,1.0,9/24,18.37%,HDAC3;EP300;RELA;RNF25;TAF4B;FAF1;NFKBIA;NPM1;HDAC2
prerank,translation initiation factor activity (GO:0003743),0.29750481068652046,0.9053574567233696,0.5921052631578947,1.0,1.0,13/36,20.22%,EIF2S1;EIF2A;EIF3B;EIF2B3;EIF4G2;EIF5;EIF3M;EIF2S2;EIF3A;EIF4G1;EIF3E;EIF4E;EIF1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3761107515061422,-0.9052199338393971,0.5895833333333333,0.7995003850404587,1.0,5/11,10.94%,RAD50;HNRNPA2B1;STN1;RPA1;HNRNPA1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3208159576415053,0.9036567575839528,0.6060606060606061,1.0,1.0,6/26,15.43%,SAG;BOD1;PPP1R11;MGAT5;CABIN1;PPP1R8
prerank,sterol binding (GO:0032934),-0.25067019858597434,-0.9036447418125931,0.6294277929155313,0.799896367717468,1.0,15/56,15.11%,OSBPL9;GRAMD1B;OSBPL11;OSBPL6;SIDT1;VDAC1;GRAMD1C;OSBP;INSIG2;OSBPL5;ABCA1;RORA;OSBP2;STARD5;GRAMD1A
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2920318521348503,-0.9025579508100446,0.573394495412844,0.7992581913580029,1.0,17/28,43.07%,PRORP;AGO3;DICER1;ELAC1;RPP30;RPP14;DROSHA;RPP21;DBR1;EDC3;RNASEH2A;ELAC2;POP4;RPP38;NUDT16;NUDT16L1;MRPL44
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.32689603829286873,0.9010714919570286,0.591869918699187,1.0,1.0,5/24,14.05%,ZDHHC17;ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,manganese ion binding (GO:0030145),0.2808388376040023,0.8987196522771698,0.6200941915227629,1.0,1.0,9/48,15.49%,PCK1;GYG1;PIM1;SOD2;EXD2;PAPOLA;MGAT5;IMPA1;DYRK2
prerank,serine-type endopeptidase activity (GO:0004252),0.2602131530627523,0.8984032336141571,0.6614950634696756,1.0,1.0,2/80,0.59%,PCSK1;CELA1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3027038164650342,0.8970936176383847,0.6260720411663808,1.0,1.0,6/35,10.61%,SRC;FYN;SYK;PEAK1;LYN;YES1
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.23162833021663728,-0.8969513574318488,0.6417445482866043,0.8083365447005966,1.0,6/73,6.20%,SORCS1;CALCRL;LGR4;SORCS3;NPR3;EDNRA
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.34235852900493013,-0.8963435755126709,0.5949895615866388,0.8065026690672168,1.0,3/15,26.99%,CCR9;CMKLR1;CX3CR1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.34890186855668115,-0.8943144478629519,0.6135371179039302,0.8075824936548984,1.0,4/15,12.10%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3345221706558612,0.894068184118594,0.6095764272559853,1.0,1.0,4/21,9.15%,CDK19;CDK11B;CDK4;CDKL4
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3345221706558612,0.894068184118594,0.6095764272559853,1.0,1.0,4/21,9.15%,CDK19;CDK11B;CDK4;CDKL4
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.3902097095651439,-0.890689488392342,0.6093418259023354,0.8121398412466895,1.0,2/10,14.25%,SLCO3A1;SLC22A6
prerank,neuropeptide receptor activity (GO:0008188),0.31076634282339843,0.8904427399248102,0.627147766323024,1.0,1.0,2/29,2.10%,NPFFR1;TACR1
prerank,metalloaminopeptidase activity (GO:0070006),0.36427825197952185,0.8874543020403974,0.6056603773584905,1.0,1.0,1/16,0.22%,LVRN
prerank,protein phosphatase activator activity (GO:0072542),0.37193941773050887,0.8859574583290889,0.6132596685082873,1.0,1.0,6/13,21.17%,CALM3;PTPA;PPP2R5A;CALM1;PPP2R5C;PHACTR4
prerank,phosphotyrosine residue binding (GO:0001784),0.292873130633293,0.885746038676988,0.6519524617996605,1.0,1.0,10/37,18.41%,BCAR3;PFN1;SAMSN1;SYK;YES1;CRKL;LDLRAP1;SHC1;PTPN11;IRS1
prerank,mannosyltransferase activity (GO:0000030),0.3354303991870314,0.8851566312214496,0.6166077738515902,1.0,1.0,5/21,11.29%,TMTC2;DPY19L4;ALG8;DPY19L1;PIGB
prerank,calcium:sodium antiporter activity (GO:0005432),-0.37479592256098737,-0.8844297053566424,0.5849802371541502,0.8220499706419678,1.0,2/10,9.99%,SLC24A3;SLC24A2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.33923950757982213,-0.8824253747323701,0.632016632016632,0.8231606184069998,1.0,8/15,38.35%,PLA2G4A;SNX3;SAP30L;SH3PXD2B;PLEKHF1;JPH2;PLA2G4E;PHLDA3
prerank,cytokine activity (GO:0005125),-0.2067325271427971,-0.8816916765394753,0.7918367346938775,0.8215184008158032,1.0,22/131,24.20%,BMP6;WNT5B;BMP5;BMP7;BMP4;IL34;WNT4;AIMP1;IL16;WNT9A;CCL14;IL18;IL33;TNFRSF11B;TGFB1;SCG2;CX3CL1;CCL13;VEGFA;IL17D;CKLF;TGFB3
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.22862479969012878,0.8815766255345733,0.7332490518331226,1.0,1.0,30/188,14.06%,ATF3;CTCFL;ARID5A;MTERF3;TAL1;ATF6;PAX8;GABPA;FLI1;SMARCA2;SOX2;YY1;RFX3;CALCOCO1;SFPQ;ZBTB14;SOX13;RELA;JUND;TFAP4;CARM1;ZBED4;SP1;MZF1;CHD3;TBP;HDAC5;DDIT3;THRA;GRHL1
prerank,sodium channel regulator activity (GO:0017080),0.2955543127245225,0.8813370626841676,0.6357504215851602,1.0,1.0,4/37,6.33%,RSC1A1;NEDD4L;FXYD6;FGF13
prerank,Notch binding (GO:0005112),-0.30271121164469295,-0.880329377430707,0.6517647058823529,0.8213706598424272,1.0,5/22,16.36%,SNED1;DNER;SNW1;MEGF10;CCN3
prerank,chemokine activity (GO:0008009),0.3010559606238331,0.8801293580630126,0.6528925619834711,1.0,1.0,2/31,8.51%,CXCL12;CCL25
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.3202890697878466,0.8785479334759646,0.6171735241502684,1.0,1.0,5/22,14.38%,APOE;SNX17;PICALM;LDLRAP1;AP2M1
prerank,ribonuclease activity (GO:0004540),0.2715857693809961,0.8781510594473956,0.6593059936908517,1.0,1.0,18/56,20.97%,ZC3H12D;RNASE6;CNOT7;EXOSC9;RNASE12;CNOT6;EXOSC1;PPP1R8;ANG;RNASE4;N4BP1;SMG6;TSNAX;DIS3L2;EXOSC7;AGO1;ERN1;RNASE1
prerank,kinase activity (GO:0016301),0.24418237777779325,0.8771292165112006,0.6774647887323944,1.0,1.0,26/109,18.04%,PIK3CG;PPIP5K2;TRIB3;DGKB;PIK3C2G;PANK2;CERKL;LYN;ETNK1;PI4KA;PIK3CD;IP6K2;MAP4K4;TRRAP;PAPSS1;PIK3C2A;PGM2L1;CDKL5;TAF1;CERK;ITPKB;PANK1;PANK4;SEPHS1;DGKK;ADPGK
prerank,MAP kinase activity (GO:0004707),0.3694945370169512,0.8768180657296863,0.6349514563106796,1.0,1.0,5/14,12.69%,MAPK3;MAPK8;NLK;MAPK6;MAPK12
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.38443789515201704,0.876326918346425,0.624031007751938,1.0,1.0,2/11,11.52%,APLF;RPS3
prerank,mechanosensitive ion channel activity (GO:0008381),-0.35554567981069574,-0.8755290417273678,0.6361746361746362,0.8281126320768987,1.0,5/12,28.79%,PIEZO2;TMEM63A;TMEM63B;TMC4;TMC6
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.3762645825383486,0.8748362386417052,0.6472795497185742,1.0,1.0,3/12,17.16%,PDE4D;PDE8B;PDE8A
prerank,MHC protein binding (GO:0042287),0.32514261014524126,0.8746106491155334,0.644808743169399,1.0,1.0,5/20,20.09%,TUBB;CD81;ATP5F1B;DERL1;TAP2
prerank,single-stranded DNA binding (GO:0003697),0.2481868760404905,0.8739999458384469,0.7225433526011561,1.0,1.0,17/93,12.85%,CTC1;PCBP1;ERCC4;SSBP1;PMS2;CDC45;LONP1;MLH1;SPRTN;POLA1;RAD23A;MSH3;PARK7;RAD51B;APTX;TOP3A;NUP35
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3524578793917405,0.873910391461104,0.6373626373626373,1.0,1.0,4/15,12.49%,SLC1A1;SLC17A6;SLC1A2;SLC25A12
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3024868128454061,0.8733170037319261,0.6533101045296167,1.0,1.0,9/32,18.00%,JMJD4;ALKBH2;KDM2A;TET3;EGLN2;PHF8;FTO;TET2;KDM4C
prerank,protein kinase regulator activity (GO:0019887),-0.22158393627448972,-0.8731795524965028,0.7684210526315789,0.8299038651038476,1.0,20/95,15.06%,PRKAG2;CCNL2;PARVA;DNAJC3;ELP4;WNK1;PRKAG1;GMFB;TAOK3;CAB39;CDKN1B;CCND3;STRADA;STK11;PRKAR1B;CCNT1;DUS2;MADD;RPLP1;CCNK
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2679527824871925,0.8727825208155512,0.6929133858267716,1.0,1.0,14/57,14.40%,NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;NDUFB7;COX15;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3033244794010792,0.8720980200916826,0.6454388984509466,1.0,1.0,8/27,16.97%,ARIH1;DCUN1D4;AUP1;UBE3D;RNF180;RNF125;DCUN1D2;DCUN1D1
prerank,signal sequence binding (GO:0005048),0.28582561287284064,0.8702990864197918,0.6672384219554031,1.0,1.0,9/35,17.45%,TOMM20;KPNA3;KDELR2;KPNA1;SEC61A2;NFKBIA;AP2M1;KPNB1;POM121
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3157696413992338,-0.869385816126302,0.6466512702078522,0.8347218046125218,1.0,17/18,68.46%,DHRS11;HSD17B7;HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,phospholipid transfer activity (GO:0120014),0.3263215923452622,0.8675573864084981,0.6360544217687075,1.0,1.0,8/21,19.03%,PRELID3B;PRELID2;PITPNA;OSBPL2;CERT1;PLEKHA3;PITPNB;PLTP
prerank,cholesterol binding (GO:0015485),0.27641131686362447,0.8674398669616562,0.6602564102564102,1.0,1.0,11/47,13.79%,PROM1;OSBPL10;TSPO;SOAT1;OSBPL1A;CD81;ERLIN2;STARD3NL;NPC2;NPC1;OSBPL2
prerank,diacylglycerol kinase activity (GO:0004143),-0.3626062350029508,-0.8674235870254384,0.6413502109704642,0.8357254405093957,1.0,3/11,12.49%,DGKI;DGKH;AGK
prerank,SUMO binding (GO:0032183),-0.3396238396649121,-0.8669034812897971,0.6495901639344263,0.8336606760583133,1.0,4/13,9.20%,CASP8AP2;PML;RNF4;USPL1
prerank,aminopeptidase activity (GO:0004177),0.31218419515146373,0.8637403750315632,0.6684303350970018,1.0,1.0,2/26,5.07%,LVRN;METAP2
prerank,tau-protein kinase activity (GO:0050321),0.3274648607100739,0.8633315517959677,0.6623616236162362,1.0,1.0,3/20,6.68%,GSK3A;FYN;SIK3
prerank,exoribonuclease activity (GO:0004532),0.3677754305381176,0.8627899459815743,0.64,1.0,1.0,4/12,13.15%,CNOT7;EXOSC9;CNOT6;EXOSC1
prerank,phosphatidylinositol binding (GO:0035091),0.2454044873818887,0.8626881930037991,0.7073170731707317,1.0,1.0,23/91,16.72%,EXOC8;MCF2L;SNX8;ESYT2;PLEKHF2;DENND1A;SNX17;EPB41;WDFY1;SNX1;PITPNA;ING2;ZFYVE9;SCARB1;PICALM;MYO1E;SNX24;AIDA;PARD3;DENND1B;PIGU;SNX16;ZFYVE1
prerank,histone deacetylase activity (GO:0004407),0.33196970875947296,0.8622288533929463,0.6329787234042553,0.9986334381290117,1.0,4/19,7.30%,HDAC9;HDAC3;SIRT3;SIRT1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3591717008559206,-0.8601239726135514,0.6363636363636364,0.8438701718713539,1.0,5/10,15.49%,DPP6;DPP4;FAP;DPP10;NAALAD2
prerank,protein kinase C binding (GO:0005080),0.27567821243335416,0.8588306764024703,0.6744186046511628,1.0,1.0,8/43,13.31%,TIRAP;HDAC7;HDAC9;PRKD2;TRPV4;PKN1;HDAC5;PLEK
prerank,ankyrin binding (GO:0030506),0.3266155942134826,0.8588000768701175,0.6358792184724689,0.9982016760266236,1.0,2/19,2.03%,SPTB;PTPRC
prerank,heme binding (GO:0020037),0.25567269604433335,0.8563224490771449,0.7189952904238619,0.9998128972136386,1.0,9/65,11.55%,HMOX2;CYCS;PTGES2;SRC;THAP4;CYB5R4;CYP1B1;NOS3;COX15
prerank,mitogen-activated protein kinase binding (GO:0051019),0.2984892858668701,0.8549658242005538,0.6493288590604027,0.9987917567200338,1.0,5/29,14.25%,DUSP7;PTPRJ;SIRT1;NBR1;GCH1
prerank,methyl-CpG binding (GO:0008327),0.31191819945722166,0.8541736208193974,0.6545454545454545,0.9966542043852226,1.0,4/22,11.13%,ZBTB33;CHTOP;TET3;ERH
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.24347783153797972,-0.8527280926077123,0.7282913165266106,0.8554653139218447,1.0,13/49,20.56%,ATP1A2;MPPED2;PLCXD3;SACM1L;DUSP16;FRA10AC1;ENPP6;PTPN22;ACP2;PTPRO;GDPD3;LHPP;SBF1
prerank,transcription coactivator binding (GO:0001223),0.32531197921268973,0.8519387795537643,0.6570327552986512,0.9977630572346302,1.0,6/20,10.75%,RPL23;PPARD;RELA;ESR1;TERT;THRB
prerank,tumor necrosis factor receptor binding (GO:0005164),0.35981649265169613,0.8502278182108578,0.6672694394213382,0.9975955765027523,1.0,2/12,9.00%,TRAF5;TRAF3
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.29162879958973814,-0.8461258147320331,0.7065462753950339,0.8653091761957806,1.0,2/21,4.75%,GLRB;P2RX4
prerank,gated channel activity (GO:0022836),0.34682423518696825,0.8449469892931301,0.6539196940726577,1.0,1.0,2/14,8.37%,TMEM266;TMC7
prerank,RNA stem-loop binding (GO:0035613),0.36254255736134283,0.8424428986893633,0.659919028340081,1.0,1.0,7/12,24.36%,DDX3X;RC3H1;DHX9;RC3H2;FMR1;MYH10;CPEB3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3449119794090338,0.8422404394205639,0.6751968503937008,1.0,1.0,3/15,8.69%,NDST3;HS6ST1;HS3ST2
prerank,alpha-tubulin binding (GO:0043014),0.2855319431223734,0.840411970792909,0.6944444444444444,1.0,1.0,9/31,16.70%,FYN;DIP2B;DNAL1;TRPV4;TBCEL;TTLL7;EFHC2;INO80;SETD2
prerank,channel activity (GO:0015267),-0.2479904309795906,-0.8359685023295642,0.7880299251870324,0.8813056175252452,1.0,11/41,26.64%,PDPN;AQP4;MPV17;TMEM120B;BCL2;MCUB;TMEM120A;PANX1;AQP11;CHRNA7;TRPV2
prerank,protein phosphatase 2A binding (GO:0051721),0.3020116659800639,0.835608959520885,0.7030201342281879,1.0,1.0,10/23,20.21%,BOD1;MFHAS1;ANKLE2;CTTNBP2NL;STRN4;PTPA;SMG5;IGBP1;SMG7;STRN3
prerank,hexosyltransferase activity (GO:0016758),0.2354313714489904,0.8348344815734421,0.7733333333333333,1.0,1.0,8/101,4.62%,CSGALNACT1;GYG1;TMTC2;CHSY3;POMGNT2;EXT2;ALG6;DPY19L4
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.25762242959949266,-0.8337765746094641,0.7256410256410256,0.882189725044128,1.0,12/34,21.32%,IQGAP1;CAB39;MAP2K2;STRADA;CCNT1;TAOK1;FAM20A;IGF2;CCNK;IRGM;PARP16;ETAA1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.32731438183854666,-0.8336936649441598,0.7198177676537585,0.8790964321452638,1.0,5/14,20.88%,MTMR7;MTMR12;MTMR9;MTMR4;MTMR11
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.3238306755657093,0.8327210536092665,0.6875,1.0,1.0,2/18,3.83%,RPS6KA1;BIRC2
prerank,DNA polymerase binding (GO:0070182),0.3217043154727822,0.8324535627156567,0.7007299270072993,1.0,1.0,7/18,20.74%,LONP1;ACD;CDK2AP1;SMARCA4;SMG6;PTGES3;HSP90AB1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.2807799540764463,0.8316674570787284,0.7061688311688312,1.0,1.0,11/35,17.31%,RUVBL2;MMP12;DRAP1;RELA;PARK7;TBP;DR1;BAZ2A;TAF1;SMARCA4;NPM1
prerank,DNA-binding transcription factor binding (GO:0140297),0.2155804779757282,0.831251822108545,0.8565891472868217,0.999091030473103,1.0,39/189,16.20%,CHCHD2;TAL1;HES6;DMAP1;HIPK2;HDAC7;HDAC9;GABPA;USF2;EP300;PPARD;SIRT1;HEY2;RELA;PIAS2;PARK7;LMO2;RBPJ;CREBBP;CTBP1;TLE4;PIAS1;IFI27;SP1;NBN;TBP;RERE;HDAC5;DDIT3;NEK6;HES1;HCFC1;CRTC3;MAP3K10;TCERG1;TAF1;ID2;TCF3;PURB
prerank,phosphatase inhibitor activity (GO:0019212),0.3068346457845827,0.8297520164788821,0.6854700854700855,0.9983540061758868,1.0,4/20,13.52%,SAG;BOD1;MGAT5;CABIN1
prerank,protein phosphatase regulator activity (GO:0019888),0.256007264932066,0.8249256146461391,0.7630769230769231,1.0,1.0,18/53,20.27%,SAG;PPP2R2D;BOD1;PPP1R16B;CALM3;RCAN2;ANKLE2;MGAT5;CABIN1;PTPA;PPP6R1;PPP2R3A;PPP2R5A;CALM1;IGBP1;PPP2R5C;PPP1R2;RCAN3
prerank,telomerase RNA binding (GO:0070034),0.30649236249729184,0.8236290895914121,0.7044247787610619,1.0,1.0,9/22,19.90%,HNRNPC;TERT;DKC1;PARN;SMG6;SMG5;SNRPD3;DHX36;SMG7
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3579161937937688,0.8224816443763651,0.6685823754789272,1.0,1.0,5/10,18.84%,EP300;USP22;NAA50;MSL3;HAT1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.34322374224495933,0.8223039042981264,0.6988636363636364,0.9985457572347177,1.0,3/14,15.70%,RDH11;RDH10;AKR1A1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.33064141166081934,0.8218687101511088,0.6827094474153298,0.9956777782232819,1.0,3/14,14.46%,CYB5R4;AIFM1;CYBA
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.31043509961945137,-0.8188767462191129,0.7173447537473233,0.902346352354757,1.0,7/14,45.89%,KCNJ2;KCNQ1;KCNJ3;KCNJ8;KCNIP2;KCNE4;KCNH2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.2643077898807549,-0.8175475571017022,0.745049504950495,0.9014457311364338,1.0,10/31,26.76%,UBE2N;UBE2E1;UBE2J2;UBE2J1;UBE2K;UBE2Q1;UBE2B;UBE2E2;UBE2S;UBE2G2
prerank,RNA cap binding (GO:0000339),0.32267219120818397,0.8167176100112195,0.7132486388384754,1.0,1.0,7/16,20.15%,NCBP1;GEMIN5;NCBP3;CYFIP1;LSM1;LARP1;EIF4E
prerank,MAP kinase kinase kinase activity (GO:0004709),0.3573388278092876,0.8160224644207413,0.6660117878192534,0.9996820711348222,1.0,2/11,5.23%,MAP3K7;MAP3K4
prerank,cytokine receptor activity (GO:0004896),0.229038708289551,0.813300910766305,0.8064046579330422,1.0,1.0,4/83,3.16%,GFRA3;IL1R1;IFNLR1;CRLF1
prerank,iron ion binding (GO:0005506),-0.2320137617658791,-0.8106022211366962,0.8172043010752689,0.9108151112569101,1.0,20/48,31.01%,AGMO;AOX1;DNAJC24;TET1;KDM7A;FTL;NFU1;PHYH;FDX1;EGLN3;PHF2;CDO1;JMJD6;ABCE1;EGLN1;HIF1AN;SNCA;ETHE1;FXN;SCD
prerank,bHLH transcription factor binding (GO:0043425),0.30613242285600634,0.8096740918018339,0.727112676056338,1.0,1.0,7/19,16.10%,USF2;SIRT1;LMO2;CREBBP;SP1;MAP3K10;TCF3
prerank,histone demethylase activity (GO:0032452),0.2903673323192243,0.8093897342722901,0.736013986013986,1.0,1.0,7/27,14.24%,KDM3A;KDM2A;KDM6A;KDM4D;JMJD1C;KDM5C;PHF8
prerank,chemokine receptor binding (GO:0042379),0.26788026582020824,0.8066703370606119,0.7703583061889251,1.0,1.0,2/35,8.51%,CXCL12;CCL25
prerank,CCR chemokine receptor binding (GO:0048020),-0.25480491932940247,-0.8061658260513711,0.7939110070257611,0.9153953636529006,1.0,5/28,22.11%,CCL14;NARS1;NES;CX3CL1;CCL13
prerank,sulfotransferase activity (GO:0008146),-0.24904273116589562,-0.8061258335274378,0.7890818858560794,0.9122095182479404,1.0,4/33,10.38%,UST;HS3ST3A1;CHST15;CHST11
prerank,calcium activated cation channel activity (GO:0005227),-0.29421962604200386,-0.8059326422176412,0.7235955056179775,0.9093165102243609,1.0,6/17,18.69%,KCNMA1;ANO1;TMEM63A;ANO6;TMEM63B;ANO10
prerank,protein phosphatase 1 binding (GO:0008157),0.3031623919670664,0.8022853096962493,0.7585616438356164,1.0,1.0,3/21,12.34%,PPP1R16B;PPP1R11;AKAP11
prerank,nucleotide diphosphatase activity (GO:0004551),0.33014029671095724,0.7997079641900214,0.7397504456327986,1.0,1.0,2/14,3.90%,NUDT11;NUDT12
prerank,lysine N-methyltransferase activity (GO:0016278),-0.28634775342515045,-0.7995487014586355,0.7744186046511627,0.9170755191420352,1.0,7/20,23.26%,SETD7;EHMT2;ATPSCKMT;EEF1AKMT1;SMYD2;SETD4;METTL21A
prerank,ADP binding (GO:0043531),-0.26510784125360465,-0.799458206299154,0.7941888619854721,0.9139794135548266,1.0,4/25,7.04%,PRKAG2;ME1;PRKAG1;GLUD1
prerank,pentosyltransferase activity (GO:0016763),0.26932643258356187,0.7981557410674005,0.7594108019639935,1.0,1.0,7/36,11.69%,UPP1;SIRT3;SIRT1;PARP11;UPP2;PNP;TNKS
prerank,ligand-gated cation channel activity (GO:0099094),-0.20856695173708922,-0.7971754326035057,0.9088145896656535,0.9144870453978023,1.0,19/75,29.70%,GRIA4;GRIA2;GRIN2B;P2RX4;KCNJ2;KCNJ6;GRIK4;KCNJ13;KCNJ10;GRIK1;GRIK3;GRIN2D;GRIN1;MCOLN1;CHRNA7;GRIA1;KCNK1;KCNJ12;CCDC51
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.330194601381042,-0.7951073063028389,0.7505112474437627,0.9146345881448678,1.0,9/11,67.00%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.22931202000439466,-0.7948473028644136,0.8386243386243386,0.9118816862420496,1.0,9/46,19.33%,MGAT4C;OGT;HEXA;HEXB;LARGE1;B3GALT5;B3GALNT1;B3GALT1;PIGA
prerank,acetyltransferase activity (GO:0016407),0.27525173627931315,0.7935925231725768,0.7706576728499157,1.0,1.0,8/31,18.78%,ACAT1;EP300;ESCO1;CREBBP;NAA80;NAA15;ELP3;NAA50
prerank,methyltransferase activity (GO:0008168),0.2536203862105857,0.7873567917010126,0.789983844911147,1.0,1.0,12/46,19.59%,BCDIN3D;PRMT3;TRMT11;METTL27;CARNMT1;RRP8;NTMT1;COQ5;LCMT1;COQ3;NSUN2;FTSJ1
prerank,serine-type peptidase activity (GO:0008236),0.22295204666459084,0.7866870644290794,0.8720445062586927,1.0,1.0,2/96,0.59%,PCSK1;CELA1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3245360068549256,-0.7864916389744406,0.7474747474747475,0.9220074343236225,1.0,6/12,19.51%,CDK6;BRD4;CDK7;CCNK;CDK9;CDK12
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3414362917923438,0.7858694022070497,0.7265774378585086,1.0,1.0,6/12,19.49%,KDM3A;KDM4D;JMJD1C;PHF8;KDM4C;KDM3B
prerank,nuclear export signal receptor activity (GO:0005049),0.33792303309997174,0.7851082879636807,0.7338403041825095,1.0,1.0,4/11,18.37%,XPO5;RANBP17;XPO1;NUP42
prerank,telomeric DNA binding (GO:0042162),0.2687380683679432,0.7823055931162017,0.788034188034188,1.0,1.0,5/32,10.58%,CTC1;SMG1;ACD;UPF2;TERT
prerank,O-methyltransferase activity (GO:0008171),0.3576585899223277,0.7821791116587766,0.7495029821073559,1.0,1.0,1/10,2.25%,BCDIN3D
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.26536393110857975,0.7818080261157387,0.8081967213114755,1.0,1.0,7/34,14.43%,EZH2;TTLL12;SMYD3;SETD3;KMT5B;DOT1L;ETFBKMT
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.2699207582681557,0.7774292369750226,0.7948303715670436,1.0,1.0,3/30,6.21%,RPS6KA1;BIRC2;CARD16
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.27391098580001944,-0.7737936708316361,0.7865168539325843,0.938137735907319,1.0,8/20,25.22%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,chloride transmembrane transporter activity (GO:0015108),0.3090959811179621,0.7732199636865684,0.7657992565055762,1.0,1.0,2/16,9.01%,SLC1A1;CLCN7
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2520056204438758,-0.7717600011402471,0.8229426433915212,0.9379063861458673,1.0,11/24,39.08%,KCNJ2;KCNJ6;ABCC9;KCNJ13;KCNJ10;KCNK1;KCNJ12;KCNJ3;KCNK6;KCNJ8;KCNJ15
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3035102913196283,-0.7698459173309898,0.7711340206185567,0.9374269359833965,1.0,3/13,5.78%,AGPAT4;ABHD5;AGPAT5
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2694610256444355,0.768560685091252,0.8237232289950577,1.0,1.0,4/29,11.63%,ACER2;ENGASE;MGAM;ACER3
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.33276102484464953,0.7673755701094226,0.7626168224299066,1.0,1.0,4/12,15.70%,RUVBL2;RELA;TBP;TAF1
prerank,leucine zipper domain binding (GO:0043522),-0.3247516485835845,-0.762664794363821,0.782051282051282,0.9441791193487595,1.0,2/10,5.24%,PAWR;AATF
prerank,ferrous iron binding (GO:0008198),0.2827889504227089,0.7613630004851929,0.777972027972028,1.0,1.0,6/21,17.72%,ALKBH2;ISCU;EGLN2;FTO;TET2;FECH
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.33159305556401253,0.7594693598858483,0.7543859649122807,1.0,1.0,3/11,16.56%,SLC25A24;SLC25A42;SLC25A25
prerank,phosphatase activity (GO:0016791),0.22504317868814494,0.7577042731599756,0.8847858197932054,1.0,1.0,12/73,13.32%,PTPRJ;ENOPH1;DUSP12;PLPP6;PXYLP1;PLPP1;PRUNE1;DUSP11;PGP;APTX;PTPMT1;PPP5C
prerank,sodium channel activity (GO:0005272),0.2516437953942797,0.7570366684964808,0.8303130148270181,1.0,1.0,3/37,4.61%,GRIK5;GRIK2;SCN2A
prerank,phosphate ion binding (GO:0042301),0.3454279024281508,0.7568456829293841,0.7965451055662188,1.0,1.0,2/10,10.60%,RELA;PNP
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.33485925111530185,0.7558085187707306,0.7542857142857143,1.0,1.0,4/10,16.70%,SETD5;SETD3;NSD2;SETD2
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3129715916330407,-0.7552966538691459,0.8037190082644629,0.9510690442513708,1.0,4/12,16.41%,BACE2;BACE1;DDI2;HM13
prerank,myosin II binding (GO:0045159),-0.32239565074185095,-0.7551584943353418,0.7908366533864541,0.9479586028220105,1.0,3/10,14.44%,GSN;STXBP5;TRIOBP
prerank,NADPH binding (GO:0070402),0.3132151022651466,0.7527752835688749,0.7690763052208835,1.0,1.0,2/13,8.85%,HMGCR;KCNAB1
prerank,N-acetyltransferase activity (GO:0008080),0.28473286285774674,0.7510071034963473,0.7873070325900514,1.0,1.0,3/19,12.78%,EP300;ESCO1;NAA80
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3155526268624585,0.7504674448832672,0.7645951035781544,1.0,1.0,3/12,15.17%,GREM1;CDH5;VEGFC
prerank,SH2 domain binding (GO:0042169),0.25755140367396245,0.7496751845593248,0.8406779661016949,1.0,1.0,6/31,14.56%,SRC;DAG1;TRPV4;NLK;PAG1;RUFY1
prerank,NADP binding (GO:0050661),0.25453274333843284,0.7495120549273473,0.8487972508591065,1.0,1.0,5/32,11.15%,SPR;ME3;HMGCR;KCNAB1;NOS3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.309190496710119,0.7467560961809245,0.7868525896414342,1.0,1.0,2/14,12.82%,NME1;DTYMK
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3285060780840529,0.7455800865793297,0.7861271676300579,1.0,1.0,2/11,8.79%,LEF1;ZXDC
prerank,MHC class I protein binding (GO:0042288),0.3058872413042555,0.7440139373946594,0.7931034482758621,1.0,1.0,4/13,20.09%,TUBB;ATP5F1B;DERL1;TAP2
prerank,thioesterase binding (GO:0031996),0.3197180191024286,0.742178820570562,0.7912087912087912,1.0,1.0,3/11,15.57%,TRAF5;TRAF3;ARF6
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3227972666918509,-0.7414699989955453,0.8015873015873016,0.9627657017151956,1.0,2/10,12.79%,CXADR;SIRPA
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.31537243067309806,0.7404184256034356,0.789272030651341,1.0,1.0,3/12,10.94%,CIAPIN1;ISCU;CISD2
prerank,BMP binding (GO:0036122),-0.31310721147315806,-0.7403796033740045,0.8,0.9608956899963195,1.0,3/11,19.91%,NBL1;GREM2;BMPR2
prerank,histone methyltransferase binding (GO:1990226),0.32597927495517354,0.7396430649798038,0.7924901185770751,1.0,1.0,3/11,15.78%,PRDM4;LCORL;WIZ
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.2787991079620369,-0.7385539442797788,0.8435374149659864,0.9598550771074102,1.0,3/16,5.65%,SLC13A3;SLC1A5;SLC25A13
prerank,RNA methyltransferase activity (GO:0008173),0.2902126754168546,0.7383522113475042,0.8336314847942755,0.9992085109816602,1.0,1/19,2.25%,BCDIN3D
prerank,methylation-dependent protein binding (GO:0140034),-0.2016756337397658,-0.7369184155173644,0.9205882352941176,0.9585540662888048,1.0,25/57,31.61%,MBTD1;KDM4A;KDM7A;MPHOSPH8;ZCWPW2;PYGO1;RBBP5;GLYR1;MTF2;SGF29;CBX5;SUZ12;BPTF;PHF2;KAT8;PHF1;L3MBTL2;ZMYND8;NCAPG2;WDR5;KDM8;MSH6;ING1;PHF13;LRWD1
prerank,Hsp70 protein binding (GO:0030544),-0.23159829382338099,-0.7368307208667856,0.8891752577319587,0.9554824536602803,1.0,11/31,29.08%,PACRG;PPID;SACS;GPR37;DNAJC2;STUB1;DNAJB2;METTL21A;DNAJA1;PPEF2;SNCA
prerank,MHC class II protein complex binding (GO:0023026),-0.31306826619199696,-0.7364100827584893,0.8088235294117647,0.9527673140130006,1.0,3/11,10.65%,ATP1B1;ANXA11;PKM
prerank,cytochrome-c oxidase activity (GO:0004129),0.29047027521688423,0.7352377308095285,0.8194945848375451,0.9998486359503139,1.0,4/15,14.40%,COX6B1;COX5A;COX15;COX10
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.2756712275715288,0.7348319569422742,0.8258426966292135,0.9971179305062626,1.0,3/22,8.81%,ILF3;ZFP36L1;EXOSC9
prerank,NAD+ binding (GO:0070403),-0.29543467202745716,-0.7333050090036681,0.79957805907173,0.95340666917608,1.0,3/12,7.04%,ZC3HAV1;SIRT2;GLUD1
prerank,E-box binding (GO:0070888),0.24563670122039283,0.733149153187621,0.8669001751313485,0.9961644939904848,1.0,5/34,16.10%,TAL1;CLOCK;TFAP4;HES1;TCF3
prerank,methylated histone binding (GO:0035064),0.22114517444430323,0.7331469713918172,0.9026946107784432,0.9929406606765997,1.0,18/62,19.14%,TTLL12;ING4;SPIN1;CDYL;ING3;ING2;CHD1;MORC4;TDRD3;RRP8;ING5;PHF8;TAF1;CHD8;MORC3;ATRX;MSL3;ZMYND11
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.32958193737803193,0.7330503586286108,0.7904761904761904,0.9898372785394256,1.0,3/10,17.41%,DCLRE1B;EXD2;DCLRE1C
prerank,receptor antagonist activity (GO:0048019),-0.26764404163278666,-0.7327543701974342,0.8633257403189066,0.9509221158642768,1.0,1/17,7.08%,DKK3
prerank,snoRNA binding (GO:0030515),-0.23073466129154682,-0.7320978012675629,0.9105882352941177,0.9486589848366566,1.0,20/30,42.78%,NUDT4;BMS1;UTP6;DDX21;NOP56;NUFIP1;NOP14;WDR3;NUDT7;BYSL;IMP3;GAR1;IMP4;TSR1;DHX37;NOP10;NUDT1;TBL3;NUDT16;NUDT16L1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3071074514363538,0.7319181188869202,0.8223062381852552,0.9880536817493805,1.0,5/12,21.52%,TENT4A;PAPOLA;PAPOLG;TENT2;MTPAP
prerank,phosphatidic acid binding (GO:0070300),-0.2638491752754264,-0.731637910789594,0.8514412416851441,0.9459906446279022,1.0,13/19,41.04%,GRAMD1B;SMPD3;PITPNC1;COMMD1;RAPGEF2;GSDMD;PLEKHN1;MICALL1;JPH2;MAPKAP1;OPA1;ATP13A2;PITPNM1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.24126589246865107,0.7294313596800511,0.8415841584158416,0.9880071813557089,1.0,8/34,16.45%,UFC1;UBE2I;AKTIP;UBE2R2;UBE2F;UBE2G1;TAF1;UBE2H
prerank,protein kinase inhibitor activity (GO:0004860),0.23620564732606925,0.7290042116252975,0.8725165562913907,0.9853892131676393,1.0,5/42,6.38%,RPTOR;SPRED1;CIB1;CDKN1A;YWHAB
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.2669351844320047,-0.726182021559052,0.8355855855855856,0.949302462119494,1.0,9/17,35.86%,ABCA1;PITPNC1;ATP8B2;ATP8B1;MTTP;ABCA7;ABCB4;ATP10B;PCTP
prerank,carbohydrate kinase activity (GO:0019200),-0.30243155112781267,-0.7244837157986503,0.8248945147679325,0.9480203941824135,1.0,7/11,48.50%,NAGK;HK2;GALK1;POMK;HK1;XYLB;KHK
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.2882275996134577,0.7209206199109702,0.8584558823529411,0.9921146090599648,1.0,4/16,12.22%,TDG;SMUG1;RPS3;ADPRH
prerank,proton transmembrane transporter activity (GO:0015078),-0.21083445389550926,-0.7178234003414935,0.9260204081632653,0.9523688122839571,1.0,17/39,33.94%,CYB5A;UQCRH;COX8A;CTNS;UQCRC1;NDUFA4;COX7A2L;COX6A1;SLC11A2;DMAC2L;UQCR10;UQCRQ;UQCR11;SLC9A1;NNT;COX5B;CLCN4
prerank,receptor ligand activity (GO:0048018),0.1816612614452118,0.7156436019398578,0.990159901599016,0.9955273543439853,1.0,15/245,9.12%,GDF1;JAG2;SEMA6A;SEMA6D;SEMA7A;GREM1;CRLF1;GNRH1;SEMA3C;SEMA6B;BDNF;CCL25;WNT5A;NPPC;SEMA4C
prerank,acyl-CoA hydrolase activity (GO:0047617),0.28631241928728357,0.7121278961018007,0.8438061041292639,0.9964493586391455,1.0,4/17,18.29%,PPT1;ACOT8;ACAA2;ACOT13
prerank,nuclear import signal receptor activity (GO:0061608),-0.2679077892585353,-0.708228788595876,0.854122621564482,0.9598388958080649,1.0,3/15,12.91%,IPO9;TNPO3;TNPO2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.303538954546754,0.7075459045220681,0.830739299610895,0.9982982981375924,1.0,1/12,1.88%,SLC25A24
prerank,DNA secondary structure binding (GO:0000217),-0.21952037931292642,-0.706895224277109,0.933806146572104,0.9580497317944683,1.0,16/31,36.89%,KMT2A;MAPT;ERCC5;LIN54;RAD51D;MSH2;XPC;BLM;MSH6;HMGA2;CLSPN;RAD51C;HMGB1;MEN1;HMGB2;XRCC2
prerank,endoribonuclease activity (GO:0004521),-0.21594566825846756,-0.700899782759719,0.9240196078431373,0.9607662314903309,1.0,13/32,31.68%,AGO3;SND1;DICER1;INTS11;ZC3H12B;RCL1;NOB1;CPSF3;LACTB2;RIDA;ZC3H12A;EXOG;RNASEL
prerank,"DNA binding, bending (GO:0008301)",-0.2703318340411028,-0.6973112269887723,0.8843683083511777,0.9611557130249555,1.0,9/14,35.82%,FOXD1;FOXC1;SAP30L;FOXL1;HMGA2;TERF1;HMGB1;HHEX;HMGB2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.29644144167272174,-0.6967478063320458,0.8654618473895582,0.9586172254571598,1.0,2/10,16.07%,CDADC1;LACC1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.30022997587327815,0.6911491182843231,0.8441814595660749,1.0,1.0,4/11,20.86%,SGMS1;PIGN;SAMD8;SGMS2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.1996535560628043,0.6888407529469587,0.9655172413793104,1.0,1.0,9/85,15.11%,NDST3;CA2;PLAAT3;PNPLA7;PGLS;ABHD12;ABHD4;PNPLA6;DAGLB
prerank,hormone activity (GO:0005179),0.2117511862771541,0.6881315424592716,0.9413629160063391,1.0,1.0,4/54,10.60%,GNRH1;CCL25;NPPC;PPY
prerank,endopeptidase activator activity (GO:0061133),0.3031737597345535,0.6866210803982725,0.8291746641074856,1.0,1.0,3/10,15.68%,VSIR;PSMD14;APH1A
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2614273908978053,0.686232026727287,0.8904109589041096,1.0,1.0,5/20,14.32%,YOD1;DESI2;USP47;OTUD5;USP9X
prerank,actin monomer binding (GO:0003785),0.25235416636462044,0.685998098093478,0.8886986301369864,1.0,1.0,4/22,14.33%,MRTFA;PFN1;NOS3;TWF1
prerank,lipid phosphatase activity (GO:0042577),0.283754772710925,0.6847000022247755,0.8493408662900188,1.0,1.0,4/14,13.88%,PLPP6;PLPP1;SGPP2;SGPP1
prerank,phosphatase activator activity (GO:0019211),0.27975613538033967,0.6822675890343264,0.8854961832061069,0.9997285639690437,1.0,6/14,21.17%,CALM3;PPP2R5A;FRS2;CALM1;PPP2R5C;PHACTR4
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.2546576418270574,-0.6787180314789009,0.8908296943231441,0.9720006039910495,1.0,4/15,29.76%,P2RX4;P2RY14;P2RY12;P2RY1
prerank,fatty acid synthase activity (GO:0004312),0.3027641102727676,0.677945531863827,0.8498098859315589,1.0,1.0,1/10,5.49%,ELOVL6
prerank,low-density lipoprotein particle binding (GO:0030169),-0.254673011193664,-0.6768275920888642,0.8875,0.9705817697801093,1.0,3/16,9.33%,SORL1;LDLR;THBS1
prerank,cAMP binding (GO:0030552),0.29705534106787673,0.6752100216948338,0.8542056074766355,1.0,1.0,1/11,1.75%,PDE4D
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2654498294135127,-0.6701668594107656,0.9068825910931174,0.9730700404808134,1.0,3/13,20.10%,SLC7A2;SLC38A7;SLC15A4
prerank,5'-3' exonuclease activity (GO:0008409),0.2813729795319933,0.6688884297536457,0.8664259927797834,1.0,1.0,3/14,9.40%,DCLRE1B;XRN2;DXO
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.2727573214811896,0.6666571999783568,0.8804554079696395,1.0,1.0,4/15,13.87%,LPCAT2;GPAT4;AGPAT3;ABHD4
prerank,mRNA methyltransferase activity (GO:0008174),0.2812275644426705,0.6547693759053381,0.8715596330275229,1.0,1.0,4/12,20.12%,TRMT61B;RNMT;NSUN2;METTL14
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.2761599631297977,-0.6497772465186562,0.9012096774193549,0.9857535797527988,1.0,2/10,5.28%,KDM4A;KDM7A
prerank,phospholipase A2 activity (GO:0004623),-0.21431393039234248,-0.6489249360561541,0.950561797752809,0.9831958967219562,1.0,10/26,39.03%,PLA2G4A;ABHD3;PLA2G6;PLA2G7;PLA2G12A;PLA2G15;PRDX6;PLA2G4E;PNPLA3;PLA2G4C
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.2760200878844948,0.6479509700323836,0.8766603415559773,1.0,1.0,11/11,72.42%,KCND3;KCNE1;KCNE3;KCNE2;KCNJ5;KCNE5;KCNH2;KCNE4;KCNJ8;KCNJ3;KCNQ1
prerank,lysophospholipase activity (GO:0004622),0.24606185050912133,0.6440330801818422,0.907942238267148,1.0,1.0,6/20,20.29%,PNPLA7;ABHD12;ABHD4;PNPLA6;LYPLA1;ENPP2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.19718168989602314,0.64321269940159,0.9745889387144993,1.0,1.0,10/60,16.13%,CTDSP1;PPP3CB;PPP2CA;PPP2CB;PHLPP1;PPP3CA;PPP3R1;PPP5C;CAMK2G;PPM1L
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.25666641249132927,0.6402218843773408,0.903041825095057,1.0,1.0,2/14,12.09%,ISCU;ACO1
prerank,P-type ion transporter activity (GO:0015662),-0.26341029609348254,-0.6367776070943167,0.928416485900217,0.9884614451155116,1.0,2/12,5.67%,ATP6V1E1;ATP7A
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.20724266351457893,0.6325321508949984,0.9613003095975232,1.0,1.0,7/40,13.06%,THUMPD2;CARNMT1;ICMT;SETD3;METTL2A;METTL2B;RRP8
prerank,transaminase activity (GO:0008483),-0.2566625050785074,-0.6276934518603652,0.9297872340425531,0.9909429917821031,1.0,4/11,24.62%,ABAT;BCAT1;GOT1;OAT
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2119432791637727,-0.6238070936333397,0.9271523178807947,0.99011021152792,1.0,2/21,10.73%,FGF1;KL
prerank,enoyl-CoA hydratase activity (GO:0004300),0.27529133173926496,0.6216030274500149,0.9137254901960784,1.0,1.0,5/10,22.43%,HSD17B4;ECHDC1;ECHS1;HADHA;AUH
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.2583548549792299,-0.6212417373529284,0.9218436873747495,0.988552678329575,1.0,6/12,38.57%,GAB2;PIK3R1;SH2B1;BLNK;SH2B2;TRADD
prerank,RNA polymerase binding (GO:0070063),0.23997736088614247,0.6083301769636665,0.9432624113475178,1.0,1.0,7/18,21.38%,PPIB;STOM;SCAF8;TCERG1;YTHDC2;PKN2;DHX9
prerank,single-stranded DNA helicase activity (GO:0017116),-0.2170748231526094,-0.6058935388954376,0.9635535307517085,0.9931137549631953,1.0,14/19,54.27%,WRNIP1;MCM6;RFC2;HELQ;POLQ;DNA2;RFC3;RAD51;RFC4;MCM7;MCM5;DSCC1;CHTF18;PIF1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.1838264832612465,-0.6006294873379897,0.987146529562982,0.9926265683932841,1.0,21/35,44.14%,DUS2;ELAC1;TARS2;NT5C3A;MTFMT;QTRT2;DUS4L;QRSL1;PTRH2;QTRT1;TRMT5;LCMT2;DTWD1;DUS3L;ELAC2;DUS1L;MRPL58;GATC;TYW3;TRMT12;TRPT1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.24605257553759083,0.5936574271721639,0.956766917293233,1.0,1.0,1/12,3.76%,NUDT5
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.2659328894596242,0.5932551875895413,0.9281553398058252,1.0,1.0,1/10,5.65%,CDKN1A
prerank,sequence-specific mRNA binding (GO:1990825),0.26495511895047397,0.5911832614063409,0.928436911487759,1.0,1.0,10/10,73.52%,SSB;DHX9;FMR1;LIN28A;LARP6;ETF1;RBM24;TYMS;DHFR;SHFL
prerank,endopeptidase regulator activity (GO:0061135),-0.17248480499092766,-0.5888767977544221,0.9924242424242424,0.9949627927628046,1.0,13/40,36.53%,TFPI;PSMF1;ITIH2;RENBP;CAST;SERPIND1;APH1B;PSME2;PSME3;ABCA2;PSME1;PSENEN;SPINT2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.24492143081033374,-0.5866994047877204,0.9330628803245437,0.9927894977104101,1.0,2/11,11.82%,PPP1R1A;PPP1R14C
prerank,CARD domain binding (GO:0050700),0.230487947147802,0.5700174117984524,0.939047619047619,1.0,1.0,2/14,11.38%,CARD16;NOD1
prerank,titin binding (GO:0031432),-0.23025717249866667,-0.5665456663329216,0.9523809523809523,0.9970550024232706,1.0,2/13,10.68%,ACTN2;CAMK2D
prerank,histone acetyltransferase activity (GO:0004402),0.19612932983661105,0.5659604286710496,0.9726027397260274,1.0,1.0,8/30,18.84%,EP300;CLOCK;CREBBP;USP22;TAF1;TADA2A;NAA50;HAT1
prerank,FMN binding (GO:0010181),-0.2419154936813035,-0.5657580497976695,0.9652509652509652,0.99423658670536,1.0,5/11,36.00%,DUS2;MTRR;POR;NOS1;NDOR1
prerank,receptor tyrosine kinase binding (GO:0030971),0.17117776267093018,0.563523447004572,0.9887459807073955,1.0,1.0,2/56,2.11%,CBL;MAP3K7
prerank,antiporter activity (GO:0015297),0.2140838705332742,0.552253328414629,0.9756521739130435,1.0,1.0,2/20,8.41%,CLCN3;SLC35A1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.21629888653464904,0.5513381747317031,0.9673704414587332,1.0,1.0,2/17,12.82%,NME1;DTYMK
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.18414651586675387,0.5479164805896817,0.9982638888888888,1.0,1.0,13/38,21.11%,DENND1A;TECPR1;LANCL2;PARD3;PLEKHA5;ZFYVE1;SNX27;KIF16B;ZFYVE19;ZFYVE26;WDR45B;ATG2B;SNX12
prerank,death domain binding (GO:0070513),0.23257110697292882,0.5447104652935961,0.9695817490494296,1.0,1.0,3/11,17.79%,CRADD;DAPL1;BAX
prerank,four-way junction DNA binding (GO:0000400),0.21269768164562186,0.5390533863230326,0.9738805970149254,1.0,1.0,2/17,10.81%,YY1;RAD51B
prerank,glucose transmembrane transporter activity (GO:0005355),0.21006028636021115,0.537960517286813,0.962756052141527,1.0,1.0,17/17,79.02%,SLC2A1;SLC2A7;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC2A5;PPBP;SLC2A2;SLC2A4;SLC2A8;SLC5A11;SLC5A3;SLC2A10;SLC2A3;MFSD4A
prerank,hyaluronic acid binding (GO:0005540),-0.2229070617178395,-0.5267790054728256,0.9788583509513742,1.0,1.0,1/10,4.65%,CEMIP
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.22462175905581028,0.5200963950170255,0.9685658153241651,1.0,1.0,12/12,77.55%,NQO2;CRYZL1;ADH4;AKR1C1;DCXR;NQO1;CBR1;CRYZ;NDUFS7;CBR4;AIFM2;DHRS4
prerank,ribonuclease P activity (GO:0004526),-0.21169005427354926,-0.5159158465637197,0.9767441860465116,1.0,1.0,6/11,41.08%,PRORP;RPP30;RPP14;RPP21;POP4;RPP38
prerank,5'-nucleotidase activity (GO:0008253),0.21354724609944942,0.5132396289401734,0.9775700934579439,1.0,1.0,3/13,18.68%,NT5C3B;NT5C2;NT5DC1
prerank,lipase activity (GO:0016298),0.16534588265327715,0.5087142745671028,1.0,1.0,1.0,5/43,15.11%,SEC23IP;DDHD1;PNPLA8;ABHD12;DAGLB
prerank,hexose transmembrane transporter activity (GO:0015149),0.20999434992780466,0.5022149450327845,0.9755639097744361,1.0,1.0,12/12,79.02%,SLC2A1;SLC2A7;SLC5A1;SLC2A6;SLC2A5;PPBP;SLC2A2;SLC2A4;SLC2A8;SLC5A3;SLC2A3;MFSD4A
prerank,neuropeptide receptor binding (GO:0071855),0.1978401456645945,0.47131527122154315,0.9871323529411765,1.0,1.0,14/14,80.23%,PPY;AGRP;APELA;UCN3;QRFP;GHRH;NPPA;UCN2;GAL;APLN;NPY;NTS;NMU;SHANK1
prerank,ribonuclease P RNA binding (GO:0033204),0.20877534366957506,0.46510027120408887,0.9922480620155039,1.0,1.0,10/10,79.14%,POP5;POP1;RPP25;RPP40;POP7;RPP38;POP4;RPP21;RPP14;RPP30
prerank,peptidoglycan binding (GO:0042834),0.19609566254472405,0.44814326891314493,0.984,1.0,1.0,10/10,80.40%,NOD1;PGLYRP2;PGLYRP3;TLR2;NLRP3;JCHAIN;NOD2;HK1;PGLYRP1;RNASE7
prerank,growth factor activity (GO:0008083),0.12576336142019812,0.42840511061735076,1.0,1.0,1.0,1/74,0.86%,JAG2
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.16422713340962222,-0.42474574066084714,0.9977876106194691,1.0,1.0,7/14,41.08%,PRORP;RPP30;RPP14;RPP21;ELAC2;POP4;RPP38
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.177133587874851,-0.41100181211420794,1.0,1.0,1.0,1/10,11.53%,NOX4
prerank,nucleotidase activity (GO:0008252),0.16006884047488282,0.39877831641989997,0.9981916817359855,1.0,1.0,2/15,12.02%,NT5C3B;NT5C2
prerank,CoA hydrolase activity (GO:0016289),-0.14598620029728634,-0.3899976620135189,0.9977324263038548,1.0,1.0,3/16,24.06%,ACOT11;ACOT7;NUDT7
prerank,pseudouridine synthase activity (GO:0009982),-0.15190095353952188,-0.38266298335720667,1.0,0.9995673021110731,1.0,10/13,51.67%,PUS7;TRUB1;PUS3;RPUSD4;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,acylglycerol lipase activity (GO:0047372),0.1632140615191463,0.372301386943922,0.9980732177263969,0.9995869566820821,1.0,11/11,83.69%,ABHD12;ABHD16A;PNLIPRP2;ABHD12B;ABHD6;ABHD2;ABHD15;MGLL;FAAH;LIPE;ABHD3
